Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGRP,Agouti-related protein,42296,0.302438875429177,0.00497606499852526,0.292685788032067,0.312191962826286,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL27,C-C motif chemokine 27,42145,0.272695633940566,0.00636291352556381,0.260224323430461,0.285166944450671,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN1,CCN family member 1,42047,0.382415538023796,0.00705366020092565,0.368590364029982,0.39624071201761,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CES1,Liver carboxylesterase 1,42163,0.357941768032612,0.00870119425647125,0.340887427289928,0.374996108775296,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCG,Pro-glucagon,41843,0.524972628086015,0.0127229974110722,0.500035553160314,0.549909703011717,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GHR,Growth hormone receptor,39736,0.116491480275777,0.00287020843529483,0.110865871742599,0.122117088808955,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF9,Protein turtle homolog A,39958,0.357880430377726,0.00873600814573285,0.34075785441209,0.375003006343362,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LDLR,Low-density lipoprotein receptor,42170,0.428052081452102,0.00415325317835133,0.419911705222534,0.436192457681671,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPL,Lipoprotein lipase,42145,-0.204944852194672,0.0049138898489293,-0.214576076298574,-0.195313628090771,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFGE8,Lactadherin,42137,0.272294939253965,0.00433535092690952,0.263797651437222,0.280792227070708,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPY,Pro-neuropeptide Y,42262,0.375109990378909,0.00610581868865504,0.363142585749146,0.387077395008673,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.134229350106043,0.00330016968301058,0.127761017527342,0.140697682684744,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0872127407900203,0.00220976230857444,0.0828816066652144,0.0915438749148262,1.11253692926379e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTH,Parathyroid hormone,39649,0.330549630604438,0.00849871371439219,0.313892151724229,0.347207109484647,1.12746381048854e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.128509060748234,0.0033339694060337,0.121974480712408,0.13504364078406,1.71235405557661e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.300158197260134,0.00788239824836847,0.284708696693332,0.315607697826936,1.13158871051371e-298
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,42230,0.188644001856901,0.00499370022718414,0.17885634941162,0.198431654302182,4.33219471947426e-297
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F7,Coagulation factor VII,42194,0.120568935551128,0.0032067533890178,0.114283698908654,0.126854172193603,2.05739711841558e-294
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.164677351446209,0.0044299571082999,0.155994635513941,0.173360067378476,3.55068868784978e-288
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FURIN,Furin,42181,0.126975363325076,0.00341937996688226,0.120273378589987,0.133677348060165,1.46372772377478e-287
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRAP1,Proline-rich acidic protein 1,39966,0.146042897922949,0.00402314739102978,0.138157529036531,0.153928266809367,4.26227935829021e-273
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.301549220225932,0.0084860427574872,0.284916576421257,0.318181864030607,2.64265511861193e-264
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD4,T-cell surface glycoprotein CD4,42100,0.106410728059405,0.00302040196517663,0.100490740207659,0.112330715911151,3.39063760522293e-260
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C9,Complement component C9,39990,-0.208342689322465,0.00594816226902833,-0.22000108736976,-0.196684291275169,2.32652130943592e-255
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.304473930122354,0.00874785064228891,0.287328142863468,0.32161971738124,4.63202005417452e-254
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.525492071471805,0.0152322542276589,0.495636853185594,0.555347289758017,6.97593213714369e-250
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLTP,Phospholipid transfer protein,42267,-0.135090369457163,0.00394406739582003,-0.14282074155297,-0.127359997361356,9.55930179224014e-247
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.302456728450173,0.00890024156708845,0.28501225497868,0.319901201921666,6.1605002380154e-243
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INHBC,Inhibin beta C chain,42137,0.138419075224156,0.00415247839945206,0.13028021756123,0.146557932887082,3.17930029366553e-234
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCHE,Cholinesterase,39806,0.0927785268254266,0.00279193787907326,0.087306328582443,0.0982507250684102,4.99886126113065e-231
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APCS,Serum amyloid P-component,39870,0.112068257435337,0.00338185783851133,0.105439816071855,0.11869669879882,7.22767295819613e-230
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.114755018076127,0.00349555984093002,0.107903720787904,0.12160631536435,1.40569262933014e-227
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL23,C-C motif chemokine 23,42185,0.144946118287031,0.00441952033061477,0.136283858439026,0.153608378135036,4.15055365959955e-227
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.206049088068756,0.00632984467404426,-0.218455583629883,-0.19364259250763,6.05030576534523e-224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADIPOQ,Adiponectin,39979,-0.233953914107028,0.00716089504973048,-0.247989268404499,-0.219918559809556,7.24824296551346e-224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROC,Vitamin K-dependent protein C,42199,0.0871917167946889,0.00268490473437608,0.0819293035153117,0.092454130074066,7.01393170993507e-223
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.271536180900304,0.00836747702376996,0.255135925933715,0.287936435866894,1.69593652805635e-222
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR37,Prosaposin receptor GPR37,41900,0.22056067709176,0.00682175454240411,0.207190038188648,0.233931315994872,7.7891160333004e-221
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC39A5,Zinc transporter ZIP5,42119,0.179527585396474,0.00555811940466257,0.168633671363335,0.190421499429612,1.5014194349194e-220
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.4207248711169,0.0133044479571975,-0.446801589113007,-0.394648153120793,6.83228067611524e-212
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN3,Contactin-3,42137,0.0920811379358758,0.00297604178766166,0.0862480960320589,0.0979141798396927,3.6725739711986e-203
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA5,Plasma serine protease inhibitor,39835,0.0972943530891628,0.00314954311142484,0.0911212485907701,0.103467457587556,3.46719000178477e-201
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA4,Kallistatin,39802,0.0755174500927528,0.0024482296050673,0.0707189200668209,0.0803159801186848,1.34959336888055e-200
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.344367163374225,0.0112119970881792,0.322391649081393,0.366342677667056,2.72718051151526e-200
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRP1,Neuropilin-1,42230,-0.0880425330134217,0.00286910679708454,-0.0936659823357074,-0.082419083691136,5.07403983819027e-200
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSG2,Desmoglein-2,42137,-0.087007444649138,0.00284323252865991,-0.0925801804053114,-0.0814347088929646,6.40126160959404e-199
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLAT,Tissue-type plasminogen activator,42272,0.164599111710345,0.00538023577215756,0.154053849596916,0.175144373823774,7.0139975771362e-199
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRIP2,Cysteine-rich protein 2,42016,0.116653975920879,0.00382501773571231,0.109156941158883,0.124151010682875,1.43013368861231e-197
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AFM,Afamin,39979,0.0646324489004739,0.0021134496282061,0.06049008762919,0.0687748101717579,1.84394420996313e-197
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.219760563503707,0.00721476286188905,0.205619628294404,0.233901498713009,3.96308091373014e-197
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,39736,-0.0975333335015146,0.00321880019739611,-0.103842181888411,-0.0912244851146182,7.16276847993574e-194
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.188277736963071,0.00631179110108451,0.175906626404946,0.200648847521197,2.73834932690404e-189
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TTR,Transthyretin,39862,0.0775430102828701,0.00260072723259892,0.0724455849069762,0.082640435658764,4.3924809663591e-188
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUSB,Beta-glucuronidase,42211,0.190739554166919,0.00642750344690394,0.178141647410987,0.203337460922851,1.40124172982521e-187
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNCA,Alpha-synuclein,39736,0.367209939815231,0.012340581764604,0.343022399556607,0.391397480073855,2.72688414994632e-187
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTA3,Glutathione S-transferase A3,41843,0.240257493500643,0.00812861653885506,0.224325405084487,0.256189581916799,5.44838985794097e-186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL6,C-X-C motif chemokine 6,42296,0.234845580637932,0.00795257945379713,0.21925852490849,0.250432636367375,7.28754415051124e-186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.0755653024714304,0.00257194877406402,0.070524282874265,0.0806063220685959,5.21869600495671e-184
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.0599050518737468,0.00204142027760761,0.0559038681296359,0.0639062356178578,1.5358596435884e-183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0637138530687012,0.00217050759793807,0.0594596581767426,0.0679680479606598,1.65374762561983e-183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPM,Carboxypeptidase M,42195,0.105044169001168,0.00358050522178072,0.0980263787664775,0.112061959235858,1.67940262467286e-183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACY1,Aminoacylase-1,42145,0.191695352807082,0.00662144813115709,0.178717314470014,0.204673391144149,7.27189420592704e-179
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHMP6,Charged multivesicular body protein 6,39958,0.174506088508948,0.00601194197645988,0.162722682235087,0.18628949478281,9.25510374594237e-179
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PON3,Serum paraoxonase/lactonase 3,42185,-0.0885742248890966,0.00309702498111811,-0.0946443938520881,-0.0825040559261051,9.64772775398957e-175
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS15,Enteropeptidase,42070,0.264742291561275,0.00927230516681345,0.24656857343432,0.282916009688229,3.86523129300321e-174
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GH1,Somatotropin,42129,-0.525895771727849,0.0187498620422358,-0.562645501330631,-0.489146042125067,2.63337642264701e-168
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTA1,Glutathione S-transferase A1,42119,0.250643557482237,0.00893631335075105,0.233128383314765,0.268158731649709,2.66988614274971e-168
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELN,Elastin,39958,0.102223547256313,0.00365297112092295,0.0950637238593041,0.109383370653322,1.07080568346968e-166
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFH,Complement factor H,39418,0.0686745511488154,0.00246548122571337,0.0638422079464172,0.0735068943512136,5.77049316352027e-165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,42016,0.0887291317654134,0.00320712580236945,0.0824431651927692,0.0950150983380575,6.77271183453787e-164
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAMR1,Inactive serine protease PAMR1,42137,0.0764380060948083,0.00279667821454717,0.0709565167942958,0.0819194953953207,3.80295271839432e-160
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,41843,0.322017124715769,0.0118178617132321,0.298854115757834,0.345180133673704,4.06951489789288e-159
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCS1,Neuronal calcium sensor 1,42262,0.0813338225038856,0.00299198269103407,0.0754695364294588,0.0871981085783123,1.59742730377925e-158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.149653858497686,0.00551107155153701,0.138852158256673,0.160455558738698,3.38865702743726e-158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",41839,0.144991444536196,0.00535633956224205,0.134493018994202,0.155489870078191,4.12817276769275e-157
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.093727575010822,0.00346955132060125,0.0869272544224435,0.1005278955992,1.43417188153726e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL13,C-X-C motif chemokine 13,42249,0.164164803517944,0.00608209249421583,0.152243902229281,0.176085704806607,2.28227303653954e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CKB,Creatine kinase B-type,39966,-0.163592280270566,0.00605197152243713,-0.175454144454543,-0.151730416086589,5.10179967601803e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFPI,Tissue factor pathway inhibitor,42152,0.0889263703183142,0.00329895001996102,0.0824604282791906,0.0953923123574378,6.05735171413088e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UPB1,Beta-ureidopropionase,39958,0.257467795442308,0.0095533774700041,0.238743175601099,0.276192415283516,4.00126456254381e-155
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KYNU,Kynureninase,42296,0.129178906070839,0.00481316641971252,0.119745099888203,0.138612712253476,1.10671022753883e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFP,Properdin,39979,0.067087129772793,0.00249626860971284,0.0621944432977558,0.0719798162478302,2.65582263734649e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.351492472200078,0.0131125969604103,0.325791782157674,0.377193162242482,2.8604731258545e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.206671598608084,0.00774218976594666,0.191496906666829,0.22184629054934,5.25540891711321e-153
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF21,Fibroblast growth factor 21,42247,0.339277004733901,0.0127141665426418,0.314357238310323,0.364196771157479,5.72104967308634e-153
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORT1,Sortilin,42129,0.1074602837404,0.00403504740354408,0.0995515908294533,0.115368976651346,2.38111368792075e-152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL16,C-C motif chemokine 16,42310,0.144525019206331,0.00543400903310477,0.133874361501446,0.155175676911217,5.19723010794948e-152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP5,Retinol-binding protein 5,42070,0.157725832283843,0.00596113083861381,0.14604201584016,0.169409648727526,1.9400782870912e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.202595080202003,0.00765867301104182,0.187584081100361,0.217606079303645,2.36487376500216e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENO3,Beta-enolase,39638,0.175064677153152,0.00663743100048455,0.162055312392203,0.188074041914102,1.00452939615847e-148
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0927206709156397,0.00355088636596771,-0.0996804081929364,-0.085760933638343,1.00069373972601e-146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFI,Complement factor I,39979,0.0536482959128301,0.00205058878771296,0.0496291418889127,0.0576674499367475,1.45920520745937e-146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAT2,Linker for activation of T-cells family member 2,42070,0.346832048408594,0.0133772226902516,0.320612691935701,0.373051404881487,1.13363878397721e-144
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHBG,Sex hormone-binding globulin,39990,-0.128533925618882,0.00494648265221887,-0.138229031617231,-0.118838819620533,1.14638953210652e-144
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRP,Gastrin-releasing peptide,39638,0.145884987403133,0.00564435136286162,0.134822058731924,0.156947916074341,4.59027634311834e-143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.105360754203401,0.00409689731089356,-0.113390672932752,-0.0973308354740496,1.83814513121401e-142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEG1,Protein HEG homolog 1,39736,0.0749518252231114,0.00291311224580991,0.0692421252213239,0.0806615252248988,7.32950540580002e-142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUMB,Protein numb homolog,39657,0.227722392466909,0.00886697217211383,0.210343127009566,0.245101657924252,2.45249510520378e-141
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDHR2,Cadherin-related family member 2,42070,0.178623431594669,0.00698453615021152,0.164933740740254,0.192313122449083,6.63556364632735e-141
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.192206690069238,0.00751329580984058,0.177480630281951,0.206932749856526,2.23992980204716e-140
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0530175373006687,0.00208479977476616,0.048931329742127,0.0571037448592103,1.97045894255532e-139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINF1,Pigment epithelium-derived factor,39815,0.0707966187806772,0.00277878199229369,0.0653502060757815,0.0762430314855728,3.04627779193229e-139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.233028488861437,0.0091556063500618,0.215083500415315,0.250973477307558,5.24527118164806e-139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.183974491849224,0.00725349018304975,0.169757651090446,0.198191332608001,1.26189542089775e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0698926367033473,0.00275934822857175,0.0644843141753467,0.075300959231348,2.583432959382e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0590738446625163,0.00233230052954253,0.0545025356246129,0.0636451537004196,1.16644999389866e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0851602963194596,0.00337217626726534,0.0785508308356195,0.0917697618032996,1.45424147270453e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.110939978242715,0.00439418439883137,0.102327376821006,0.119552579664425,1.87125688461002e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPPC,C-type natriuretic peptide,42119,0.141124334016095,0.00559206843640113,0.130163879880749,0.152084788151442,2.34887298105801e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTYMK,Thymidylate kinase,39958,0.179610468289964,0.00711780567226991,0.165659569172315,0.193561367407613,9.52229630760405e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F9,Coagulation factor IX,42199,0.0488405487816029,0.0019464113282448,0.0450255825782431,0.0526555149849627,7.2087912678808e-136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTSS1,Protein MTSS 1,39930,0.296676350690651,0.0118003555014255,0.273547653907857,0.319805047473445,8.89264634630769e-136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.175551905264609,0.00698609446791392,0.161859160107497,0.18924465042172,1.17529150284017e-135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATRN,"Attractin, Isoform 2",39979,0.0442845308115432,0.00176323145641033,0.040828597156979,0.0477404644661075,1.58617845602757e-135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,39657,0.230484626423625,0.00918067504777677,0.212490503329983,0.248478749517268,2.55994557441519e-135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,42140,0.104846793338138,0.00420359434853522,0.096607748415009,0.113085838261267,2.72677980554968e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROS1,Vitamin K-dependent protein S,39979,0.067117539392832,0.00268819696196625,0.0618486733473781,0.0723864054382858,5.35637596239291e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.172275219921051,0.00693697534604459,0.158678748242804,0.185871691599299,4.13658902150892e-133
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOMO1,Nodal modulator 1,42137,0.0612941615384251,0.00247332918390433,0.0564464363379726,0.0661418867388776,1.23724354580004e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,42181,0.0658502851719183,0.00266574812093792,0.0606254188548799,0.0710751514889566,8.01315755217917e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,42145,0.081157176953903,0.00329493420269646,0.0746991059166179,0.0876152479911881,4.41789774836352e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EEF1D,Elongation factor 1-delta,39958,0.236475836772258,0.00966534512253434,0.217531760332091,0.255419913212425,7.05264734322791e-129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,39736,0.197342824820339,0.00808221878287434,0.181501676005905,0.213183973634773,2.57808478874097e-128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYH9,Myosin-9,39966,0.29317104583052,0.0120422390639463,0.269568257265185,0.316773834395855,1.16989688974532e-127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPIND1,Heparin cofactor 2,39959,0.0751843331369684,0.00309247832633169,0.0691230756173583,0.0812455906565785,2.53706647036454e-127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGR3,Anterior gradient protein 3,41827,0.152894193155933,0.0063007503725804,0.140544722425676,0.165243663886191,2.66097350834989e-127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300LG,CMRF35-like molecule 9,42137,-0.0961542555029581,0.00397019104983991,-0.103935829960644,-0.0883726810452719,6.8886740099801e-127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,42181,0.057929242521788,0.002392420417696,0.0532400985031039,0.0626183865404722,7.6584571078524e-127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OXT,Oxytocin-neurophysin 1,42249,0.372824235568153,0.0154135494745493,0.342613678598036,0.40303479253827,1.34675955586783e-126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAP29,Synaptosomal-associated protein 29,42181,0.234663841963982,0.00973628821540424,0.21558071706179,0.253746966866175,1.0219195852121e-125
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YES1,Tyrosine-protein kinase Yes,42070,0.29239944819181,0.0121401359931142,0.268604781645306,0.316194114738314,1.57621285568293e-125
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.125440588045128,0.00521878520722061,0.115211769038975,0.13566940705128,5.11900706393734e-125
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.142324872249618,0.00592931649244627,0.130703411924423,0.153946332574812,1.12237772269865e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,P4HB,Protein disulfide-isomerase,42073,0.0984820471815302,0.00410709187069588,0.0904321471149663,0.106531947248094,1.85311048757279e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.0820446616541493,0.00342686338805029,0.0753280094135707,0.0887613138947278,4.07741222679084e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOST,Sclerostin,42129,0.0985928871605361,0.00411865611585045,0.0905203211734693,0.106665453147603,4.58703477683277e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.356233024952799,0.0148825469608995,0.327063232909436,0.385402816996163,1.454443827883e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.145886274209168,0.00610015789226464,0.133929964740329,0.157842583678007,2.81785957745783e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.173324585482921,0.00726218059411059,0.159090711518464,0.187558459447377,8.82376674010201e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPY30,Protein dpy-30 homolog,42216,0.151330833652786,0.00639711145257506,0.138792495205739,0.163869172099833,2.80902555587952e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEP,Leptin,42145,0.174995732507028,0.00740144775835615,0.16048889490065,0.189502570113407,3.85683549656048e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FYB1,FYN-binding protein 1,42115,0.23267293289023,0.00985404637624995,0.21335900199278,0.25198686378768,7.99399877288172e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.074687029984625,0.00315911186178418,0.068495170735528,0.0808788892337219,1.14511434853807e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPY,Pancreatic prohormone,42089,0.257041243461957,0.0109548753507159,0.235569687774553,0.27851279914936,2.32225621176814e-119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORD,Sorbitol dehydrogenase,42204,0.17164893990679,0.007319144121739,0.157303417428181,0.185994462385398,2.88375165918888e-119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SARG,Specifically androgen-regulated gene protein,39915,0.274003832090796,0.0116818237715746,0.25110745749851,0.296900206683083,7.73052054791684e-119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YTHDF3,YTH domain-containing family protein 3,41913,0.213490869693168,0.00912569735400101,0.195604502879326,0.23137723650701,1.18503198919873e-118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MME,Neprilysin,42070,0.193922172050804,0.00829087474459475,0.177672057551399,0.21017228655021,1.23598669759338e-118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLA,Alpha-galactosidase A,39713,0.0970851104092288,0.00415887767542298,0.0889337101653997,0.105236510653058,1.0467037571149e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL16,Pro-interleukin-16,42296,0.104943470783297,0.00450756921136149,0.0961086351290281,0.113778306437565,1.29087254181916e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MLN,Promotilin,42119,0.221452787551557,0.00952573919465699,0.202782338730029,0.240123236373085,2.94230438789775e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HJV,Hemojuvelin,39934,0.104063098010572,0.00447125506980361,0.0952994380737567,0.112826757947387,4.43115822952409e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.128269975214751,0.00552537243173845,0.117440245248544,0.139099705180958,6.1875336664539e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.143961560855406,0.00620201129023131,-0.156117502984259,-0.131805618726552,6.81175273214703e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KHK,Ketohexokinase,39638,0.155210250309831,0.00669657978290169,0.142084953935344,0.168335546684319,4.41529475313209e-116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,42070,0.166011126426611,0.00718801282942727,0.151922621280933,0.180099631572288,8.9794787067607e-116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.195168020959517,0.00844839860322675,0.178609159697193,0.211726882221841,2.05375172585813e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA1,Ephrin type-A receptor 1,42162,0.0792367011573214,0.0034377024120047,0.0724988044297922,0.0859745978848506,2.42673426119448e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F10,Coagulation factor X,39990,0.071085703843341,0.00307897041163693,0.0650509218365327,0.0771204858501494,2.67864700181547e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FN1,Fibronectin,39979,0.0668280728420619,0.00289594514817593,0.0611520203516371,0.0725041253324868,3.43970829323902e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLKB1,Plasma kallikrein,39759,0.0599836437081056,0.00260572438762358,0.0548764239083634,0.0650908635078479,1.34131969367987e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYAP1,Synapse-associated protein 1,39736,0.143192752501309,0.00622263848658733,0.130996381067598,0.15538912393502,1.63249344124204e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAPIN,SNARE-associated protein Snapin,39934,0.142222645521954,0.00619999409157923,0.130070657102458,0.154374633941449,7.23699786169793e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAA80,N-alpha-acetyltransferase 80,39649,0.300064806898807,0.0130967147780881,0.274395245933754,0.32573436786386,1.54147724938267e-113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCLY,Selenocysteine lyase,42224,0.117748929556208,0.00518901181789477,0.107578466393134,0.127919392719282,6.30721343780139e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MVK,Mevalonate kinase,41913,0.199612920187022,0.008825170158834,0.182315586675708,0.216910253698337,3.49579903828079e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.132044773687133,0.00584297477342345,0.120592543131223,0.143497004243043,5.6257238060146e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTN4R,Reticulon-4 receptor,42262,0.0811531149209621,0.00359685749916442,0.0741032742225999,0.0882029556193244,1.06065672493453e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F11R,Junctional adhesion molecule A,42137,0.133977046654456,0.00594517468892847,0.122324504264156,0.145629589044756,1.98243739421696e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM20A,Pseudokinase FAM20A,39958,0.0675628027582171,0.00299591055816265,0.0616908180642183,0.0734347874522159,3.32799654911912e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDHR5,Cadherin-related family member 5,42145,0.0927844126658983,0.00412702485818981,0.0846954439438463,0.10087338138795,6.29496907629578e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STC1,Stanniocalcin-1,42249,0.109773119537589,0.00488791190042203,0.100192812212762,0.119353426862416,1.02582314607347e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD2AP,CD2-associated protein,42145,0.150865012976042,0.00672558057068718,0.137682875057495,0.164047150894589,1.88807626856863e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,39575,0.144464125201917,0.00646251194597212,0.131797601787811,0.157130648616022,2.81011046584009e-108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL10,C-X-C motif chemokine 10,42185,0.1564357472088,0.00703396193988824,0.142649181806619,0.170222312610981,1.16231328889383e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAB2,Stabilin-2,39966,0.0665979952135809,0.00299077713560923,0.0607360720277868,0.072459918399375,1.48514078982335e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ISM1,Isthmin-1,42119,0.0937356017363002,0.00421839129865634,0.0854675547909338,0.102003648681667,1.79958197155986e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLUL1,Clusterin-like protein 1,42123,-0.105520529884325,0.00476595126991542,-0.11486179437336,-0.0961792653952911,1.00364649318688e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0707864341191741,0.00319796282615826,0.0645184269799039,0.0770544412584443,2.5683725789229e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TJAP1,Tight junction-associated protein 1,42181,0.195723257650324,0.0088705877184958,0.178336905722072,0.213109609578575,5.02572433902364e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.117283458376948,0.00531608772668525,0.106863926432645,0.127702990321251,1.31509921103082e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCXR,L-xylulose reductase,42181,0.127400804708193,0.00579067001366093,0.116051091481418,0.138750517934969,1.93509024847497e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTSS2,Protein MTSS 2,39919,0.235853206957477,0.0107036096116936,0.214874132118557,0.256832281796396,2.1504081148107e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CES3,Carboxylesterase 3,42070,0.166639804245533,0.00758334659921442,0.151776444911072,0.181503163579993,3.52580023819131e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.211039665568906,0.00961088047386962,0.192202339840121,0.22987699129769,5.07755588221094e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.233359197720068,0.0106212581724686,0.21254153170203,0.254176863738107,8.26210961237552e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.198468664642085,0.00903319805440882,0.180763596455444,0.216173732828726,9.40216994313099e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAMDC4,Apical endosomal glycoprotein,39919,0.132382103120707,0.00602825673948131,0.120566719911324,0.144197486330091,1.04217411945291e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.265332099262702,0.0121472348310793,0.241523518993786,0.289140679531617,1.31909138582041e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCN2,Ficolin-2,42116,0.0942723289657883,0.00432696286923683,0.0857914817420841,0.102753176189492,1.83355441300255e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.227254333620471,0.0104325516244753,0.206806532436499,0.247702134804443,2.02169064905526e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0853628247802629,0.00392954352069072,0.0776609194797091,0.0930647300808168,7.13070034004891e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,41997,0.0533324127683763,0.00246313815982387,0.0485046619751215,0.0581601635616311,3.24379910344599e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0953483064124867,0.00439691046294243,0.0867303619051196,0.103966250919854,3.32786738483638e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HGF,Hepatocyte growth factor,42296,0.0797687070973546,0.00368793300802154,0.0725403584016324,0.0869970557930768,4.77834028605353e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.24577769435587,0.0113715864850137,0.223489384845244,0.268066003866497,7.07404480626804e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXLNA,Alpha-taxilin,42016,0.202838826932889,0.00940481463238326,0.184405390253417,0.22127226361236,1.89745081497079e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0822660335757033,0.00381535899824428,-0.0897441372122621,-0.0747879299391445,2.07726506892487e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0640945045067145,0.00297538038073429,0.0582627589604753,0.0699262500529537,3.16649711767696e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BPIFB1,BPI fold-containing family B member 1,42098,-0.148782616339708,0.00691191935500349,-0.162329978275515,-0.135235254403901,4.45725514569586e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.179634002924283,0.00835706121762561,0.163254162937737,0.196013842910829,1.7545730064444e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1R2,Interleukin-1 receptor type 2,42100,0.0458502288414656,0.00213970998010576,0.0416563972804583,0.0500440604024728,3.37287383463006e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD63,CD63 antigen,41992,0.115289061998988,0.00539173950939815,0.104721252560568,0.125856871437408,8.97201891503653e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGRN,Agrin,42185,0.0819010631590912,0.00383111853431541,0.074392070831833,0.0894100554863494,9.37507920299944e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP20,Centrosomal protein 20,41843,0.17185223717514,0.0080414688245915,0.156090958278941,0.18761351607134,1.19446940867384e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.186041070551514,0.00871278451955002,0.168964012893196,0.203118128209832,1.54872517172063e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.110574015297595,0.00517454440136328,0.100431908270923,0.120716122324267,2.5406614116288e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.139617225316763,0.00655560902270558,0.12676823163226,0.152466219001266,5.4503437308268e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,39929,0.109381811515517,0.00514153862825938,0.0993043958041281,0.119459227226905,1.64248000465673e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BECN1,Beclin-1,39638,0.134959242110824,0.00634241502124023,0.122528108669193,0.147390375552455,1.67101289096432e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA3F,Semaphorin-3F,42145,0.0604617742444866,0.00284744228142069,0.0548807873729021,0.0660427611160712,1.86188053735012e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18R1,Interleukin-18 receptor 1,42296,0.0748591912675552,0.00353115247063056,0.0679381324251194,0.0817802501099911,3.60781516051447e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFC,Platelet-derived growth factor C,41843,0.0632065030211275,0.00298865011785852,0.0573487487901248,0.0690642572521302,1.15551230180227e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.225959857991417,0.0107028541959652,0.204982263767325,0.246937452215509,2.27845287218237e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.118411273875284,0.00561908061875003,0.107397875862534,0.129424671888034,5.20435234130771e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACE2,Angiotensin-converting enzyme 2,41900,0.122781057236474,0.00583431507522453,0.111345799689034,0.134216314783914,9.59260288662664e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP85,Centrosomal protein of 85 kDa,41843,0.146575822119038,0.00696697704298591,0.132920547114785,0.16023109712329,1.10053923745304e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.163781934270878,0.00779691417947461,0.148499982479108,0.179063886062648,1.94025363145892e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.164641246825972,0.00783708785934494,0.149280554621655,0.180001939030288,2.05775352617846e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A4,Protein S100-A4,42181,0.125804904466187,0.00599016649375977,0.114064178138417,0.137545630793956,2.13207276913032e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFX1,Transcriptional repressor NF-X1,39575,0.151497230038481,0.00720382936469354,0.137377724483682,0.16561673559328,2.72036339769093e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL22,C-C motif chemokine 22,41991,0.116307334510793,0.00554735612812498,0.105434516499668,0.127180152521918,4.62602955852398e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.0632730106471344,0.00301346396519021,0.0573666212753616,0.0691794000189072,4.67944627356225e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",42070,0.19026971981873,0.00907755023805865,0.172477721352135,0.208061718285325,5.09996432707132e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,42119,0.0960549355384247,0.00458424740542943,0.087069810623783,0.105040060453066,5.83210698774466e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.148733373937201,0.00710948735416654,0.134798778723035,0.162667969151367,1.22092247842983e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EZR,Ezrin,42249,0.0543514418874143,0.00259931380776355,0.0492567868241977,0.0594460969506309,1.36221408956145e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOA2,Apolipoprotein A-II,39990,-0.110030587334311,0.00526778657574428,-0.12035544902277,-0.0997057256458527,4.1732626474083e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKK1,Dickkopf-related protein 1,42249,0.131369011597691,0.00630398900029776,0.119013193157107,0.143724830038274,5.73390422335893e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AXIN1,Axin-1,42119,0.214955556637846,0.0103319770091073,0.194704881699996,0.235206231575696,1.18095369130924e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,42137,-0.0886144414728048,0.00426082210011399,-0.0969656527890282,-0.0802632301565814,1.36484764027608e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.117414936948053,0.00564577396423182,0.106349219978159,0.128480653917948,1.48705112903152e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARF6,ADP-ribosylation factor 6,39930,0.241397876976321,0.0115991426887985,0.218663557306276,0.264132196646366,1.95731411701962e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTN1,Dynactin subunit 1,42262,0.141725095484452,0.00683441128765415,0.12832964936065,0.155120541608254,4.48888382305779e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0594908653473193,0.00287188419060823,0.0538619723337272,0.0651197583609115,7.25368577554376e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.117891875041811,0.00568249205671157,0.106754190610657,0.129029559472966,7.26632905664471e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F13B,Coagulation factor XIII B chain,39925,0.0566209511960302,0.00273369091363471,0.0512629170053062,0.0619789853867542,1.43899292758755e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINF2,Alpha-2-antiplasmin,39786,0.02965975154083,0.00143279707199759,0.0268514692797147,0.0324680338019452,1.90715646842849e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PYY,Peptide YY,39575,0.22063392644137,0.0106724898812273,0.199715846274165,0.241552006608576,3.55653130377868e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL17,C-X-C motif chemokine 17,42296,0.0939508252232666,0.00455731537825309,0.0850184870818905,0.102883163364643,5.1278575698329e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUOM,Fucose mutarotase,39736,0.141848124032857,0.00687920866242032,0.128364875054513,0.155331373011201,9.71773762134516e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.181806371516825,0.00885220149225863,0.164456056591999,0.199156686441652,4.94219638901838e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EHBP1,EH domain-binding protein 1,39958,0.164166484221163,0.0080017636475318,0.148483027472001,0.179849940970325,7.05384910693494e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSD,Cathepsin D,41225,0.0906869254557919,0.0044265107788361,0.0820109643292732,0.0993628865823107,8.63713399308276e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.238013338880775,0.0116283865068555,0.215221701327338,0.260804976434212,1.84219351210956e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0516632587291878,0.00253465960739031,0.0466953258987028,0.0566311915596728,5.42371125275765e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KAZN,Kazrin,39930,0.228601402753028,0.0112009840251864,0.206647474063663,0.250555331442394,5.93859475429006e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANG,Angiogenin,42152,0.0713773758957056,0.00350857390676376,0.0645005710384487,0.0782541807529626,1.18593407961619e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTD,Biotinidase,39979,0.0445905834634211,0.00219107364795981,0.0402960791134199,0.0488850878134223,1.83449618484667e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,41839,0.172025313275709,0.00847073107048426,0.15542268037756,0.188627946173858,2.57025876711393e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAXX,Protein PAXX,39736,0.100402418982115,0.00494135089513038,0.090717371227659,0.11008746673657,3.73734080158186e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBIN,Erbin,42070,0.222402508713308,0.0109644510590407,0.200912184637589,0.243892832789028,3.93290376161202e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.0432345345410265,0.00213303007938088,0.03905379558544,0.047415273496613,5.27571967449567e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH2,Cadherin-2,42145,0.0760637979874591,0.00377435609187351,0.068666060047387,0.0834615359275311,5.10741793631452e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE4,Ribonuclease 4,39645,0.0596262056384288,0.00296221241290451,0.053820269309136,0.0654321419677217,1.57664965436778e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KITLG,Kit ligand,42145,-0.0817891961467752,0.00408510041044611,-0.0897959929512495,-0.0737823993423008,6.67519279569205e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5E,5'-nucleotidase,42181,0.115121904136862,0.00575909646367893,0.103834075068052,0.126409733205673,1.23003395535979e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXNA4,Plexin-A4,42119,0.172281336150948,0.00862286039122546,0.155380529784146,0.18918214251775,1.5130829621587e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,42185,0.267869066551699,0.0134250728208673,0.241555923822799,0.294182209280599,2.50848586377743e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.116884765116231,0.00586103450090749,0.105397137494452,0.12837239273801,3.23987126711599e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0826930407991054,0.00415999060244146,0.0745394592183201,0.0908466223798906,1.04748264021612e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.224056661336644,0.0112964637484177,0.201915592389745,0.246197730283543,2.56796531649821e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP5,Microfibrillar-associated protein 5,42310,0.0856802745869177,0.0043303987207419,0.0771926930942636,0.0941678560795718,6.21653663380712e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCR,Breakpoint cluster region protein,42119,0.195431206059155,0.00989976304974025,0.176027670481664,0.214834741636646,1.52963479783799e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,42249,0.201884942240147,0.0102296504028044,0.18183482745065,0.221935057029643,1.66411234447816e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP10,Stromelysin-2,42124,-0.121590930925891,0.00617145256340533,-0.133686977950165,-0.109494883901616,3.22365555961275e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.157511170469865,0.00799047738606985,0.141849834793168,0.173172506146562,4.94959472337493e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASAH2,Neutral ceramidase,42016,0.112092239341804,0.00569968644396858,0.100920853911626,0.123263624771983,6.54254694687503e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0787520590710001,0.00400254065389356,0.0709070793893687,0.0865970387526315,9.53084099953661e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD6,T-cell differentiation antigen CD6,42284,0.109549136118991,0.00558236038920758,0.0986077097561444,0.120490562481838,1.39342381202157e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.231107702429615,0.0117748456891086,0.208029004878962,0.254186399980268,2.27761356036168e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPL,N-acetylneuraminate lyase,39958,0.0974371341093231,0.00496571381096672,0.0877043350398284,0.107169933178818,2.48125008703658e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCTN3,Tectonic-3,39958,0.0636727720154837,0.00325189017756902,0.0572990672674484,0.0700464767635189,5.48647658264725e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R9B,Neurabin-2,42296,0.198527177963854,0.0101564727781756,0.17862049131863,0.218433864609078,6.0857820262131e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS8,Prostasin,42080,0.0874531491689688,0.00447602991891417,0.078680130527897,0.0962261678100406,7.49439219867254e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.18754678934201,0.00959779317225631,0.168735114724387,0.206358463959632,1.17263446083802e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.191357701252835,0.00982602766714165,0.172098687025238,0.210616715480433,2.5985555792891e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,42070,0.285663397907709,0.0146862247486009,0.256878397400451,0.314448398414967,3.92443943836955e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAB2,Disabled homolog 2,42262,0.230540390983075,0.011881005787039,0.207253619640479,0.253827162325672,9.22473816713506e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATG16L1,Autophagy-related protein 16-1,39930,0.178958329330058,0.00922322331073939,0.160880811641009,0.197035847019107,1.57742886905908e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOE,Apolipoprotein E,39979,0.144852548752098,0.00746803063834114,0.130215208700949,0.159489888803247,1.76520994612263e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,39934,-0.0923979124840513,0.00476585717245759,-0.101738992542068,-0.0830568324260344,2.11128930286446e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IKBKG,NF-kappa-B essential modulator,42119,0.189317784271109,0.00980331703931696,0.170103282874048,0.20853228566817,5.43581364499106e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.215255143100726,0.0111625892883371,0.193376468095585,0.237133818105867,9.20689931729953e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.196095739864718,0.0101747479711284,0.176153233841306,0.216038245888129,1.11617886528348e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELP,P-selectin,42217,0.11499920823857,0.00597740769518876,0.103283489156,0.12671492732114,2.09355935658032e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLA2,Src-like-adapter 2,39934,0.219836066518826,0.0114156736195518,0.197461346224505,0.242210786813148,2.42181876637218e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.221717288194536,0.0115245209606894,0.199129227111584,0.244305349277487,3.41047820838788e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.0411652285499969,0.00214466762619623,0.0369616800026523,0.0453687770973415,4.96431954774626e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,39929,0.181636903440925,0.00945471435153653,0.163105663311913,0.200168143569936,5.74000834884524e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,42310,0.136566028757523,0.00712222863872723,0.122606460625618,0.150525596889429,6.88437639364142e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.115386349592111,0.00602115264109509,0.103584890415565,0.127187808768658,8.93282448590891e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFC,Vascular endothelial growth factor C,42181,0.11356325549983,0.00593819491931977,0.101924393457964,0.125202117541697,1.8075691934371e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NHLRC3,NHL repeat-containing protein 3,39481,0.0658601036096283,0.00345275590182411,0.059092702042053,0.0726275051772036,8.17164239944055e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEFTY2,Left-right determination factor 2,42247,0.10519986633396,0.00552595068482727,0.0943690029916987,0.116030729676222,9.0038315757261e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLIN1,Perilipin-1,41839,0.0691537112246212,0.00364062580685906,0.0620180846431774,0.0762893378060649,2.12625431502301e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAP23,Synaptosomal-associated protein 23,42145,0.176704108375856,0.00930839734384149,0.158459649581927,0.194948567169785,2.50321203846558e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LSP1,Lymphocyte-specific protein 1,42119,0.0824738204663481,0.00434512072025525,0.0739573838546478,0.0909902570780484,2.63430488440613e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.141957103110682,0.00747523644471314,0.127305639679045,0.15660856654232,3.46191778416925e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD5,Programmed cell death protein 5,42249,0.11638424317307,0.00614098762838041,0.104347907421444,0.128420578924696,4.38923967615282e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.100345471368432,0.00529658501022997,0.0899641647483817,0.110726777988483,5.33290944983668e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,42119,0.133672196097428,0.0070581559742985,0.119838210387803,0.147506181807053,5.74522671269568e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMOT,Angiomotin,39736,0.0775990931651935,0.00410138323111035,0.0695603820322172,0.0856378042981698,1.32025068814939e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THOP1,Thimet oligopeptidase,42081,0.0634404837245481,0.00335892088470226,0.0568569987905316,0.0700239686585645,1.49810695339854e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FETUB,Fetuin-B,42199,0.0650747444222557,0.00344800304268672,0.0583166584585898,0.0718328303859217,1.90118169693579e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLSCR3,Phospholipid scramblase 3,39911,0.11654854641505,0.00617285572912769,0.10444974918596,0.128647343644141,2.6090170320205e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CMIP,C-Maf-inducing protein,39919,0.169513010296873,0.00898557105395458,0.151901291031122,0.187124729562624,3.47919056740077e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.147252214479392,0.00780926011520129,0.131946064653597,0.162558364305186,4.38825570263879e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.169712959461666,0.00902797037931801,0.152018137518203,0.187407781405129,1.17053731810487e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.142841082554485,0.00760836615240831,0.127928684895765,0.157753480213205,1.2313145944827e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRPK2,SRSF protein kinase 2,42119,0.171326917817147,0.00913905791369581,0.153414364306303,0.189239471327991,1.97099121481021e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUCB2,Nucleobindin-2,42231,0.0753453873183519,0.00402031748805969,0.0674655650417549,0.0832252095949489,2.14129942452596e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEP1A,Meprin A subunit alpha,39930,0.152750313460147,0.00814313971854329,0.136789759611802,0.168710867308492,2.45093277194468e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,42070,0.0743777819260819,0.00397026136454899,0.0665960696515659,0.0821594942005979,2.51871799114223e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL5,C-C motif chemokine 5,42217,0.202136715908516,0.0108144410722498,0.180940411406906,0.223333020410125,5.33693549599229e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCK2,Cytoplasmic protein NCK2,42185,0.214237179217403,0.0114633098871848,0.19176909183852,0.236705266596285,5.60732180818986e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BACH1,Transcription regulator protein BACH1,42119,0.150379367953562,0.00805224611869002,0.13459696556093,0.166161770346195,7.25077481780335e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C19orf12,Protein C19orf12,41839,0.133845653913474,0.00716759470709163,0.119797168287574,0.147894139539373,7.83833449606988e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAT,Linker for activation of T-cells family member 1,42296,0.151818326057765,0.00813261862253804,0.135878393557591,0.16775825855794,8.10213263106493e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.226488166951399,0.0121365923126044,0.202700446018694,0.250275887884104,9.33801872585087e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOP2B,DNA topoisomerase 2-beta,39657,0.160997839784502,0.00861590533613626,0.144110665325675,0.17788501424333,9.70423417060407e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.137333717138097,0.00735311637074387,0.122921609051439,0.151745825224755,1.1517207848111e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINH1,Serpin H1,39757,0.25723352543062,0.0137949350617459,0.230195452709598,0.284271598151642,1.9291852005061e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL5,C-X-C motif chemokine 5,42101,0.224524062103334,0.0120724324790462,0.200862094444403,0.248186029762264,2.97825537484574e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSO,Cathepsin O,42296,0.0609843430868431,0.00328361383232737,0.0545484599754815,0.0674202261982048,4.61303347777698e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOXO1,Forkhead box protein O1,42119,0.172809121236504,0.00930518188331603,0.154570964745204,0.191047277727803,4.83343478163016e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.194774215463047,0.0104909025611911,0.174212046443112,0.215336384482981,5.17363434416993e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PXN,Paxillin,41839,0.10221231457673,0.00550565430646084,0.0914212321360664,0.113003397017393,5.67035079032953e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.104905967799682,0.0056577054062059,0.0938168652035184,0.115995070395846,8.23674958952816e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.126617645860383,0.00684460384373509,0.113202222326662,0.140033069394104,1.8756056006121e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.0476247584731091,0.00257677177312623,0.0425742857977817,0.0526752311484365,2.41541318236461e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.226243008349119,0.0122316976348461,0.202268880984821,0.250217135713417,2.82164435421354e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSME1,Proteasome activator complex subunit 1,42002,0.0718494597870092,0.00389637431147924,0.0642125661365099,0.0794863534375085,5.29047559889522e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMBP,Protein AMBP,42239,0.039867279164806,0.00216237340714978,0.0356290272867924,0.0441055310428196,5.41063671210235e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.13138219939209,0.00713763412500407,0.117392436507082,0.145371962277098,9.85821299541419e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GMPR,GMP reductase 1,42296,0.0940464426482166,0.00511066284522601,0.0840295434715736,0.10406334182486,1.00473392997339e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MINK1,Misshapen-like kinase 1,39929,0.183843512529555,0.00998316175652292,0.16427651548677,0.20341050957234,1.20891117350795e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN2,CCN family member 2,42146,0.111404905030157,0.00605874343927286,0.0995297678891826,0.123280042171132,1.33519329726164e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.146203620944427,0.00795526522543938,0.130611301102566,0.161795940786288,2.50740127575426e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELE,E-selectin,42310,0.0994290103501225,0.00541865279338453,0.0888084508750888,0.110049569825156,2.58284605316836e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPB2,Carboxypeptidase B2,39959,0.0442170656583736,0.00240868349433499,0.039496046009477,0.0489380853072702,3.39360937791393e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.0799442502945423,0.00435802684953415,0.0714025176694554,0.0884859829196293,4.32476826876461e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,42137,0.104613725013448,0.00571602770629645,0.0934103107091065,0.115817139317789,6.22053863202493e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.137155453313617,0.007511337735096,0.122433231352829,0.151877675274405,1.36479404389725e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCBP2,Poly(rC)-binding protein 2,39934,0.142731395834778,0.00782257814915734,0.12739914266243,0.158063649007127,2.4808816826487e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.163438942415025,0.00898304480833325,0.145832174590692,0.181045710239358,4.29857252088664e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.150442531700889,0.00826232284049772,0.134248378933514,0.166636684468265,4.83257192046483e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.0468687759194868,0.00257924571563418,0.0418134543168438,0.0519240975221298,6.56228213231308e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.15089463895205,0.00832403155279193,0.134579537108578,0.167209740795523,1.40394779737074e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFRP4,Secreted frizzled-related protein 4,39736,0.0778084231240244,0.00428755711070578,0.0694048111870411,0.0862120350610078,1.48506548565928e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGF,Placenta growth factor,42296,0.0509205637340538,0.00281192335866017,0.0454091939510798,0.0564319335170277,1.89746129341357e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL32,Interleukin-32,42119,-0.0863758119839791,0.0047764944988217,-0.0957377412016696,-0.0770138827662886,3.0455811258716e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0722151630520591,0.00399879301962368,0.0643775287335966,0.0800527973705215,4.63939914275425e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP43,Centrosomal protein 43,41797,0.136384993206957,0.00755498277056677,0.121577226976646,0.151192759437268,5.54191613582922e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17RB,Interleukin-17 receptor B,41934,-0.104752024233289,0.00581156846109949,-0.116142698417044,-0.0933613500495341,8.84064625866678e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL17,C-C motif chemokine 17,42107,0.176565939034768,0.00982309218552493,0.157312678351139,0.195819199718397,2.08874222181881e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.120776646670626,0.00671225308433332,0.107620630625333,0.133932662715919,2.13991735036177e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.198289243127588,0.0110260384386033,0.176678207787926,0.219900278467251,2.70793282081769e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.182632255656742,0.0101902766933047,0.162659313337865,0.202605197975619,5.31267075477266e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CREG1,Protein CREG1,41960,0.0776419888183357,0.00433887335052515,0.0691377970513064,0.086146180585365,8.70537725934201e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPD52L2,Tumor protein D54,39736,0.20901016898043,0.0116701582993816,0.186136658713642,0.231883679247218,9.67402200808535e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOC1,Apolipoprotein C-I,39959,0.0739872328504847,0.00413555764949846,0.0658815398574677,0.0820929258435017,1.29658642530453e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH2B3,SH2B adapter protein 3,41843,0.189148367465595,0.0105937246987395,0.168384667056066,0.209912067875125,1.7749900233666e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.20736749196623,0.0116106534576426,0.18461061118925,0.230124372743209,2.21566309500147e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOK2,Docking protein 2,42145,0.234857903736126,0.0131857492140522,0.209013835276584,0.260701972195668,3.62630933515681e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOLM2,Protein GOLM2,42249,0.0433943695955684,0.00244298013891327,0.0386061285232984,0.0481826106678384,8.34899423606354e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.181240759695885,0.0102239020493636,0.161201911679132,0.201279607712637,1.62810450629651e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,42185,0.162872315978032,0.00920484963621022,0.14483081069106,0.180913821265004,2.77892995918362e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC27,Cell division cycle protein 27 homolog,41843,0.115791106181966,0.00655126729932204,0.102950622275295,0.128631590088637,4.08272304066349e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP3B1,AP-3 complex subunit beta-1,39930,0.146247335306685,0.00826849184593124,0.13004109128866,0.16245357932471,4.43866934111139e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTBS,Di-N-acetylchitobiase,39860,0.0522122922168916,0.00295374179405787,0.0464229583005381,0.058001626133245,5.40369824050727e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.0969686516046635,0.00548876976239636,0.0862106628703666,0.10772664033896,6.73730132314945e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USO1,General vesicular transport factor p115,42070,0.168233036366587,0.00956156551293476,0.149492367961235,0.186973704771939,1.57682119516761e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OTUD7B,OTU domain-containing protein 7B,39934,0.119110399118806,0.00677941396088162,0.105822747755478,0.132398050482134,3.37394544696847e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL13,C-C motif chemokine 13,42275,0.128349053724075,0.0073196714844136,0.114002497614624,0.142695609833526,4.31329493167892e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA5,Integrin alpha-5,42137,0.0468132226397506,0.00267238067054202,0.0415753565254882,0.0520510887540129,5.91715523156805e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3GLB2,Endophilin-B2,39929,0.123580920857834,0.00705556776840266,0.109752008031764,0.137409833683903,8.52520459161451e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NIT2,Omega-amidase NIT2,39903,0.1371384592803,0.00783021002542153,0.121791247630474,0.152485670930126,8.76574514244285e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0514603230818732,0.00294190997141358,0.0456941795379026,0.0572264666258438,9.14911088824798e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYTL4,Synaptotagmin-like protein 4,39958,0.13661378800955,0.00780581064172932,0.121314399151761,0.15191317686734,1.07439245796862e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYN,Tyrosine-protein kinase Lyn,42070,0.159293490770854,0.0091156902650574,0.141426737851342,0.177160243690367,1.24338238066701e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.209670974244283,0.0120132469939417,0.186125010136158,0.233216938352409,1.80857036891938e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEC31A,Protein transport protein Sec31A,39638,0.145170093861103,0.00831341661453573,0.128875797296613,0.161464390425593,2.23081775420802e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STK11,Serine/threonine-protein kinase STK11,41900,0.136182772922749,0.00784090709331015,0.120814595019862,0.151550950825637,7.82858110568581e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.11919845226129,0.0068684619886567,0.105736266763523,0.132660637759057,1.32183167575441e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SULT2A1,Bile salt sulfotransferase,42119,0.109628364249972,0.00632457584373456,0.0972321955962518,0.122024532903691,1.37185647073078e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.100432670875258,0.00578911077237828,0.0890860137613962,0.111779327989119,1.50563809532423e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,METAP2,Methionine aminopeptidase 2,42247,0.103523787568856,0.00599133711612301,0.0917807668212551,0.115266808316457,3.42779732650902e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,42145,-0.072828715206937,0.00421905803129242,-0.0810980689482702,-0.0645593614656039,4.63368117294395e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.117317594202897,0.00679791206075068,0.103993686563826,0.130641501841968,5.13914895284604e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.145589832181879,0.00844299418245856,-0.162138100779498,-0.12904156358426,6.26780813981158e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OPHN1,Oligophrenin-1,39929,0.200925194159415,0.011642784950376,0.178105335656679,0.223745052662152,6.81728180442072e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.152862907446,0.00887211063011532,0.135473570610974,0.170252244281026,8.29416423431625e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,39736,0.142414310471813,0.00826661477630022,0.126211745510265,0.158616875433362,1.16493738116606e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,39657,0.179042320786371,0.0104105983401612,0.158637548039656,0.199447093533087,1.941890216705e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTBDN,Retbindin,42070,0.0553202771512547,0.00322076138155286,0.0490075848434111,0.0616329694590984,1.99033449921567e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.189476513634553,0.0110203581438899,0.167876611672528,0.211076415596577,2.00858743443793e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0985583611996539,0.00573806031999244,0.0873117629724687,0.109804959426839,2.04245706520064e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,42070,0.110300060085502,0.00642479270335298,0.0977074663869298,0.122892653784073,2.28816326321041e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.101932299001704,0.00594251617132618,0.0902849673059043,0.113579630697503,2.86223987914503e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM5,Tripartite motif-containing protein 5,42119,0.159988949799165,0.00933682313872783,0.141688776447259,0.178289123151072,3.94054951493371e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.0777572635817117,0.0045394803984283,0.0688598820007923,0.0866546451626312,4.3071192452006e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0959793737905652,0.00561083132107762,0.0849821444012531,0.106976603179877,6.40167191438003e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEXIM1,Protein HEXIM1,42119,0.148456407140782,0.00868384643126655,0.1314360681355,0.165476746146065,7.6633544941769e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0698158686605655,0.00409047946763178,0.0617985289040072,0.0778332084171238,1.22182180900119e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NSFL1C,NSFL1 cofactor p47,42249,0.115321697425674,0.00675812097558928,0.102075780313519,0.128567614537829,1.28173520160934e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMN,Protein amnionless,41913,0.0867091905196398,0.00508114283503065,0.0767501505629797,0.0966682304762999,1.31558775459533e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.202736889971161,0.011885456735839,-0.226032385173405,-0.179441394768916,1.44859823863414e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.0892947568419575,0.00524926502282472,0.079006197397221,0.0995833162866939,3.27326027941794e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.0537279495497696,0.00315856406569789,0.0475371639810018,0.0599187351185375,3.31116295631867e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.142822181616345,0.00839679373106617,0.126364465903455,0.159279897329235,4.3717156782271e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.186865098915652,0.0110099435044045,0.165285609647019,0.208444588184285,5.97062989538559e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.189742457010839,0.0111800698570946,0.167829520090933,0.211655393930744,6.07920719917056e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.147715877212744,0.00870282353027712,0.130658343093401,0.164773411332087,7.92845431803797e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSTN,Growth/differentiation factor 8,41900,0.0983227927834996,0.0058057490955772,0.0869435245561683,0.109702061010831,1.14453237890879e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.131264016784893,0.00775433766741978,0.11606551495675,0.146462518613036,1.69072411856526e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLK1,Protein delta homolog 1,42310,0.105155450344022,0.00622086468349138,0.092962555564379,0.117348345123665,1.8546885158394e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0538027454774847,0.00319067762102108,0.0475490173402834,0.060056473614686,3.67413179453286e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RLN2,Prorelaxin H2,39709,0.0932807501892953,0.00552838654251599,0.0824451125659639,0.104116387812627,4.32344711868192e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGCC,Regulator of cell cycle RGCC,39934,0.138658748552791,0.00822157059999618,0.122544470176799,0.154773026928784,4.74838071202361e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,39627,0.103064597641369,0.00611223585764763,0.0910846153603794,0.115044579922358,5.25618838463173e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNMBP,Dynamin-binding protein,42016,0.10980526108613,0.00652165569821977,0.0970228159176194,0.122587706254641,5.78081543260058e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AZI2,5-azacytidine-induced protein 2,39934,0.100627210650024,0.0059715464910256,0.0889229795276143,0.112331441772435,5.99486379846634e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GASK1A,Golgi-associated kinase 1A,39575,0.0772970311556724,0.00458937117192634,0.0683018636586968,0.086292198652648,7.2976381669392e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.046163388756095,0.00274516577142419,0.0407828638441036,0.0515439136680864,7.91080173765025e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.111746906512345,0.00664155245391163,0.0987294637026786,0.124764349322012,9.16214565475565e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.197324718885106,0.0117527126560278,0.174289402079292,0.220360035690921,1.24059776599964e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LBR,Delta(14)-sterol reductase LBR,42249,0.122800745096395,0.0073180543817649,0.108457358508136,0.137144131684655,1.43431224848021e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRAP,BRCA1-associated protein,39813,0.198166927707493,0.0118264232926806,0.174987138053839,0.221346717361147,2.90608168863754e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AAMDC,Mth938 domain-containing protein,39638,0.0952846916734469,0.00569286807463432,0.0841266702471637,0.10644271309973,4.05904496709685e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.152706090298734,0.00913487009686204,0.134801744908884,0.170610435688583,5.69765140131841e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAMBP,STAM-binding protein,41997,0.113097149978702,0.00677733741845169,0.0998135686385362,0.126380731318867,6.79884933386157e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,42185,0.229195459202364,0.0137387026490532,0.20226760201022,0.256123316394508,7.24639761694964e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX15,Sorting nexin-15,39736,0.0967728848013482,0.0057945684366645,0.0854155306654857,0.108130238937211,7.31733578425757e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTDH,Protein LYRIC,39657,0.170774459194631,0.0102401281068129,0.150703808105277,0.190845110283984,1.08974403045684e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNST,Consortin,42145,0.194964641534068,0.0117049961525053,0.172022849075157,0.217906433992978,1.11315763946511e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,39958,0.163426587237631,0.00981796059396023,0.144183384473469,0.182669790001794,1.73635360891073e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAG1,Dystroglycan,42185,0.0848719175907351,0.00510542590245286,0.0748652828219274,0.0948785523595427,1.89214936791785e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.0594491474412986,0.0035852036926242,0.0524221482037552,0.0664761466788421,3.78670226018965e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.169554246886338,0.0102296617470111,0.149504109862197,0.18960438391048,4.34317778351836e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGLN1,Egl nine homolog 1,42119,0.0996341721716242,0.00601739478872939,0.0878400783857146,0.111428265957534,5.60853789652112e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COCH,Cochlin,39958,0.0816581304446524,0.00493419073596251,0.0719871166021658,0.0913291442871389,8.30400670189607e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0786871508231003,0.00476320915877214,0.0693512608719069,0.0880230407742937,1.04445434082072e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PENK,Proenkephalin-A,39736,0.0549681177184288,0.00333074368621578,0.0484398600934459,0.0614963753434118,1.81133254396016e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.160906942978151,0.00975914372190268,0.141779021283222,0.180034864673081,2.35183436571019e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,39934,0.106183576713433,0.00644363240350129,0.0935540572025707,0.118813096224296,2.61263756585456e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0346072887941589,0.00210357326093061,-0.0387302923855828,-0.0304842852027349,3.15228211684396e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAX1BP1,Tax1-binding protein 1,39929,0.109777346632118,0.00667010988045967,0.0967039312664166,0.122850761997818,3.65391222707631e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EREG,Proepiregulin,41997,0.141573612641704,0.00863302688488778,0.124652879947324,0.158494345336084,7.4290263228893e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0584488057366688,0.00356695929562623,0.0514575655172414,0.0654400459560962,8.95928116750193e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.101751724471079,0.00621305026951251,0.0895741459428349,0.113929302999324,1.0568307373819e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.101532059894566,0.00620138984202309,0.0893773358042007,0.113686783984931,1.1168878464781e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOLGA3,Golgin subfamily A member 3,39934,0.136689879081276,0.00834461794439264,0.120334427910266,0.153045330252285,1.27124315429852e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.07746682542482,0.0047353517974906,0.0681855359017384,0.0867481149479016,1.42303398846247e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUC13,Mucin-13,41839,0.0927805418343906,0.00567242905115409,0.0816625808941286,0.103898502774653,1.50086146516465e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.179233441371146,0.0109598013508404,0.157752230723499,0.200714652018793,1.52485207597753e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,QDPR,Dihydropteridine reductase,42081,0.0739922830528187,0.00453454683928496,0.0651045712478202,0.0828799948578172,2.74132607153313e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,42137,0.0875564820322535,0.00537245302951442,0.0770264740944052,0.0980864899701017,3.76861106721642e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAO1,Hydroxyacid oxidase 1,42262,0.216723504841591,0.0132999458375814,0.190655610999932,0.242791398683251,3.86068840351512e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.127018174565099,0.00780412900008955,0.111722081724924,0.142314267405275,6.79031985294983e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM13A,Protein FAM13A,39930,0.118628859408341,0.00730397632012076,0.104313065820904,0.132944652995777,1.17374560565176e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0753814869435581,0.00464166410074833,0.0662838253060913,0.0844791485810248,1.20381113268965e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,39934,0.199079238882732,0.0122773658168293,0.175015601881746,0.223142875883717,1.78990703181846e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.134948729440716,0.00832989828506826,0.118622128801982,0.151275330079449,1.82222173387872e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NIT1,Deaminated glutathione amidase,39638,0.0773611199560871,0.00477541873657736,0.0680012992323955,0.0867209406797788,2.37487532673456e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARSB,Arylsulfatase B,42070,0.096629204783712,0.00597479185372095,0.084918612750419,0.108339796817005,2.77370848697212e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOF,Apolipoprotein F,39990,-0.0448613198604236,0.00278301096582836,-0.0503160213534471,-0.0394066183674,8.0760753611397e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0501135620909342,0.0031097631448238,0.0440184263270796,0.0562086978547889,9.00460485826278e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MITD1,MIT domain-containing protein 1,42016,0.167087672690561,0.0104007735706,0.146702156492185,0.187473188888937,1.54515721310016e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST13,Hsc70-interacting protein,39736,0.0938463598748452,0.00584359224378925,0.0823929190770183,0.105299800672672,2.15216350264429e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.125509481164746,0.00782991691757646,0.110162844006296,0.140856118323196,2.68106894691433e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.114086605220208,0.00711246093402018,0.100146181789529,0.128027028650888,2.84431880937956e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.0648688236062188,0.00404789449022657,0.0569349504053747,0.0728026968070628,2.87529040784511e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0529384802601462,0.00330087029594588,0.0464687744800923,0.0594081860402002,3.14521198083364e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELOA,Elongin-A,42070,0.0925190948365589,0.00578854129781624,0.0811735538928391,0.103864635780279,5.59110660669651e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.145719438709094,0.00912167688643114,0.127840952011689,0.163597925406499,6.29572448249357e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.15537151748304,0.00972760467912427,0.136305412311956,0.174437622654123,8.30424451830154e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBNL,Drebrin-like protein,42185,0.159159002158312,0.00997829156770979,0.139601550685601,0.178716453631023,9.24711021907784e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST3,Cystatin-C,42184,0.0492005867978823,0.00308506312627001,0.0431538630703931,0.0552473105253715,9.62249276763954e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.180895459577681,0.0113397605164377,0.158669528965463,0.203121390189899,1.159385740167e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,41900,0.131913742348138,0.00827706639077974,0.11569069222221,0.148136792474066,1.16790166711131e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUS,RNA-binding protein FUS,41831,0.0680431591947018,0.00427797233425869,0.0596583334195547,0.0764279849698488,1.93472678005851e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.133755093728088,0.00841319090587948,0.117265239552564,0.150244947903612,2.64074197187335e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB27B,Ras-related protein Rab-27B,39958,0.141085170642215,0.00887548205053809,0.123689225823161,0.15848111546127,2.72516936368374e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IST1,IST1 homolog,39850,0.168277799623375,0.01059525344759,0.147511102866099,0.189044496380652,3.41843087578821e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,39934,0.202454702477262,0.0127596658765042,0.177445757359314,0.22746364759521,4.31547540891603e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRKL,Crk-like protein,42143,0.179724072773297,0.0113528268713692,0.157472532105413,0.20197561344118,6.0542345270389e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.146860270214283,0.00927547329068527,0.12868034256454,0.165040197864026,7.29280024573861e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL3,C-X-C motif chemokine 3,42129,0.162430201544372,0.0102683837651262,0.142304169364725,0.182556233724019,7.34331198890708e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIAE,Sialate O-acetylesterase,42147,0.0791350551863713,0.00500377140862848,0.0693276632254594,0.0889424471472831,7.73089638056003e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.104194074958626,0.00659154634929324,0.0912746441140114,0.117113505803241,8.75819259223852e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS8,Galectin-8,42249,0.103452764698325,0.00655218139831804,0.0906104891576221,0.116295040239029,1.14983555548351e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXNB3,Plexin-B3,42099,0.0816298668944959,0.00517067243842706,0.0714953489151788,0.0917643848738129,1.20043981557014e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDUA,Alpha-L-iduronidase,42262,0.0801160159406495,0.00507521492574973,0.07016859468618,0.0900634371951189,1.20949960351673e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0471815520053076,0.00298938807893064,0.0413223513706036,0.0530407526400117,1.2741391556166e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,42105,0.108551767419516,0.00688096445271087,0.0950650770922032,0.12203845774683,1.43328095671697e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,41900,0.0597060619400607,0.00378612020915378,0.0522852663301193,0.0671268575500021,1.59949167516456e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.043334399506189,0.00275245125201079,0.0379395950522479,0.0487292039601302,3.01147542369704e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.150193614460423,0.00954735866808174,0.131480791470983,0.168906437449863,3.52748029098786e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0808390583990836,0.0051404679956603,0.0707637411275894,0.0909143756705778,3.83565568785775e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBPL,FK506-binding protein-like,39930,0.100350544113396,0.00638481965670766,0.0878362975862492,0.112864790640543,4.40499186674973e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BID,BH3-interacting domain death agonist,42119,0.11203210552375,0.00713745852608558,0.0980426868126224,0.126021524234878,4.89973712841061e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD1,Sushi domain-containing protein 1,41900,0.0822438697283204,0.00524059148784784,0.0719723104121386,0.0925154290445021,5.20530549427669e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGFR,Opioid growth factor receptor,42070,0.0541761663983872,0.00345608280033314,0.0474022441097343,0.0609500886870402,6.78207695836651e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDRKH,Tudor and KH domain-containing protein,41839,0.143632512747224,0.00916437717856258,0.125670333477241,0.161594692017206,7.20641417328035e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBC1D23,TBC1 domain family member 23,42070,0.151908559921271,0.00969695092405292,0.132902536110127,0.170914583732415,7.91510910664148e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBKS,Ribokinase,41830,0.0835536471110974,0.00533332395436068,0.0731003321605505,0.0940069620616444,7.98338743534433e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYDGF,Myeloid-derived growth factor,39958,0.167767508878328,0.0107061759933974,0.146783403931269,0.188751613825387,9.0489719548844e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.111945772617607,0.00716207659217392,0.0979081024969466,0.125983442738268,1.67389601117816e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESM1,Endothelial cell-specific molecule 1,42123,-0.0583325702285884,0.00373830304800814,-0.0656596442026844,-0.0510054962544925,2.03675676438233e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.0759710790348998,0.00488248304370017,0.0664014122692475,0.0855407458005521,4.02818018698855e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.126635430337176,0.00814532153744089,0.110670600123792,0.142600260550561,4.91967128710369e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.178212965999898,0.0114537750589229,0.155763566884409,0.200662365115387,4.97292033480113e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL4,C-C motif chemokine 4,42148,0.104004591039329,0.00670426636373497,0.0908642289664082,0.117144953112249,8.19415822933165e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0773461309208691,0.0049860713418151,0.0675734310909115,0.0871188307508267,8.29651784895431e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBCC,Tubulin-specific chaperone C,42016,0.134313094112577,0.00866088820479902,0.117337753231171,0.151288434993983,8.96376398443831e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.140014835209686,0.00902134869334843,0.122332991770724,0.157696678648649,9.02946531132007e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.098389941879279,0.00634597845688297,0.0859518241037884,0.11082805965477,9.41030158051925e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.142340479896414,0.00918542034839319,0.124337056013563,0.160343903779265,1.0861791031127e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP5,Fatty acid-binding protein 5,42218,0.111085109528774,0.00717302266187661,0.0970259851114963,0.125144233946053,1.22568237262777e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.205826407621803,0.0133327468832779,0.179694223730578,0.231958591513027,2.68385253058993e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.104092903306333,0.00674368679902849,0.0908752771802367,0.117310529432428,3.41027352638564e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.119812053099062,0.00776435525146178,0.104593916806197,0.135030189391927,3.58880351710971e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.241996027314621,0.0157157659507078,0.211193126051234,0.272798928578008,5.77086985539734e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK10,Kallikrein-10,42138,0.0677220140539632,0.00440179306064139,0.059094499655106,0.0763495284528203,5.78002855818461e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.19322451454137,0.0125834153405068,0.168561020473976,0.217888008608763,9.10344085138216e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,41839,0.0633825960818812,0.00412805239906057,0.0552916133797224,0.0714735787840399,9.46131663982315e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.093048565643477,0.00605924359074925,0.0811724482056085,0.104924683081346,1.08779497501339e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0677813639605809,0.00441604659049072,0.0591259126432191,0.0764368152779427,1.24420276572547e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.0464957539382514,0.00303275819474835,0.0405515478765446,0.0524399599999582,1.31554018838242e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD207,C-type lectin domain family 4 member K,41832,0.0643857527371586,0.00420192525640519,0.0561499792346045,0.0726215262397128,1.51791986387986e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRAF2,TNF receptor-associated factor 2,42119,0.114578953065058,0.00747963829160793,0.0999188620135068,0.12923904411661,1.58103434942779e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.0807238171053429,0.00526610078201613,0.0704022595725913,0.0910453746380945,1.64772528847595e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",41900,0.153120850029693,0.00999978482286436,0.133521271776879,0.172720428282508,1.7697713644523e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERMAP,Erythroid membrane-associated protein,39657,0.0735382677386385,0.00479983276429127,0.0641305955206276,0.0829459399566494,1.91078252839407e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN2L,Ataxin-2-like protein,39934,0.0790961932559276,0.00517609369127705,0.0689510496210246,0.0892413368908306,3.38394715711494e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.0736663860182508,0.00482453934360374,0.0642102889047875,0.0831224831317142,3.41704128337242e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,42119,0.0983940067342853,0.00645265800908705,0.0857467970364747,0.111041216432096,4.55839874042884e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,42189,0.0564633591610038,0.00370794410664473,0.0491957887119802,0.0637309296100275,6.21385483732639e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPC5,Glypican-5,42016,0.0924256558204783,0.00606981651473461,0.0805288154515985,0.104322496189358,6.34764916904598e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP2B1,AP-2 complex subunit beta,39649,0.0796896442293167,0.00523742575513237,0.0694242897492573,0.0899549987093762,9.33602887551698e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNMT,Histamine N-methyltransferase,41961,0.0781411363486185,0.00516103824564326,0.0680255013871577,0.0882567713100793,2.33113076839013e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,39930,0.157031970432914,0.0103833080857338,0.136680686584876,0.177383254280953,3.57620464323696e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GTPBP2,GTP-binding protein 2,39649,0.13372427588593,0.00884413186823725,0.116389777424185,0.151058774347675,3.87108415356175e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.096108242273773,0.0063644973227391,0.0836338275212044,0.108582657026342,4.27170461521127e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,42181,0.055353355362443,0.00366652125329172,0.0481669737059912,0.0625397370188947,4.40159024256619e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.114034057464264,0.00754847591116773,0.0992390446783754,0.128829070250153,4.71177324564496e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,39736,0.13511979822285,0.00894698307167084,0.117583711402375,0.152655885043325,5.00158013803931e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDHD2,Phospholipase DDHD2,39934,0.107601124733148,0.00714024747809265,0.0936062396760866,0.12159600979021,7.95748479468363e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,39735,0.107058423873779,0.00710679051656186,0.0931291144613174,0.12098773328624,8.79740157367162e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGA,Protein O-GlcNAcase,39930,0.115795610078087,0.0076883206354966,0.100726501632514,0.13086471852366,9.02068489278772e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN3,Ataxin-3,39929,0.0987896271240342,0.00657302894245949,0.0859064903968136,0.111672763851255,1.44275855255334e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS1BP3,HCLS1-binding protein 3,39638,0.14779674997688,0.00983413251164251,0.128521850254061,0.167071649699699,1.4984120888958e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADD1,Alpha-adducin,39736,0.112767338415904,0.00750626632991644,0.0980550564092675,0.12747962042254,1.61793483499264e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VNN1,Pantetheinase,39990,0.118018389075353,0.0078763722958108,0.102580699375564,0.133456078775142,2.81790818655611e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.104453152929663,0.00697898652694891,0.0907743393368429,0.118131966522483,3.02974204316044e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFA,Vascular endothelial growth factor A,42253,0.0912332362742474,0.00610631509976601,0.079264858678706,0.103201613869789,4.44548103318559e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAT2,Signal transducer and activator of transcription 2,39657,0.126441291133978,0.00846656216687334,0.109846829286906,0.14303575298105,6.04983414314544e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.0826147347126178,0.0055403793416354,0.0717555912030124,0.0934738782222231,8.23751043410233e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD5,T-cell surface glycoprotein CD5,42239,0.0571268074982363,0.00383437975961057,0.0496114231693996,0.064642191827073,8.2928893174231e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6AP2,Renin receptor,41843,0.0632245445759002,0.00424486370154886,0.0549046117208644,0.071544477430936,9.06192210667349e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMMD1,COMM domain-containing protein 1,39638,0.0978969305838333,0.00657355077202082,0.0850127710706725,0.110781090096994,1.11724836222433e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1S,Complement C1s subcomponent,39979,0.0338128165497662,0.00227188155731258,0.0293599286974335,0.0382657044020988,1.24051239879583e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0953811736366199,0.00641623677251696,0.0828053495624867,0.107956997710753,1.37663893811565e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.110163790192825,0.00741417892848615,0.0956319994929924,0.124695580892658,1.49355143696179e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD36,Platelet glycoprotein 4,39657,0.0744409285573899,0.00501327857355617,0.0646149025532198,0.08426695456156,2.11780818326771e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.116396240850964,0.00784938104761919,0.10101145399763,0.131781027704298,2.33270379591581e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YJU2,Splicing factor YJU2,39919,0.0528655076062789,0.00356324105492636,0.0458815551386232,0.0598494600739345,2.47606749363517e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASC3,Protein CASC3,39649,0.0688856999852944,0.00465031765934504,0.0597710773729781,0.0780003225976107,3.56682840547543e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0621698436220583,0.00420984366810244,0.0539185500325775,0.0704211372115391,5.66830330613896e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DGKA,Diacylglycerol kinase alpha,39657,0.0881259788842395,0.00596493684313642,0.0764347026716921,0.0998172550967869,6.30230781582443e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GET3,ATPase GET3,39958,0.0859206221417612,0.00582233876817664,0.074508838156135,0.0973324061273874,7.84069003700696e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLB,Beta-klotho,41839,-0.118880949333244,0.00806328452174264,-0.134684986995859,-0.103076911670628,8.25661418349876e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA11,Annexin A11,42087,0.105302567304447,0.0071439767356879,0.0913003729024984,0.119304761706395,8.54160304270599e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,39934,0.121243948117082,0.00822494552809671,0.105123054882012,0.137364841352151,9.92415796201004e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.138134683051655,0.009383210031841,0.119743591389247,0.156525774714064,1.12071801753077e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIP,Gastric inhibitory polypeptide,39638,0.0802949850884579,0.00545386157633047,0.0696054163988502,0.0909845537780656,1.33250083132792e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TWF2,Twinfilin-2,39966,0.134998721269962,0.00917409912548535,0.11701748698401,0.152979955555913,1.43920574554684e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HPSE,Heparanase,39866,0.151106447499346,0.0102831793142317,0.130951416043452,0.17126147895524,1.95966914472503e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,39990,0.0422730734777907,0.00287771941594798,0.0366327434225327,0.0479134035330487,2.07590319485073e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.165141439363812,0.0112503767308319,0.143090700971382,0.187192177756243,2.07899737526863e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GHRL,Appetite-regulating hormone,42145,0.1311889933789,0.00895036858823185,0.113646270945966,0.148731715811835,2.82959236367188e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOXJ3,Forkhead box protein J3,39657,0.071455811876023,0.00487717207247361,0.0618965546139748,0.0810150691380713,3.74444510127212e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.125266030011397,0.0085581352462927,0.108492084928663,0.142039975094131,3.87237168432679e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0796341231034757,0.00544897805627081,0.068954126113185,0.0903141200937665,5.26862308233183e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,41913,0.059370984118801,0.00407056415188749,0.0513926783811015,0.0673492898565004,8.12423738538009e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.114490170716936,0.00785471695746695,0.0990949254803011,0.129885415953572,1.1052392220583e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,39657,0.138165143192487,0.00948137863737605,0.11958164106323,0.156748645321744,1.16495763635269e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMPACT,Protein IMPACT,39929,0.0849866212829723,0.00584063116135645,0.0735389842067136,0.0964342583592309,1.54485736467882e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNPY4,Protein canopy homolog 4,42070,0.117777500596736,0.00810052143782155,0.101900478578606,0.133654522614866,1.55938419154521e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.0961422596007786,0.00661685780967469,0.0831732182938162,0.109111300907741,1.78486626269157e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPP,Lipoma-preferred partner,39575,0.103415667601309,0.00711307742682137,0.0894740358447391,0.117357299357879,1.89675920119704e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0767033086686334,0.00527628267210989,0.0663617946312981,0.0870448227059688,1.92503505619896e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,41843,0.142034823048022,0.00978467598392476,0.122856858119529,0.161212787976514,2.21495027879692e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAX,Protein max,41839,0.166202267033969,0.0114544198980822,0.143751604033728,0.18865293003421,2.42054573871057e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCG2,Secretogranin-2,42193,0.0516227799496944,0.00355832802806404,0.0446484570146888,0.0585971028846999,2.44796928324822e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0886124129248354,0.00611104237649724,0.0766347698669008,0.10059005598277,2.77345042395505e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RWDD1,RWD domain-containing protein 1,42249,0.0971073877049711,0.00671470154881251,0.0839465726692986,0.110268202740644,4.69635142284039e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.111938371401586,0.00774811285556729,0.0967520702046746,0.127124672598498,5.82063597735389e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOK1,Docking protein 1,39929,0.213699230863464,0.0147872205161621,0.184716278651786,0.242682183075142,6.39516612528795e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFASC,Neurofascin,42296,0.0453887809661754,0.00314327402785438,0.0392279638715808,0.0515495980607699,6.40962177358629e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,39657,0.0787401957438107,0.00545369613377251,0.0680509513216166,0.0894294401660049,7.95276992242018e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNLR1,Interferon lambda receptor 1,42119,0.056609995968811,0.0039282423884103,0.0489106408875269,0.0643093510500952,9.78898577425408e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLG4,Disks large homolog 4,39929,0.112032153490693,0.00777199254493646,0.0967990481026172,0.127265258878768,1.07941396616791e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD226,CD226 antigen,39657,0.0661517623251418,0.00458865988650793,0.0571579889475863,0.0751455357026973,1.08129478695425e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.133687960171422,0.00927663913801696,0.115505747460909,0.151870172881935,1.15712156305587e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOM,Apolipoprotein M,42199,0.0440184558348591,0.00305706914758893,0.0380266003055848,0.0500103113641334,1.15808548680493e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TALDO1,Transaldolase,39948,0.0685899531733936,0.00476145382661117,0.0592575036732357,0.0779224026735515,1.23536854196108e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MGLL,Monoglyceride lipase,42166,0.135387929777671,0.00940737668591445,0.116949471473279,0.153826388082063,1.28617729391539e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASHC3,WASH complex subunit 3,39929,0.117849949309132,0.00818427755046215,0.101808765310226,0.133891133308038,1.34170233623885e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0942498968178582,0.0065598003655509,0.0813926881013784,0.107107105534338,1.80513814871657e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0733411738145504,0.0051011526160115,0.0633429146871678,0.0833394329419329,1.83834657755472e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF19,Fibroblast growth factor 19,42185,0.120307624170308,0.00837788239534633,0.103886974675429,0.136728273665187,2.01214760195065e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREH,Trehalase,39966,0.116562028441825,0.00811182645304337,0.10066284859386,0.13246120828979,2.05242506295186e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18,Interleukin-18,42069,0.0686119980200201,0.00477945127707326,0.0592442735169565,0.0779797225230837,2.16012350924818e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPART,Spartin,39736,0.12031562756933,0.00838090657973477,0.10388905067305,0.13674220446561,2.53201565995848e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,42310,0.0353816337306806,0.00247043213929695,0.0305395867376586,0.0402236807237026,3.43192680391379e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH9,Protocadherin-9,39930,0.0522599915303281,0.00364839214982543,0.0451091429166703,0.059410840143986,3.90801912497233e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",39934,0.0979740586985418,0.00683985683168513,0.0845679393084389,0.111380178088645,3.91356449174376e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.072025877605067,0.00502922703530838,0.0621685926158626,0.0818831625942714,4.15687572813672e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GMPR2,GMP reductase 2,39736,0.102507266800107,0.0071592582103685,0.0884751207077849,0.116539412892429,4.32066317598065e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEXN,Nexilin,39990,0.10756628615266,0.00751368291490182,0.0928394676394521,0.122293104665867,4.35866176170015e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOXO3,Forkhead box protein O3,41843,0.148183887810409,0.0103723374869807,0.127854106335926,0.168513669284891,5.83391848399585e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.108045007363138,0.00757801824107443,0.093192091610632,0.122897923115644,8.60032637457105e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FMNL1,Formin-like protein 1,41839,0.0971632044813663,0.00682244119967004,0.0837912197300131,0.11053518923272,1.09743280920556e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMP6,Bone morphogenetic protein 6,41886,0.0615097146692368,0.00432030069278393,0.0530419253113803,0.0699775040270933,1.16344655712623e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CETN2,Centrin-2,41839,0.10456639013594,0.00734693002377323,0.0901664072893441,0.118966372982535,1.24655403783914e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBXN1,UBX domain-containing protein 1,39736,0.105517946719938,0.00741913931024258,0.090976433671862,0.120059459768013,1.66378843001531e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINC1,Antithrombin-III,39959,0.0221697027574914,0.00155937467526574,0.0191133283939705,0.0252260771210122,1.76196716951862e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAS6,Growth arrest-specific protein 6,42236,-0.0386187801034487,0.00272170539499367,-0.0439533226776363,-0.0332842375292611,2.24770287420709e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSC22D1,TSC22 domain family protein 1,39934,0.100995427337577,0.00711317832900962,0.0870535978127179,0.114937256862436,2.29468420532014e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0392669247753714,0.00277010643770256,0.0338375161574744,0.0446963333932684,2.74761076679722e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53,Cellular tumor antigen p53,41843,0.0680370423990097,0.00480207459783792,0.0586249761872474,0.077449108610772,3.08153593829814e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0563024141218605,0.0039722959505544,0.0485167140587739,0.0640881141849472,3.23919164631475e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.0878954937778966,0.00620223559291466,0.0757391120157839,0.100051875540009,3.391149863198e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDC,Nuclear migration protein nudC,42296,0.0969444588991616,0.00684922520853795,0.0835199774904272,0.110368940307896,3.66726700321294e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL11,Eotaxin,42296,0.0570167312451645,0.00403154678266225,0.0491148995511465,0.0649185629391825,4.30448668169119e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCAM,Cell surface glycoprotein MUC18,42217,-0.0487947264795258,0.00345266713471264,-0.0555619540635625,-0.042027498895489,4.98416130849977e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBM17,Splicing factor 45,39934,0.117146524095485,0.00828437386687885,0.100909151316403,0.133383896874568,5.14390476372213e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.116068895982208,0.00821830696002137,0.0999610143405657,0.132176777623849,5.79086195019622e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.145942036383814,0.0103387072771603,0.125678170120579,0.166205902647048,6.30164547996526e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0793641796715156,0.00561902739171904,0.0683508859837463,0.0903774733592849,6.48127932390345e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.069070671160737,0.00489779718607007,0.0594709886760397,0.0786703536454343,8.79939815132596e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.134711368025932,0.00955919726459944,0.115975341387317,0.153447394664547,1.00724072347106e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.0814863768254369,0.00578670184374389,0.0701444412116989,0.0928283124391749,1.02171340056561e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS2,Trypsin-2,42217,0.0866531954597797,0.00616239775071083,0.0745748958683865,0.098731495051173,1.34080095479855e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,42145,0.122071091534388,0.00868364027361856,0.105051156598096,0.13909102647068,1.4231710306962e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0536349034809775,0.00381497711798581,0.0461575483297253,0.0611122586322297,1.60486555610264e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP2,Microtubule-associated protein 2,39929,0.0709667359882976,0.00504842440763618,0.0610718241493306,0.0808616478272645,1.64497733098497e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F2,Prothrombin,39979,0.0225175254221428,0.00160279599240643,0.0193760452770262,0.0256590055672594,1.8390326172495e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRAS,Ras-related protein R-Ras,39649,0.199273418150504,0.0141839165414063,0.171472941729348,0.227073894571661,1.87690806965611e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CETN3,Centrin-3,39930,0.118995318824859,0.00848084822223689,0.102372856309274,0.135617781340443,2.36390524784629e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TADA3,Transcriptional adapter 3,39919,0.0611919988780402,0.00436301004812526,0.0526404991837147,0.0697434985723658,2.56683446469666e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRY2,Protein sprouty homolog 2,41913,0.140310748998087,0.0100236814387967,0.120664333378046,0.159957164618129,3.30125690437992e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICA1,Islet cell autoantigen 1,41913,0.120749065657554,0.00863143449064917,0.103831454055882,0.137666677259226,3.71252103482913e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0729751522394953,0.00521401434503989,0.0627556841232171,0.0831946203557734,3.83507631259445e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,A1BG,Alpha-1B-glycoprotein,39979,0.0249042653573233,0.00178193456367905,0.0214116736125124,0.0283968571021343,5.04767471706872e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RFC4,Replication factor C subunit 4,39919,0.0332901277404426,0.0023906629638532,0.0286044283312904,0.0379758271495949,1.02274806530612e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.0645729508713897,0.00464140695492107,0.0554757932397444,0.073670108503035,1.0715812596319e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRAP2,GRB2-related adapter protein 2,42145,0.193518803687471,0.0139182444681588,0.166239044529879,0.220798562845062,1.19519269921538e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.141367013386066,0.0101732134477752,0.121427515028427,0.161306511743706,1.52326549176283e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNM3,Dynamin-3,39934,0.0824962989633682,0.00594064862769171,0.0708526276530924,0.0941399702736439,1.72963317650422e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.118438361221044,0.00853112987470922,0.101717346666614,0.135159375775474,1.86039794596162e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNCG,Gamma-synuclein,42016,0.0999934134584061,0.00720858948117655,0.0858645780753,0.114122248841512,1.88264880808558e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.0689473047064286,0.00496889840181002,0.059208263838881,0.0786863455739763,2.0393726671858e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,39513,0.0793831529571525,0.00572396432450527,0.0681641828811221,0.0906021230331828,2.28978310431093e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,42016,0.118577370566853,0.00856201721253188,0.10179581683029,0.135358924303415,2.55358711947574e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEPR,Leptin receptor,42145,-0.0469184547007434,0.00338978643027119,-0.0535624361040749,-0.0402744732974119,2.83572583736572e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,42310,0.107292026757341,0.00775258149474085,0.0920969670276488,0.122487086487033,2.87538097987357e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGF,Pro-epidermal growth factor,42081,0.155296007354109,0.0112240049102349,0.133296957730049,0.177295056978169,3.04938618372145e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.0845370782997367,0.00611302017569122,0.0725555587553819,0.0965185978440915,3.35020539331756e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0435867054239323,0.00315084580117745,0.0374110476536245,0.0497623631942401,3.61376502672625e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EHD3,EH domain-containing protein 3,39638,0.176239786681796,0.0127393803941194,0.151270601109322,0.20120897225427,3.62742840029471e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP10,Caspase-10,41839,0.106369595232289,0.00769892322431295,0.0912797057126357,0.121459484751942,4.05445345229366e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPT1,Angiopoietin-1,42085,0.124504471074071,0.00901417641722568,0.106836685296309,0.142172256851834,4.23501805839373e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UROD,Uroporphyrinogen decarboxylase,39736,0.101007287933883,0.00730924686666697,0.0866811640752158,0.11533341179255,4.42908530490365e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0608662210026375,0.00440792457748844,0.0522266888307602,0.0695057531745149,4.48005616750619e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSNL1,Visinin-like protein 1,39929,0.0577530054956606,0.00417980079585698,0.0495605959357809,0.0659454150555402,4.48597648389813e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,39919,0.0824460719244851,0.00597580958697732,0.0707334851340095,0.0941586587149606,5.94098241312686e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RILPL2,RILP-like protein 2,39958,0.146909155125325,0.0106581802620263,0.126019121811754,0.167799188438897,7.06769334433483e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEMIP2,Cell surface hyaluronidase,39657,0.048155204863652,0.00349397815636051,0.0413070076771854,0.0550034020501186,7.35504547582331e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0726050952033452,0.00527539335752847,0.0622653242225894,0.082944866184101,9.38806941079162e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINE2,Glia-derived nexin,39958,0.0962749751835967,0.00699569602708655,0.0825634109705071,0.109986539396686,9.49364032288869e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.122270295754595,0.00889542397330487,0.104835264766917,0.139705326742272,1.05113373795122e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WDR46,WD repeat-containing protein 46,39919,0.0543114178666429,0.00395020582107782,0.0465690144573304,0.0620538212759555,1.13632339769491e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMPER,BMP-binding endothelial regulator protein,39736,0.0342352686035453,0.00249149553562497,0.0293519373537204,0.0391185998533702,1.28590804665746e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTF1,Cardiotrophin-1,41900,0.125226403314369,0.00912207547256217,0.107347135388147,0.143105671240591,1.34939334470362e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.0687546619191695,0.00502852205426407,-0.078610565145527,-0.0588987586928119,2.79727541887757e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF23,Fibroblast growth factor 23,42250,0.0744922566863083,0.00545392926025831,0.063802555336202,0.0851819580364146,3.40361160880384e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.123752373262455,0.00906436640540197,0.105986215107867,0.141518531417043,3.76957075948686e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.0859075972318766,0.00629373618161372,0.0735718743159137,0.0982433201478395,4.442128148391e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0733135014697836,0.00537290095356779,0.0627826156007908,0.0838443873387765,4.69689562209771e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,39736,0.185713751279213,0.0136182858473376,0.159021911018431,0.212405591539994,5.23701963760854e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0825252314500409,0.00605641085112243,0.0706546661818409,0.0943957967182409,5.27375788355057e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PF4,Platelet factor 4,39914,0.143371098684557,0.0105219435335363,0.122748089358826,0.163994108010289,6.01535911622374e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,41843,0.0665560154315594,0.00488773545062182,0.0569760539483406,0.0761359769147782,6.08335050425247e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.0757190672557645,0.00556288508429129,0.0648158124905536,0.0866223220209754,7.43546982974819e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL7,Interleukin-7,42119,0.0946935258831605,0.00697535103867093,0.0810218378473655,0.108365213918956,1.05058111419664e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESYT2,Extended synaptotagmin-2,39929,0.122090797187815,0.00899308716511254,0.104464346344194,0.139717248031436,1.17505342931117e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGL1,Fibrinogen-like protein 1,39990,-0.0946632664743993,0.00698737123000789,-0.108358514085215,-0.0809680188635838,1.71114306941043e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMVK,Phosphomevalonate kinase,41832,0.15889061497543,0.0117384281113859,0.135883295877114,0.181897934073746,1.81122252833533e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMT,Catechol O-methyltransferase,41740,0.121629359981931,0.00899034210403388,0.104008289458025,0.139250430505837,1.9995942561326e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0980629394105777,0.00724943058710761,0.0838540554598468,0.112271823361309,2.29813556693497e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL3,C-C motif chemokine 3,42119,0.0865164957432267,0.00640997874613938,0.0739529374007935,0.0990800540856599,3.00595314937805e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPARC,SPARC,42181,0.101763366088094,0.00754378106258458,0.0869775552054282,0.11654917697076,3.3122038199221e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STK24,Serine/threonine-protein kinase 24,41839,0.0905156522512535,0.00671579436837724,0.0773526952892341,0.103678609213273,3.93303327585189e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.111726568095126,0.00829268871360829,0.0954728982164539,0.127980237973798,4.15503040167732e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,42119,0.0486505699707068,0.00361325472333689,0.0415685907129664,0.0557325492284471,4.65405650974081e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMG3,Proteasome assembly chaperone 3,42119,0.0718622148560051,0.00533848702973725,0.06139878027772,0.0823256494342901,4.86478304495432e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,42106,0.049857506021792,0.00370413200241908,0.0425974072970506,0.0571176047465334,4.94541294212692e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LARP1,La-related protein 1,39919,0.0904862011850852,0.00671980127647302,0.0773153906831981,0.103657011686972,5.15394827734908e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.0463072232524628,0.0034428544312765,0.0395592285671609,0.0530552179377648,6.44055483857641e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,41843,0.0878737749540786,0.00656618877989523,0.075004044945484,0.100743504962673,1.39896952499352e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARA5,Scavenger receptor class A member 5,42249,0.0439932125215058,0.00329421520659221,0.0375365507165851,0.0504498743264266,1.99458548055268e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA4D,Semaphorin-4D,42249,0.0432892784155468,0.00324741254461883,0.0369243498280939,0.0496542070029997,2.75167763129295e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.095936614737745,0.00719788105122661,0.0818287678773408,0.110044461598149,3.20896083756801e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F12,Coagulation factor XII,39979,0.0592552926549228,0.00445074087547223,0.0505318405389972,0.0679787447708484,3.85144941665068e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.0722649416869917,0.00543243739153898,0.0616173643995753,0.0829125189744081,3.96894244944648e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NID1,Nidogen-1,42189,0.0516871039819301,0.00388855483603801,0.0440655365032956,0.0593086714605646,4.57471773450451e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.14014181678291,0.0105638223293286,0.119436725017426,0.160846908548394,6.533055532282e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNRD2,Protein ZNRD2,39930,0.0998333304929384,0.00752982737475765,0.0850748688384134,0.114591792147463,7.9848847371305e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0748483772628711,0.00565298981391856,0.0637685172275907,0.0859282372981514,1.02161043619493e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD22,B-cell receptor CD22,42296,0.0608978454343036,0.00460502992411507,0.051871986783038,0.0699237040855691,1.11343040700415e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.0806004176235275,0.00610255716350145,-0.0925614296639904,-0.0686394055830647,1.58006763091344e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMOX2,Heme oxygenase 2,41839,0.068157016151845,0.0051640540974211,0.0580354701208997,0.0782785621827903,1.59288697786391e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDT,D-dopachrome decarboxylase,39966,0.0579567269732989,0.00438942915591177,0.0493534458277118,0.066560008118886,1.6312010249066e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0808482157856256,0.0061311015132701,0.0688312568196162,0.092865174751635,1.84061111922798e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.0455361608147491,0.00346250173986406,-0.0523226642248827,-0.0387496574046156,2.90609879706233e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.123442866620559,0.00938361901317404,0.105050973354738,0.14183475988638,3.11662398053431e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED8,Protein TMED8,39930,0.146626933316361,0.0111522525748108,0.124768518269732,0.16848534836299,3.39325103298413e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPBP,Platelet basic protein,39908,0.121574890691185,0.00925089878754054,0.103443129067605,0.139706652314764,3.66347726878226e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,42217,0.065434545704346,0.00498329214324044,0.0556672931035947,0.0752017983050972,3.79265386868738e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0918160416676524,0.00699359648168445,0.0781085925635509,0.105523490771754,3.89803703928188e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PQBP1,Polyglutamine-binding protein 1,41843,0.080212173979534,0.00611148711725938,0.0682336592297057,0.0921906887293624,4.16263899236681e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATG4A,Cysteine protease ATG4A,41843,0.0824534503819357,0.00628877607592931,0.0701274492731143,0.0947794514907572,4.97013727739722e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.139979899953688,0.010678030864247,0.119050959459763,0.160908840447612,5.60563193337918e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0927478222440667,0.00707627810121214,0.078878317165691,0.106617327322443,5.89589751010738e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",42107,0.154765002392973,0.0118210494962659,0.131595745380292,0.177934259405654,6.28600488471293e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP7,Caspase-7,39929,0.119451340404606,0.00912246558875548,0.101571307850646,0.137331372958567,6.80656993443141e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.053148300281382,0.00406391530335344,0.0451830262868093,0.0611135742759547,7.62570531434558e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,42296,0.0943018901982799,0.00721317939595051,0.0801640585822169,0.108439721814343,7.96285577193785e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0359178871914613,0.00274759283563062,0.0305326052336253,0.0413031691492973,9.00320319524515e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APPL2,DCC-interacting protein 13-beta,39736,0.159251251528368,0.0121853902939762,0.135367886552174,0.183134616504561,9.53623752172244e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.111253881611661,0.00852735164301304,0.0945402723913556,0.127967490831967,1.14050338094552e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,39922,0.0282669955896498,0.002166386278498,0.0240208784837937,0.0325131126955059,1.23869220838579e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD72,B-cell differentiation antigen CD72,39736,0.0610366013081939,0.00468570733159489,0.0518526149382679,0.0702205876781199,1.6605290498982e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.10638438341756,0.00817095512799088,0.0903693113666983,0.122399455468423,1.81142417553139e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL8,C-C motif chemokine 8,42239,0.0851031243464439,0.00654188963751852,0.0722810206569076,0.0979252280359802,1.84297012311924e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FIS1,Mitochondrial fission 1 protein,42125,0.107807294722431,0.00828720205028113,0.09156437870388,0.124050210740982,1.85258837339368e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0916698066525986,0.00705028905380186,0.077851240107147,0.10548837319805,2.04054722514582e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RILP,Rab-interacting lysosomal protein,42224,0.0822456184625257,0.00632823203158673,0.0698422836806157,0.0946489532444357,2.16251967619229e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK13,Kallikrein-13,41839,0.062926696604732,0.00484664167076718,0.0534272789300283,0.0724261142794357,2.59818883501539e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0375859967979573,0.00289490733962576,0.0319119784122908,0.0432600151836237,2.84089208190766e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUB1,NEDD8 ultimate buster 1,42119,0.117882205540367,0.00909298896334248,0.100059947172216,0.135704463908518,3.30347782890385e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL1,Growth-regulated alpha protein,42117,0.130164624275164,0.0100461739250202,0.110474123382124,0.149855125168203,3.63589534324859e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TTF2,Transcription termination factor 2,39649,0.0696906034555667,0.00537504890024035,0.0591555076110956,0.0802256993000378,3.63910572474808e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLB1,Beta-galactosidase,42016,0.0602108779303375,0.00465587649803373,0.0510853599941914,0.0693363958664836,4.99581041986841e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS1,Galectin-1,42145,0.0488531079847206,0.00377802228724571,0.041448184301719,0.0562580316677222,5.05911264359726e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIFBP,KIF-binding protein,42070,0.115242606513443,0.00891359353505226,0.0977719631847402,0.132713249842145,5.20616922273852e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0646346709376906,0.00500258988330128,0.0548295947664201,0.0744397471089611,5.77633447438631e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS9,Galectin-9,42129,0.0438196437511478,0.00339243512252099,0.0371704709110067,0.050468816591289,6.05908390201384e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,39736,0.166978496714054,0.0129251632383282,0.141645176766931,0.192311816661177,6.59177011352576e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPB1,Carboxypeptidase B,42310,0.0864006087643986,0.00670101993593906,0.073266609689958,0.0995346078388391,8.10606241692948e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.118507937290168,0.0091923093080299,0.10049101104643,0.136524863533907,9.18706440184986e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MENT,Protein MENT,39736,-0.0330728375784149,0.00256556850506963,-0.0381013518483513,-0.0280443233084784,9.41035614779239e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL18,C-C motif chemokine 18,42020,0.0976074075739598,0.00758119776888776,0.0827482599469398,0.11246655520098,1.04134528098394e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPA1,Carboxypeptidase A1,42310,0.089727787702041,0.00698815408480296,0.0760310056958272,0.103424569708255,1.61022683439127e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GDF2,Growth/differentiation factor 2,42145,0.0489092998117713,0.00381461927559094,0.0414326460316131,0.0563859535919296,2.04947181802412e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,42185,0.0412650097581987,0.00321852166274146,0.0349567072992255,0.047573312217172,2.05784961089164e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.154295228221442,0.0120559743356177,0.130665518523631,0.177924937919252,2.78905045660719e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBCB,Tubulin-folding cofactor B,42016,0.138170234011845,0.0108048754697295,0.116992678091175,0.159347789932515,3.16508355724726e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.0435067842987891,0.00340834492310969,0.0368264282494941,0.0501871403480841,4.21815908618743e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,39990,0.100977485587719,0.00790831942235461,0.0854771795199041,0.116477791655534,4.41210765560602e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.0676220560360025,0.00529937583772741,0.0572352793940568,0.0780088326779482,4.97646715703209e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD69,Early activation antigen CD69,42082,0.120512090484628,0.00945769536116411,0.101975007576746,0.13904917339251,5.62728557661879e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0588595680843813,0.00462402739905637,0.0497964743822308,0.0679226617865318,6.61529313713715e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0753281501805282,0.0059224993977197,0.0637200513609976,0.0869362490000588,7.59863367990161e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.115769070764287,0.00911116581360335,0.0979111857696243,0.133626955758949,8.94386234069978e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0911105691467923,0.0071669160491725,0.0770634136904142,0.10515772460317,9.1317699042997e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.0365088362296012,0.00287268951687059,-0.0421393076826676,-0.0308783647765349,9.37177276386037e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPB1,Heat shock protein beta-1,41949,0.0961946085344043,0.00757428122914151,0.081349017325287,0.111040199743522,9.6251875900783e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,39952,0.0651715236224728,0.00513224222268473,0.0551123288660108,0.0752307183789349,1.07106441351314e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.135729223698548,0.0106878247219714,0.114781087243484,0.156677360153612,1.07824579909886e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0920627676251404,0.00726355311290211,0.0778262035238523,0.106299331726429,1.33355479789402e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YWHAQ,14-3-3 protein theta,39736,0.1015119672734,0.00800493537793999,0.085822293932638,0.117201640614163,1.34600288583162e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCRG1,Scrapie-responsive protein 1,39958,0.0373937258829588,0.00295117116550785,0.0316094303985634,0.0431780213673542,1.51618922980152e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.103883298245095,0.00822227840293832,0.0877676325753361,0.119998963914854,2.18757992658741e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XCL1,Lymphotactin,42262,0.074363502938778,0.00589270340944619,0.0628138042562635,0.0859132016212925,2.62506262372683e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F11,Coagulation factor XI,39822,0.0428564795403402,0.00339417626524841,0.0362038940604534,0.0495090650202271,2.66268410155498e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.101164789078344,0.00801382901348822,0.0854576842119067,0.116871893944781,2.76322171486253e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,42262,0.050029384894021,0.00397074754124922,0.0422467197131726,0.0578120500748695,3.37781689247333e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RASSF2,Ras association domain-containing protein 2,41843,0.0777004923450495,0.00617215131946168,0.0656030757589046,0.0897979089311944,3.91404063351009e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0505024144390814,0.00401326248440745,0.0426364199696428,0.05836840890852,4.5144230898156e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0980181487236055,0.00779364838150798,0.0827425978958499,0.113293699551361,4.56086745238181e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0723907870531634,0.00576363950917953,0.0610940536151715,0.0836875204911553,5.62294488664385e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JAM3,Junctional adhesion molecule C,39736,0.0688990666165842,0.00549109269371417,0.0581365249369044,0.079661608296264,7.17673115427156e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRADD,Death domain-containing protein CRADD,41997,0.101056465105009,0.0080666082653149,0.0852459129049921,0.116867017305026,8.35338017219485e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD244,Natural killer cell receptor 2B4,42296,0.0372510239551638,0.00297390995056364,0.0314221604520591,0.0430798874582685,8.45882736026734e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MATN2,Matrilin-2,42144,0.04008176521081,0.00320171888941307,0.0338063961875603,0.0463571342340596,9.28938601419343e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRA1,GDNF family receptor alpha-1,42247,0.0385869230606168,0.00308403165396036,0.0325422210188545,0.0446316251023791,1.00987134766733e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.126509823479323,0.0101120555556747,0.106690194590201,0.146329452368446,1.03109927823082e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.037672315966512,0.00301281552359068,0.0317671975402743,0.0435774343927498,1.11131699117966e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATOX1,Copper transport protein ATOX1,42181,0.0959538864262471,0.00767646080634682,0.0809080232458073,0.110999749606687,1.17632274204779e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEP1B,Meprin A subunit beta,42145,0.154552076954807,0.0123782750678065,0.130290657821906,0.178813496087708,1.40162081204108e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPON2,Spondin-2,42070,-0.0470361166520262,0.00376869447772419,-0.0544227578283656,-0.0396494754756868,1.4952581215462e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.141228878463783,0.0113124815105681,0.11905641470307,0.163401342224497,1.5710566573452e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0824065684323903,0.00660494388754633,0.0694608784127995,0.0953522584519811,1.73967630052623e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEPH,Hephaestin,39958,0.0375876380891756,0.00301403868623804,0.031680122264149,0.0434951539142022,1.83713309124038e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,39649,0.106867208205551,0.00857617559644077,0.0900579040365266,0.123676512374574,2.10784876269255e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.0841877137612318,0.00677509547348509,0.070908526633201,0.0974669008892626,2.93721724600559e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0529936707862328,0.00426622047591826,0.044631878653433,0.0613554629190325,3.09607462698263e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHRDL2,Chordin-like protein 2,42145,0.0612981540683598,0.00493598662804206,0.0516236202773974,0.0709726878593222,3.21988527711662e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CERT,Ceramide transfer protein,41839,0.0822335541841798,0.00663738482197497,0.0692242799331088,0.0952428284352507,4.66202130067817e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BIN2,Bridging integrator 2,42137,0.119414556332255,0.00964379822792571,0.10051271180552,0.138316400858989,5.02822800051133e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,39638,0.0766721378985332,0.00618951297194163,0.0645406924735276,0.0888035833235387,5.22113295861584e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.0897546848124111,0.00725144185735574,0.0755418587719939,0.103967510852828,5.348216281748e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACYBP,Calcyclin-binding protein,39713,0.138746774543548,0.0112043192050134,0.116786308901722,0.160707240185374,5.47128030518397e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C3,Complement C3,39445,0.061507187938496,0.0049720010401144,0.0517620658998718,0.0712523099771203,6.4721446523593e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.119663289364984,0.00967622013611457,0.100697897898199,0.138628680831768,6.63288328903136e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOD,Apolipoprotein D,39468,-0.0566844667207042,0.00458486203066945,-0.0656707963008163,-0.047698137140592,7.07206038644679e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GZMA,Granzyme A,42296,0.0452481779213963,0.00366627162653082,0.0380622855333959,0.0524340703093967,8.26343679328669e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA11,Integrin alpha-11,42119,-0.0451905401716254,0.003661819887715,-0.0523677071515468,-0.038013373191704,8.38477112162566e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THPO,Thrombopoietin,41900,0.0519807980968547,0.0042125105583429,0.0437242774025026,0.0602373187912068,8.58853366868457e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN4,CCN family member 4,42262,0.0521395384111829,0.0042268420967338,0.0438549279015847,0.0604241489207812,8.94868317859186e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REEP4,Receptor expression-enhancing protein 4,39934,0.0831286115952024,0.00673624076927154,0.0699255796874302,0.0963316435029747,9.16117918944242e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDC4,Syndecan-4,42145,0.0630455873364336,0.00511298983662224,0.053024127256654,0.0730670474162132,9.53437855998137e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.120403384529875,0.00976548881055954,0.101263026461178,0.139543742598572,1.06202249665275e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,39915,0.116662686795512,0.00947065526761035,0.0981002024709957,0.135225171120028,1.2029007340983e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THTPA,Thiamine-triphosphatase,39897,0.11673025437642,0.00948258790687566,0.0981443820789435,0.135316126673896,1.33372774536738e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,39930,0.0770954558793657,0.00626305558059496,0.0648198669413996,0.0893710448173318,1.33825955317431e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD164,Sialomucin core protein 24,42137,0.0358800644106883,0.00291953508318012,0.0301577756476553,0.0416023531737213,1.57269065912549e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRLF1,Cytokine receptor-like factor 1,42185,0.03302198484568,0.00268811926177165,0.0277532710926076,0.0382906985987524,1.67410367277252e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOA1,Apolipoprotein A-I,39979,-0.0364056549059162,0.00296260374332904,-0.0422123582428411,-0.0305989515689913,1.72930862893334e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSZ,Cathepsin Z,42168,0.0427739877558174,0.00348366659555611,0.0359460012285275,0.0496019742831074,1.80204104979094e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYO9B,Unconventional myosin-IXb,41913,0.0875160295789858,0.00712916281527919,0.0735428704610385,0.101489188696933,1.87653442085271e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB33A,Ras-related protein Rab-33A,39575,0.0880825248653018,0.00717887156975316,0.0740119365885856,0.102153113142018,2.21261091184887e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.127112357652775,0.0103738461886349,0.106779619123051,0.1474450961825,2.45479315539195e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIF1,Allograft inflammatory factor 1,41843,0.0692253966500838,0.00565292384844566,0.0581456659071303,0.0803051273930372,2.70671474597814e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STXBP1,Syntaxin-binding protein 1,39934,0.10308834595107,0.00842125356586423,0.0865826889619763,0.119594002940164,3.07012435772944e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.0403235638300043,0.00329588197193993,0.0338636351650021,0.0467834924950066,3.07344582813944e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMEM106A,Transmembrane protein 106A,39919,0.0948030029745369,0.00774566711730369,0.0796214954246217,0.109984510524452,3.1462538198129e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PARK7,Parkinson disease protein 7,42137,0.0669257816049975,0.00547187473075301,0.0562009071327216,0.0776506560772734,3.2227251117195e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.0737288519843105,0.00602837144730488,0.0619132439475929,0.0855444600210281,3.24472361469653e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0439467725222078,0.0035946685376835,0.0369012221883481,0.0509923228560674,3.42466729078002e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0524911950383082,0.00429769843889499,0.044067706098074,0.0609146839785424,3.94658336182003e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.0423392171443825,0.00346657034016435,-0.0491336950111046,-0.0355447392776604,3.9570112386469e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD99L2,CD99 antigen-like protein 2,42137,0.0324673954768008,0.00265834532827078,0.0272570386333901,0.0376777523202115,3.98675446822347e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PVR,Poliovirus receptor,42249,0.0493385142121604,0.00404109906062718,0.0414179600533311,0.0572590683709896,4.18169452489793e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APP,Amyloid-beta precursor protein,42112,0.0873074900940198,0.0071516833069806,0.0732901908123379,0.101324789375702,4.26161396206788e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAP18,Chromatin complexes subunit BAP18,39929,0.0899082926771171,0.00736154339130314,0.075479667630163,0.104336917724071,4.32588655713377e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0969054904568895,0.00794572693904751,0.0813318656563564,0.112479115257423,5.4053457681431e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.084752830391235,0.00695779050183128,0.0711155610076457,0.0983900997748243,6.39367168763882e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2L1,Bcl-2-like protein 1,39929,0.131082832432192,0.0107665321915805,0.109980429336694,0.15218523552769,6.87290841216757e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.0654771595710039,0.00538144800985313,0.0549295214716917,0.076024797670316,7.04741184873786e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0485336829766479,0.00399843004954638,0.040696760079537,0.0563706058737588,9.91921940048831e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0605840563901349,0.00499725496352217,0.0507894366616314,0.0703786761186383,1.29587769757682e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MESD,LRP chaperone MESD,42137,0.159535715227215,0.0131717492155526,0.133719086764732,0.185352343689698,1.36176856314923e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0700167153698369,0.00578733078163603,0.0586735470378303,0.0813598837018435,1.73453646567678e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB9,Serpin B9,42016,0.0429081518774474,0.00354857806348477,0.0359529388730172,0.0498633648818775,1.74576412196422e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0804009467423136,0.00665020638992721,0.0673665422180563,0.093435351266571,1.91379821054702e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB6,Serpin B6,42216,0.0763601983877183,0.00632674500951497,0.0639597781690689,0.0887606186063677,2.26754488855774e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FEN1,Flap endonuclease 1,41843,0.0839596599581044,0.00695775301365502,0.0703224640513406,0.0975968558648682,2.35859795983004e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,42093,0.116701532487841,0.00967624615924158,0.0977360900157271,0.135666974959954,2.52969353633751e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,39930,0.108714303360019,0.00901864490975851,0.0910377593368927,0.126390847383146,2.93706641553805e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.129393673660149,0.0107437254301245,0.108335971817105,0.150451375503193,3.09896997931602e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0623131085677779,0.00517280663507792,0.0521744075630252,0.0724518095725307,3.23612190857335e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.123242689149223,0.0102343369410524,0.10318338874476,0.143301989553685,3.40540787318073e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSNAX,Translin-associated protein X,39575,0.0510890727451909,0.00424567707892343,0.042767545670501,0.0594105998198808,3.84240082762783e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.0608992387085267,0.00506191653453564,0.0509778823008368,0.0708205951162165,3.89197720207298e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBC1D5,TBC1 domain family member 5,42119,0.101415666726978,0.00843552903531044,0.0848820298177691,0.117949303636186,3.99593045402303e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0897868929851767,0.00746640551571067,0.0751527381743838,0.10442104779597,4.21522692122502e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MIF,Macrophage migration inhibitory factor,42105,0.086921550057835,0.00723749266191301,0.0727360644404855,0.101107035675185,4.64523181322489e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C2,Complement C2,42199,0.0292884848467293,0.0024409376280881,0.0245042470956767,0.034072722597782,5.28628986874792e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP2,Caspase-2,42119,0.0886437322314065,0.00739166996333758,0.0741560591032648,0.103131405359548,5.7251092154094e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CIAPIN1,Anamorsin,42181,0.079445228843362,0.00662474922599362,0.0664607203604145,0.0924297373263094,5.72850508199184e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA3,Annexin A3,42224,0.0899878193157567,0.00750991056962847,0.0752683945992848,0.104707244032228,6.42016839158767e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKD2,Polycystin-2,39575,0.0756795425575613,0.0063207170536013,0.0632909371325028,0.0880681479826199,7.85517484652794e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.055477075091099,0.00463398251790256,0.04639446935601,0.064559680826188,7.93918701305123e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.125365808692052,0.0104757320997706,0.104833373776502,0.145898243607602,8.41329495155645e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0865931046800466,0.0072453474321486,0.0723922237130354,0.100793985647058,1.01366373032073e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.134287916484899,0.011239440804134,0.112258612508796,0.156317220461001,1.04630924383649e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA12,Serpin A12,41751,0.139767996477135,0.0117101604718988,0.116816081952213,0.162719911002056,1.13817444172939e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.050537308449874,0.00423750052806336,0.0422318074148698,0.0588428094848781,1.35283443771735e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL16,C-X-C motif chemokine 16,42295,0.030046288973476,0.00252095829842375,0.0251052107085654,0.0349873672383865,1.37217968028212e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL2,C-C motif chemokine 2,41992,0.0668169563833271,0.00560801558492371,0.0558252458368767,0.0778086669297776,1.45187464700842e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.0821623829439209,0.00690345488285247,0.06863161137353,0.0956931545143117,1.82548143566574e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSPN,Persephin,42119,0.111185733108527,0.00935208187456025,0.0928556526343891,0.129515813582665,1.96163758610076e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX8,Syntaxin-8,42119,0.0614965939111392,0.00517561224076491,0.05135239391924,0.0716407939030384,2.12821322863533e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.116540882008724,0.0098161865644333,0.0973011563424344,0.135780607675013,2.59165478154751e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUGT1,Protein SGT1 homolog,41843,0.102537362595131,0.00864193392069361,0.0855991721105719,0.119475553079691,2.61927666820727e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLG,Plasminogen,39742,0.0280265126629847,0.00236208583956091,0.0233968244174453,0.0326562009085241,2.80850417121199e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STXBP3,Syntaxin-binding protein 3,41843,0.055746762438007,0.00470328462422919,0.0465283245745178,0.0649652003014962,3.03134093269151e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],41874,0.06066999631306,0.00512084913897947,0.0506331320006602,0.0707068606254597,3.21618180312744e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.0975389766837671,0.00823403450022424,0.0814002690633276,0.113677684304207,3.49766387039576e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.116736268518228,0.00990847246632764,0.0973156624842263,0.136156874552231,6.96487727076596e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPI,Glucose-6-phosphate isomerase,39990,0.0608940499963106,0.00516646622795685,0.0507677761895152,0.071020323803106,7.02506427816575e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.0734990954831582,0.00624077696365128,0.0612671726344017,0.0857310183319148,7.33915565459049e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPI,Mannose-6-phosphate isomerase,42070,0.108334278983398,0.00920176497616586,0.0902988196301131,0.126369738336683,7.68346340505477e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC3B,Tetranectin,39726,0.0267356079764331,0.00227085642968314,0.0222847293742541,0.031186486578612,8.26764686540709e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.0777828475803339,0.00661612343314846,0.0648152456513629,0.0907504495093049,1.00940324045482e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LACTB2,Endoribonuclease LACTB2,42145,0.0835826166132278,0.00712020048081694,0.0696270236708266,0.097538209555629,1.14768993902668e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACYP1,Acylphosphatase-1,39701,0.082413614925673,0.0070298117589427,0.0686351838781453,0.0961920459732007,1.48301076135759e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.143946807724346,0.0122889980914769,0.119860371465051,0.16803324398364,1.54103491566741e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0813073049971052,0.00693787435807777,0.0677090712552728,0.0949055387389376,1.54246847096439e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAP,Prolyl endopeptidase FAP,42310,0.0348511435521681,0.00297568130803914,0.0290188081884114,0.0406834789159248,1.56366672983468e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX1,Peroxiredoxin-1,41742,-0.116200657987093,0.00992833636765567,-0.135660197267698,-0.0967411187064882,1.74332308693783e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MICALL2,MICAL-like protein 2,39649,0.0866891021411677,0.00740763802467525,0.0721701316128042,0.101208072669531,1.89311561761256e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.070066974291923,0.00599063573069292,0.0583253282597649,0.0818086203240812,2.04320461441625e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,39966,0.0438091596051432,0.0037487033749396,0.0364617009902616,0.0511566182200249,2.25858087965532e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX4,Syntaxin-4,42070,0.0744016044124877,0.00637699072628133,0.0619027025889762,0.0869005062359991,2.65176832379755e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCOF1,Treacle protein,39958,0.0409136515076292,0.0035079798730712,0.0340380109564097,0.0477892920588488,2.96721360354442e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.136063479831551,0.011667880976796,0.113194433117031,0.158932526546071,3.02894411221611e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.141071276739149,0.0121028501272975,0.117349690489646,0.164792862988652,3.03246246472266e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP7,Matrilysin,41881,0.0653176341454439,0.00560702956612338,0.054327856195842,0.0763074120950457,3.28329595863044e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYBB1,Beta-crystallin B1,39958,0.0832588670992107,0.00715034041891399,0.0692441998781393,0.0972735343202821,3.69800055905528e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12A_IL12B,Interleukin-12,42070,0.0968538680110335,0.00832243002761847,0.0805419051569013,0.113165830865166,3.7362411522516e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.0748943978237555,0.0064349760217667,0.0622818448210928,0.0875069508264182,3.9684818275332e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0418095483669128,0.00359469688295626,0.0347639424763185,0.048855154257507,4.03507503158442e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.0307218648845587,0.00264185252559145,0.0255438339343994,0.0358998958347179,4.13380140317865e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA4,Protein disulfide-isomerase A4,39966,0.076974708253809,0.00662396420616331,0.0639917384097289,0.089957678097889,4.84758673928711e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NBN,Nibrin,41913,0.0682852767939258,0.00588000933571654,0.0567604584959214,0.0798100950919303,4.98729081060784e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADM,Pro-adrenomedullin,42262,0.0328192080597915,0.00282934221197555,0.0272736973243194,0.0383647187952636,5.7825502443439e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.160147684042254,0.0138081954308765,0.133083620997736,0.187211747086772,6.30328611727322e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP1,Guanylate-binding protein 1,39911,0.0810231737037261,0.00698707288193217,0.067328510855139,0.0947178365523131,6.44553595967628e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.0948990188538258,0.00819218550309861,0.0788423352677526,0.110955702439899,7.40319133892046e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0662989646474273,0.00572640651366276,0.0550752078806482,0.0775227214142063,7.96367794554445e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GMFG,Glia maturation factor gamma,39958,0.0900973265874211,0.00778495403969655,0.0748388166696158,0.105355836505226,8.37910203733311e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.0384901671461731,0.00333740295486355,0.0319488573546406,0.0450314769377057,1.33330892203451e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSS,Cathepsin S,39358,0.0302268451299831,0.00262238332605348,0.0250869738109183,0.035366716449048,1.46644196179406e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTGR1,Prostaglandin reductase 1,39958,0.104188693758734,0.00904283754372098,0.0864647321730408,0.121912655344427,1.51624919876363e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,42181,0.104029910741523,0.00904554925343454,0.0863006342047917,0.121759187278255,1.81116726622263e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.100365089916588,0.00873776320494897,0.0832390740348882,0.117491105798288,2.29634373124113e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.149466884198797,0.0130202853195408,0.123947124972497,0.174986643425097,2.30750003168467e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3BP1,SH3 domain-binding protein 1,39930,0.0612958967081688,0.00534271083327084,0.050824183474958,0.0717676099413797,2.65585119582852e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,42032,0.0357094493006996,0.00311402569445541,0.029605958939567,0.0418129396618322,2.66442401826345e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0936226613920872,0.00816478514850741,0.0776196825010127,0.109625640283162,2.84969333654109e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAG6,Large proline-rich protein BAG6,41900,0.0457494544864361,0.0039927786073012,0.0379236084161258,0.0535753005567465,2.97103648111517e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCA,Calcitonin,41997,0.0859610474011948,0.00751341932716684,0.0712347455199478,0.100687349282442,3.60132967047446e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RP2,Protein XRP2,42070,0.0526030205189222,0.0046050897002511,0.0435770447064301,0.0616289963314144,4.42469811618356e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.034932850955699,0.00306202526005889,0.0289312814459836,0.0409344204654144,5.19151639139167e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0794736388756297,0.00696852660558673,0.0658153267286797,0.0931319510225797,5.47051094127009e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCRIB,Protein scribble homolog,39638,0.108048494113187,0.00947321316987829,0.0894809963002258,0.126615991926149,5.7627672735842e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.133503672813795,0.0117096997197622,0.110552661363061,0.156454684264529,6.11563691431402e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0709713724667955,0.00623779849561798,0.0587452874153843,0.0831974575182068,7.43669561905489e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.115283666863096,0.0101400387089331,0.0954091909935875,0.135158142732605,8.14418521682977e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0892016136194116,0.0078540669188091,0.0738076424585457,0.104595584780277,9.85877788392215e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0749232195175902,0.00660167281212662,0.0619839408058221,0.0878624982293584,1.0208781445881e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,41843,0.047614517483857,0.00419812867435037,0.0393861852821303,0.0558428496855837,1.11575993579037e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OCLN,Occludin,39934,0.0542492143206738,0.00478239855322995,0.0448757131563431,0.0636227154850045,1.15410353695404e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.120824116355205,0.0106535207498289,0.0999432156855408,0.14170501702487,1.1832838013453e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTRB1,Chymotrypsinogen B,42137,0.0715963676755619,0.00631869505077006,0.0592117253760526,0.0839810099750713,1.25458567022188e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POSTN,Periostin,39966,-0.046276889610906,0.00409086321953591,-0.0542949815211964,-0.0382587977006156,1.6407364852754e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,39930,0.107533240385041,0.00950589435689507,0.088901687445527,0.126164793324556,1.64235252260089e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0645141215011203,0.00570741625088637,0.053327585649383,0.0757006573528576,1.82906107387612e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.071069100361124,0.00629052505227493,0.0587396712586652,0.0833985294635829,1.83734059237301e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,42145,0.0429262467431475,0.00380211630200929,0.0354740987912093,0.0503783946950857,1.98800905850848e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.0975691253770072,0.00864496051765866,-0.114513247991618,-0.0806250027623962,2.07616154378939e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.0516868056799911,0.00458508913107404,0.0427000309830859,0.0606735803768962,2.58489408926208e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.148244022221437,0.0131613932239967,0.122447691502404,0.174040352940471,2.68191235172561e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA2,Annexin A2,39492,0.0859146273311367,0.00763022801355996,0.0709593804245592,0.100869874237714,3.00666796905398e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.106450555629964,0.0094549858999807,0.0879187832660016,0.124982327993926,3.01958913116998e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLF4,Krueppel-like factor 4,39586,0.0492775005746591,0.0043881396141429,0.040676746930939,0.0578782542183792,4.19778957401068e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL7,C-C motif chemokine 7,42119,0.0682589479449397,0.00608192551000489,0.0563383739453301,0.0801795219445493,4.21643239613438e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1R,Complement C1r subcomponent,39979,0.0227886570130898,0.00203302064378135,0.0188039365512783,0.0267733774749012,5.21043905577145e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.100349374562805,0.00895831422620607,0.0827910786794411,0.117907670446169,5.35989271900732e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,42185,0.106856488787601,0.00954121008511727,0.0881557170207707,0.12555726055443,5.49455305280665e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTD,Deoxycytidylate deaminase,39736,0.115974492371625,0.0103575059588006,0.095673780692376,0.136275204050874,6.01051993568015e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0839778008145206,0.00750158564751566,0.0692746929453899,0.0986809086836513,6.21063454865879e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP3,Caspase-3,42310,0.106433250695796,0.00952148815874975,0.0877711339046461,0.125095367486945,6.9490794117973e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS3BP,Galectin-3-binding protein,39979,0.0377525406014788,0.00337632764518007,0.0311349384169259,0.0443701427860318,7.09959275679653e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.0330365652251772,0.00296177138409054,0.0272314933123598,0.0388416371379947,9.70669786055329e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0792306262362191,0.00710769738821078,0.065299539355326,0.0931617131171123,1.04235867318466e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.0357591261297168,0.00321063789301742,0.0294662758594027,0.042051976400031,1.09920931201726e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.0484039048255969,0.0043460633279036,0.0398856207029059,0.056922188948288,1.16069449252675e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0406431543989725,0.003652566461432,0.0334841241345658,0.0478021846633792,1.29990113550625e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRG2,Bone marrow proteoglycan,39966,-0.0616426682505949,0.00554359830085623,-0.0725081209202731,-0.0507772155809167,1.41382005039464e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCS,Copper chaperone for superoxide dismutase,42016,0.055682819496334,0.00501229902632038,0.0458587134047461,0.065506925587922,1.50674520299241e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLMH,Bleomycin hydrolase,42310,0.0370566441794666,0.00334320757450118,0.0305039573334443,0.0436093310254889,1.97754412844229e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0522668111028131,0.00472018099444474,0.0430152563537014,0.0615183658519248,2.38930055515461e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALM2,Paralemmin-2,39929,0.0464065586462195,0.00419168742054124,0.0381908513019587,0.0546222659904803,2.42109599907797e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLTA,Clathrin light chain A,41900,0.0559831066778003,0.0050621492799434,0.0460612940891113,0.0659049192664894,2.62966303078024e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRK5,G protein-coupled receptor kinase 5,41900,0.0613829225722114,0.00556547258243695,0.050474596310635,0.0722912488337879,3.65805212280908e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0483626885607675,0.00438763806909534,0.0397629179453406,0.0569624591761944,3.9113967569177e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBLN4,Cerebellin-4,42262,0.0378373795941831,0.00343366094557255,0.0311074041408609,0.0445673550475053,4.04026790293244e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ING1,Inhibitor of growth protein 1,41820,0.0568190144448549,0.00516033026829725,0.0467047671189923,0.0669332617707175,4.49217884669175e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN9,Septin-9,42070,0.0342387934016802,0.00311073177703572,0.0281417591186902,0.0403358276846702,4.67324578279098e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.0444156030836775,0.00403610530443174,0.0365048366869913,0.0523263694803637,5.06401356830508e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.118852432603606,0.01082132267564,0.0976426401593512,0.14006222504786,6.36663132575159e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLNK,B-cell linker protein,39657,0.0496535474712829,0.00452537006928724,0.04078382213548,0.0585232728070859,7.23226578190878e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX6,Peroxiredoxin-6,42262,-0.0710968943218377,0.00649665101358152,-0.0838303303084574,-0.0583634583352179,9.29527063520021e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP2,Retinol-binding protein 2,42070,-0.0922340429539371,0.00842936142798193,-0.108755591352782,-0.0757124945550925,9.4976393562136e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNGR2,Interferon gamma receptor 2,42016,0.0625038183359421,0.00571253619374826,0.0513072473961955,0.0737003892756887,9.55772151604985e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0608184267610371,0.00556039927387896,0.0499200441842343,0.0717168093378399,1.04488271850555e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OPLAH,5-oxoprolinase,39638,0.0821426393240356,0.00751272192000007,0.0674177043608354,0.0968675742872357,1.10146470211571e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TST,Thiosulfate sulfurtransferase,41809,0.0892956886379768,0.00817426700497294,0.0732741253082299,0.105317251967724,1.16223010972339e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0685967579272643,0.00628193223823982,0.0562841707403143,0.0809093451142143,1.21734038900329e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0734804131058553,0.0067304145277982,0.0602888006313708,0.0866720255803398,1.23429825800759e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMB1,Laminin subunit beta-1,39638,0.0370746010716664,0.00339630031058158,0.0304178524629265,0.0437313496804063,1.33480680343934e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBI,Acyl-CoA-binding protein,42085,0.0919020000950506,0.00842368824900215,0.0753915711270064,0.108412429063095,1.34731002546748e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.12028800727915,0.0110261092228357,0.0986768332023918,0.141899181355908,1.43725848775953e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGXT,Serine--pyruvate aminotransferase,42145,0.0904436416787526,0.00829859295390868,0.0741783994890916,0.106708883868414,1.52171293593461e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MIA,Melanoma-derived growth regulatory protein,42181,0.0434877458915907,0.00399984275223881,0.0356480540972026,0.0513274376859788,2.02465373640499e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.035562285928803,0.00327122160184593,0.0291506915891849,0.041973880268421,2.05091090863687e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNAS,Neuroendocrine secretory protein 55,39934,0.101533899900319,0.00935096526499331,0.0832060079809318,0.119861791819706,2.48692876765529e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.0354334443910245,0.00326577673800651,0.0290325219845317,0.0418343667975172,2.58524751573566e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBN1,Drebrin,39657,0.0598931400566468,0.00552020439115681,0.0490735394499794,0.0707127406633141,2.74229403594087e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRGN,Neurogranin,39990,0.108297632949595,0.00999048308578496,0.0887162861014563,0.127878979797733,3.01883420900547e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLO1,Lactoylglutathione lyase,41900,0.0662296099386402,0.00611200004941282,0.0542500898417911,0.0782091300354894,3.02043763127219e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.0403114598732833,0.00372472587483712,0.0330109971586026,0.0476119225879641,3.47793443650184e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP3,Stromelysin-1,42137,-0.0581332289006425,0.00537811060415263,-0.0686743256847817,-0.0475921321165034,4.01669597694841e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKN3,Serine/threonine-protein kinase N3,39757,0.0860847716833523,0.00796263536509566,0.0704780063677648,0.10169153699894,4.15531473643357e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.054123020841443,0.00500936249419719,0.0443046703528165,0.0639413713300695,4.25691014617017e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPPK1,Epiplakin,39638,0.0864902265371897,0.00801456424281876,0.070781680621265,0.102198772453114,5.14195418720964e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.0722345942986985,0.00669627304313828,0.0591098991341474,0.0853592894632495,5.3884299554716e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP4,Dipeptidyl peptidase 4,41948,0.0325133308569079,0.00301981576054754,0.0265944919662347,0.0384321697475811,6.37990488683518e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBCA,Tubulin-specific chaperone A,39736,0.097827293507968,0.00908935064480773,0.0800121662441448,0.115642420771791,6.98898758030872e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLIT2,Slit homolog 2 protein,41839,0.06017522250612,0.00559475394944291,0.0492095047652119,0.0711409402470281,7.19709761020139e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DXO,Decapping and exoribonuclease protein,39929,0.0527373982077895,0.00490248904456996,0.0431285196804324,0.0623462767351466,7.38238251513343e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SWAP70,Switch-associated protein 70,39930,0.0426438231264877,0.00396573686159391,0.0348709788777636,0.0504166673752117,7.7231892152186e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTN6,Dynactin subunit 6,41839,0.0840347752309361,0.00782084843153997,0.0687059123051177,0.0993636381567544,8.07270596030833e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.097002251241116,0.00903496085718376,0.0792937279610358,0.114710774521196,9.24278021911556e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BGLAP,Osteocalcin,39966,0.09775573580961,0.00910852652022517,0.0799030238299686,0.115608447789251,9.63732112634943e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.05751149953204,0.00536439058518903,0.0469972939850695,0.0680257050790105,1.10482819297274e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,42249,0.0400737928040624,0.00375032740580354,0.0327231510886875,0.0474244345194374,1.51673903030361e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CES2,Cocaine esterase,42070,0.0641371239445935,0.00602252099005801,0.0523329828040798,0.0759412650851072,2.23090763202848e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F2R,Proteinase-activated receptor 1,42166,0.0660024262004145,0.0062002686166046,0.0538498997118695,0.0781549526889595,2.33536849980468e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,41843,0.0363526692876358,0.00342454910064204,0.0296405530503774,0.0430647855248942,3.22377462683381e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL15,C-C motif chemokine 15,42310,0.0499302342843997,0.0047113332066538,0.0406960211993583,0.0591644473694412,3.84648848829659e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFB,Complement factor B,39794,0.0375315123905947,0.00354585623607517,0.0305816341678874,0.0444813906133021,4.66319950689708e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNF,Tumor necrosis factor,41880,0.0416436142420336,0.00393693591352801,0.0339272198515187,0.0493600086325485,4.80133887297275e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,41992,0.0463889209760855,0.00439254465293638,0.0377795334563302,0.0549983084958408,5.72580479273639e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0321506289098133,0.00304631214664071,0.0261798571023976,0.0381214007172291,6.48143083747228e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0338892851574651,0.00321506502940475,0.0275877576998318,0.0401908126150984,7.37562363611338e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FRMD4B,FERM domain-containing protein 4B,39575,0.08000349653591,0.00760844779515409,0.065090938857408,0.094916054214412,9.75554585629267e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMIGO2,Amphoterin-induced protein 2,42070,0.0266308086109756,0.00253428739761007,0.0216636053116599,0.0315980119102913,9.95791251844385e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCN1,Ficolin-1,39978,0.0633600827352579,0.00602875900540415,0.0515437150846657,0.07517645038585,1.02282650445612e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UNC79,Protein unc-79 homolog,39560,0.0634295904698946,0.00603639438153123,0.0515982574820934,0.0752609234576958,1.0528629615327e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AFP,Alpha-fetoprotein,41976,0.0740440786887127,0.00705582793192549,0.0602146559421387,0.0878735014352866,1.15755557056798e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.0693035076305326,0.00661621028231947,0.0563357354771864,0.0822712797838787,1.41404800338942e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARSA,Arylsulfatase A,42137,0.0510955565753528,0.00488389549355525,0.0415231214079845,0.0606679917427211,1.61442615430106e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.080414863969268,0.0076869432447576,0.0653484552095431,0.0954812727289929,1.69941903900495e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0655382998009168,0.00627606155673687,0.0532372191497126,0.0778393804521211,1.98302031972104e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0962220354994496,0.00923445312964682,0.0781225073653419,0.114321563633557,2.63444007958696e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BDNF,Brain-derived neurotrophic factor,39966,0.0946306241255947,0.00908560360753335,0.0768228410548293,0.11243840719636,2.73930127481289e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.0412480653885286,0.00396286638609952,0.0334808472717736,0.0490152835052837,2.82580832426807e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NGRN,Neugrin,39929,0.0252461698239327,0.00242584036406215,0.0204915227103708,0.0300008169374945,2.98777196470787e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA9,Serpin A9,42025,0.0811352008293501,0.00782214032951493,0.0658038057835008,0.0964665958751993,4.11455103211126e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0400493108677889,0.00386769121901092,0.0324686360785275,0.0476299856570503,5.16634589432124e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB10,Ras-related protein Rab-10,39958,0.0597902873886373,0.00578573079445059,0.0484502550315141,0.0711303197457605,6.37005893008865e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF6,SLAM family member 6,41843,0.0432568344400317,0.00418854540349651,0.0350472854491786,0.0514663834308849,6.58463348263945e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL24,C-C motif chemokine 24,42166,0.0919485880430418,0.00891310839646167,0.0744788955859769,0.109418280500107,7.3626626064863e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.04160513373344,0.00403477959745878,0.0336969657224208,0.0495133017444592,8.03694074073435e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.0508324240386755,0.00493376128696667,0.0411622519162208,0.0605025961611301,8.46297491424466e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0506049461746715,0.00491254155869628,0.0409763647196268,0.0602335276297162,8.60376059432265e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0594384410016771,0.00577361292719384,0.0481221596643772,0.0707547223389771,9.61781046050633e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASS1,Argininosuccinate synthase,39575,0.0861198382778696,0.00836745921878813,0.0697196182090449,0.102520058346694,9.89418941196502e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.0553592925060402,0.00538259714607349,0.0448094020997361,0.0659091829123442,1.01628948533976e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.0492715985829768,0.00479643566605142,0.039870584677516,0.0586726124884376,1.20172841998289e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOL1,Apolipoprotein L1,39990,0.0592905589456931,0.00577685869650575,0.0479679159005418,0.0706132019908443,1.31747784337195e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,39930,0.10983852704124,0.0107070482036246,0.0888527125621354,0.130824341520344,1.38770754402824e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",39638,0.0974804838756866,0.00950387459160432,0.0788528896761421,0.116108078075231,1.41994966792638e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,39934,0.0402958865948166,0.00392941787386918,0.032594227562033,0.0479975456276002,1.43978655688255e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.133054571873473,0.0130060362742202,0.107562740776002,0.158546402970945,1.78291569844863e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLRX,Glutaredoxin-1,42057,0.0614589740092621,0.00601173227846271,0.0496759787434752,0.073241969275049,1.91813046695212e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FST,Follistatin,42166,0.0539000482889872,0.00527375371095868,0.0435634910155081,0.0642366055624662,1.96943938549892e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMTN,Smoothelin,39897,0.102391262089084,0.010027931433807,0.0827365164788224,0.122046007699346,2.26788957840837e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0742694833989014,0.00727470869245126,0.060011054361697,0.0885279124361059,2.31537675025742e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL19,C-C motif chemokine 19,42249,0.124689946783798,0.0122231887294984,0.100732496873981,0.148647396693615,2.39717626020333e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.039734278075257,0.00389418093370988,0.0321016834451856,0.0473668727053283,2.45586016530503e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAP25,Synaptosomal-associated protein 25,39586,0.0531416126949008,0.00521112075354834,0.0429278160179461,0.0633554093718555,2.60405832553508e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.0251885990161931,0.00247521784504299,0.0203371720399089,0.0300400259924774,3.09122428001496e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BPIFB2,BPI fold-containing family B member 2,39927,0.0675290327002628,0.00663371805236471,0.0545269453176279,0.0805311200828976,3.10724499449963e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPL14,60S ribosomal protein L14,39638,0.0430335628716762,0.00422925767976102,0.0347442178193446,0.0513229079240078,3.27196255940862e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDCP1,CUB domain-containing protein 1,42016,0.0615900189303648,0.00606328511369674,0.0497059801075192,0.0734740577532104,3.7383383555619e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARF1,Scavenger receptor class F member 1,42310,0.0466897899188801,0.00459896433528829,0.037675819821715,0.0557037600160451,3.94150070830814e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0432661728459695,0.00426470886487024,0.0349073434708239,0.0516250022211152,4.41251705947969e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BPIFA2,BPI fold-containing family A member 2,39281,-0.121800290210599,0.0120055091874725,-0.145331088218045,-0.0982694922031528,4.46681327854925e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,42070,0.035957642187718,0.00354811150991764,0.0290033436282795,0.0429119407471566,4.74605318033784e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAP3,Cytosol aminopeptidase,41913,0.0526839845293183,0.00520016215616605,0.0424916667032328,0.0628763023554037,4.90845193665817e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0814838558760451,0.00804283845499309,0.0657198925042587,0.0972478192478316,4.91305339502681e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.022322056516703,0.00220615401388874,-0.0266461183839249,-0.0179979946494811,5.58564072503559e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12B,Interleukin-12 subunit beta,42296,0.0600045440171506,0.00593351892821651,0.0483748469178462,0.0716342411164549,5.88327918194127e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0455266735612724,0.00450298197661706,0.0367008288871029,0.0543525182354418,6.32406844646993e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.123116546996935,0.0122037959819718,-0.1470359871216,-0.0991971068722704,7.56372607272027e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,39919,0.0479196783412122,0.00474960900984945,0.0386104446819073,0.0572289120005171,7.77819311708783e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.130342057128542,0.0129249171698461,0.105009219475644,0.15567489478144,7.84495376201366e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPAG1,Sperm-associated antigen 1,39934,0.0635606702961861,0.00632227634552597,0.0511690086589552,0.075952331933417,1.11472533944678e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.0790848550866552,0.00787508963973916,0.0636496793927665,0.094520030780544,1.20262595042137e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXNB2,Plexin-B2,42255,0.0265561417587167,0.00264984813900614,0.0213624394062647,0.0317498441111687,1.47517975347306e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.0782781089582422,0.00781634888110901,0.0629580651512685,0.0935981527652158,1.59171946720699e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",39929,0.116097423310737,0.011593526990009,0.0933741104103197,0.138820736211155,1.65695176877698e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD274,Programmed cell death 1 ligand 1,42016,0.0365671114162044,0.00365455440829437,0.0294041847759475,0.0437300380564614,1.73545409222064e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C4BPB,C4b-binding protein beta chain,42181,0.0413216846617354,0.00413536200135562,0.0332163751390783,0.0494269941843924,1.98483516322929e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL11,C-X-C motif chemokine 11,42249,0.0843597645940404,0.00845178691141753,0.067794262247662,0.100925266940419,2.2135192432749e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.0419110355667194,0.00420275768627626,0.0336736305016179,0.0501484406318208,2.42106085060139e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX9,Sorting nexin-9,42145,0.0733039971747738,0.00735294015970111,0.0588922344617596,0.087715759887788,2.49797238118306e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.0892425585345252,0.00895974160902201,0.0716814649808421,0.106803652088208,2.73259290879117e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP170,Centrosomal protein of 170 kDa,39638,0.0833642213598861,0.00836805626290197,0.0669628310845982,0.0997656116351739,2.79704959961761e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PARD3,Partitioning defective 3 homolog,39757,0.0797926661366142,0.00803138377846784,0.0640511539308172,0.0955341783424111,3.65441810055823e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,39958,0.0300832167830012,0.0030289966974359,0.0241463832560268,0.0360200503099756,3.76410189689415e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.093141592652371,0.00940379254320556,0.0747101592676881,0.111573026037054,4.92725371199456e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM1,Intercellular adhesion molecule 1,42126,0.0311964732295212,0.00315244713057418,0.0250176768535959,0.0373752696054466,5.18938221321739e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD40LG,CD40 ligand,42296,0.0847779311719382,0.00858071174790191,0.0679597361460505,0.101596126197826,6.06190693991926e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NADK,NAD kinase,42145,0.0584306087189418,0.00591509315459921,0.0468370261359274,0.0700241913019563,6.18524226946802e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFRP1,Secreted frizzled-related protein 1,41968,0.0460029698626818,0.00465885666673953,0.0368716107958723,0.0551343289294912,6.44511114825591e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX16,Syntaxin-16,41843,0.0610666493760332,0.00618516058966341,0.0489437346202929,0.0731895641317735,6.53412849378467e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS27,Serine protease 27,42107,0.0427958189631504,0.00434913196932635,0.0342715203032707,0.05132011762303,9.02296300825673e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL26,C-C motif chemokine 26,42119,0.0957432483754303,0.0097301813238949,0.0766720929805963,0.114814403770264,9.04484900224666e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.0566604764879535,0.00575834578149588,0.0453741187562216,0.0679468342196854,9.06021889638237e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0248103508291251,0.00252805181408768,0.0198553692735132,0.0297653323847369,1.163580504435e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,42249,0.0502389260145284,0.00512068200403449,0.0402023892866208,0.060275462742436,1.19979988220237e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POMC,Pro-opiomelanocortin,39638,0.0780435717332937,0.00795296745407441,0.0624557555233078,0.0936313879432795,1.22326689875667e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH7,Protocadherin-7,39930,0.037070197524187,0.00377786861579869,0.0296655750372216,0.0444748200111524,1.22470397638469e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DHPS,Deoxyhypusine synthase,39919,0.0428174248232922,0.00436356875686592,0.034264830059835,0.0513700195867494,1.22476735404296e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.0735608396081696,0.00749718230390712,0.0588663622925117,0.0882553169238276,1.23903494545008e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGR,Tyrosine-protein kinase Fgr,41839,0.0623684158198856,0.00636207249089293,0.0498987537377355,0.0748380779020357,1.30266703438371e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TF,Serotransferrin,39979,0.0227425983120161,0.00232036098520665,0.0181946907810111,0.0272905058430212,1.36518503540649e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPXM1,Probable carboxypeptidase X1,42181,0.0729598416519665,0.00744706937399385,0.0583635856789386,0.0875560976249945,1.37621890881626e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.0284641939702417,0.00290483592690394,0.02277071555351,0.0341576723869734,1.40681040493402e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.0335724049744732,0.00342765562135412,0.0268541999566192,0.0402906099923273,1.41294699305538e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMSB10,Thymosin beta-10,42137,0.0803576456982803,0.00823069740248794,0.064225478789404,0.0964898126071567,1.92140352166279e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.0257488142203471,0.0026380298316977,0.0205782757502196,0.0309193526904746,1.97147543071563e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP3R1,Calcineurin subunit B type 1,42016,0.0426758203134681,0.0043722607590334,0.0341061892257627,0.0512454514011736,1.97356976004799e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB2B,Ras-related protein Rab-2B,39919,0.0659014386922705,0.00675172632067673,0.0526680551037441,0.0791348222807969,2.03515763892599e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROK1,Prokineticin-1,42119,0.0525679438494425,0.00538796741396416,0.0420075277180727,0.0631283599808122,2.05051651405069e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.0934519849537059,0.00959704878261607,0.0746417693397784,0.112262200567633,2.56254258744133e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.0659048290858024,0.00678926657647014,0.052597866595921,0.0792117915756839,3.44565494899291e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMOTL2,Angiomotin-like protein 2,39882,0.0513204775420543,0.0052887098502525,0.0409546062355594,0.0616863488485492,3.54687821521395e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMMT,MICOS complex subunit MIC60,39919,0.0468351417847902,0.00482888214294705,0.037370532784614,0.0562997507849665,3.71457386262568e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.041498061893265,0.00428383740056251,-0.0498943831983675,-0.0331017405881625,4.03599625714498e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFC1,Cryptic protein,41843,0.0502487526836291,0.00518742440018244,0.0400814008592715,0.0604161045079867,4.06864975853298e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABHD14B,Protein ABHD14B,41976,0.0586284969375275,0.00605476964270016,0.0467611484378352,0.0704958454372198,4.20732158924493e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARFIP1,Arfaptin-1,39934,0.0725659506916656,0.00749477781742308,0.0578761861695163,0.0872557152138148,4.36998665571377e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA13,Carbonic anhydrase 13,41967,0.110209571019606,0.0113921993779328,0.0878808602388579,0.132538281800355,4.58771315654515e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.0381687322182482,0.00394784678023262,0.0304309525289923,0.0459065119075042,5.02793792381529e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,39820,0.034594237933915,0.00358086038220921,0.0275757515847849,0.041612724283045,5.38418602665296e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA6,Carbonic anhydrase 6,42103,-0.0654499750296119,0.00678189210067696,-0.0787424835469387,-0.052157466512285,5.74834123334235e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPPB,Natriuretic peptides B,41900,-0.146484508944664,0.0151912363592188,-0.176259332208733,-0.116709685680595,6.22646139536735e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0643421415955156,0.00668587253317484,0.0512378314304929,0.0774464517605382,7.48806053636348e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.0464027046067314,0.00482395129113551,0.0369477600761058,0.055857649137357,8.07386888175475e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTN,Pleiotrophin,41900,0.0518511845899105,0.00539293932167281,0.0412810235194318,0.0624213456603892,8.16543715653202e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0730594350843848,0.00760024631152516,0.0581629523137955,0.0879559178549741,8.55490236644706e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.101920797644954,0.0106096529029806,0.081125877955112,0.122715717334796,8.8161232869942e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0677696618328781,0.00705459424039339,0.053942657121707,0.0815966665440491,8.83480539934596e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSR,"Glutathione reductase, mitochondrial",39949,0.0237985210250111,0.0024832958406565,0.0189312611773244,0.0286657808726978,1.133712207214e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP5,Platelet glycoprotein V,39736,0.0379612179363111,0.00396104566719402,0.0301975684286108,0.0457248674440113,1.13567587860358e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,41843,0.048269080629626,0.0050492405330837,0.0383725691847819,0.0581655920744701,1.38678198990506e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP6,Platelet glycoprotein VI,42115,0.0910143658073471,0.00954307416969995,0.0723099404347352,0.109718791179959,1.71434615503685e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0385952359769191,0.00404654918708011,0.0306639995702421,0.0465264723835961,1.76427217119267e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.0506228050328218,0.00530887571414561,0.0402174086330964,0.0610282014325471,1.79548783386522e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0499389260869519,0.00524075655623854,0.0396670432367243,0.0602108089371794,1.91183772539109e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEK,Angiopoietin-1 receptor,42181,0.0227667618925413,0.00239747897725244,0.0180677030971265,0.0274658206879561,2.53688014764685e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF2,Fibroblast growth factor 2,42119,0.0710632191982031,0.00748925365724937,0.0563842820299943,0.0857421563664118,2.72506362234132e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.0710657996954381,0.00749621081837186,0.0563732264914293,0.085758372899447,2.95541173189516e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPA,Apolipoprotein(a),39775,-0.187048815308068,0.0197689270333023,-0.225795912293341,-0.148301718322796,3.63366736041556e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAL,Integrin alpha-L,39657,0.0447879168791093,0.00473457784839659,0.035508144296252,0.0540676894619667,3.7107943266616e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0904845524395531,0.00957248021594676,0.0717224912162974,0.109246613662809,3.95471720460036e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFNA4,Ephrin-A4,41992,0.0330552831831015,0.00350253801725857,0.0261903086692747,0.0399202576969283,4.43792652229622e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSE,Cathepsin E,39736,0.0540165679654502,0.00574606075462699,0.0427542888863813,0.0652788470445191,6.48281518379994e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERI1,3'-5' exoribonuclease 1,39757,0.0349484491901826,0.0037199999862009,0.0276572492172288,0.0422396491631363,6.85012662467181e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPT,Dermatopontin,42310,0.0257653785641213,0.00275042795818849,0.0203745397660719,0.0311562173621708,8.54692536506609e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.0602281686266752,0.006432366493646,0.047620730299129,0.0728356069542214,9.18362841746381e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASAH1,Acid ceramidase,39876,0.0478618946986375,0.00511982516351822,0.0378270373781418,0.0578967520191332,1.05769569642726e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.0234823602994091,0.00251275663904423,0.0185573572868824,0.0284073633119357,1.0872915926806e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0409614757592428,0.00438538366989524,0.0323661237662481,0.0495568277522374,1.10951505757155e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREML2,Trem-like transcript 2 protein,42137,0.0348606340266179,0.00373442699387184,0.0275411571186291,0.0421801109346067,1.1656802800435e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.038402613296023,0.00412329565093125,0.0303209538201977,0.0464842727718482,1.42843527394032e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARB2,Lysosome membrane protein 2,41777,0.0331837544618273,0.00357540030795659,0.0261759698582324,0.0401915390654222,1.93548354252347e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROBO2,Roundabout homolog 2,42249,0.0226912333508825,0.00245184907104209,0.01788560917164,0.027496857530125,2.46257156278778e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDK2,Protein sidekick-2,39736,0.0394478230148496,0.0042612039682743,0.031095863237032,0.0477997827926672,2.47670769066412e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.0312767902964572,0.00337991649473019,-0.0379014266261284,-0.024652153966786,2.53586720712252e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FRZB,Secreted frizzled-related protein 3,41973,0.0247096973100517,0.00267505765363074,0.0194665843089355,0.029952810311168,2.91023710518781e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BST2,Bone marrow stromal antigen 2,42249,0.0509453834886976,0.00552373062715522,0.0401188714594733,0.0617718955179218,3.30675006712403e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0658515434731665,0.00715381141190865,0.0518300731058255,0.0798730138405074,3.90142351663787e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FADD,FAS-associated death domain protein,42145,0.075834889531198,0.00826024672732905,0.0596448059456331,0.092024973116763,4.89524252353174e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0359715544403207,0.00392043037266815,0.0282875109098912,0.0436555979707503,5.29741640572913e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA14,Carbonic anhydrase 14,42262,-0.0364317602702714,0.00397651956936631,-0.0442257386262294,-0.0286377819143134,5.82513828746696e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGS10,Regulator of G-protein signaling 10,39934,0.0590553663121439,0.00644603753875289,0.0464211327361882,0.0716895998880996,5.99596229654474e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA2,Carbonic anhydrase 2,42103,0.0657035990178228,0.00718613584821101,0.0516187727553292,0.0797884252803164,6.92417558368824e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPMT,Thiopurine S-methyltransferase,41843,0.0708729938336202,0.00775719701706541,0.0556688876801719,0.0860770999870684,7.38203702209837e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.0961345176955161,0.0105376262836352,0.0754807701795912,0.116788265211441,8.33864525444327e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTX3,Pentraxin-related protein PTX3,42119,-0.0491771736069951,0.00539104124227642,-0.0597436144418569,-0.0386107327721334,8.40235471285804e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HRG,Histidine-rich glycoprotein,39925,0.0307411447618458,0.00337026079044693,0.0241354336125698,0.0373468559111218,8.67375025861681e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.0674992154118565,0.00740334790705872,0.0529886535140214,0.0820097773096916,8.79064508012161e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.0381696687394978,0.00418679684910149,0.0299635469152588,0.0463757905637367,8.82268999199167e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAGED1,Melanoma-associated antigen D1,41843,0.0476366840854231,0.00523256250180713,0.0373808615818811,0.0578925065889651,9.94731144960263e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSL,Cathepsin L1,42145,0.0241011152080454,0.00264955797782754,0.0189079815715035,0.0292942488445874,1.06339122776343e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN5,CCN family member 5,42137,0.0373964730112353,0.00411369808530329,0.0293336247640409,0.0454593212584297,1.11893194895412e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC16A1,Monocarboxylate transporter 1,41839,0.0543526642362454,0.00597982098235966,0.0426322151108205,0.0660731133616704,1.13633019282987e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.0430817390927193,0.00474157683930301,0.0337882484876854,0.0523752296977532,1.19821426415166e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPA2,Carboxypeptidase A2,42205,0.0654470618254566,0.00720632692422743,0.0513226610539708,0.0795714625969424,1.21218501544473e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTNB,Dystrobrevin beta,39900,0.0446916035373803,0.0049257710290788,0.0350370923203858,0.0543461147543747,1.3487955222507e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOM3,Myomesin-3,39736,-0.095318710978588,0.010505773598627,-0.115910027231897,-0.0747273947252791,1.35222981608369e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.0395724393405528,0.0043617290190543,0.0310234504632064,0.0481214282178992,1.35311674569208e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,42181,0.024281536419255,0.00267991366798255,0.0190289056300092,0.0295341672085008,1.47283212000156e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.0412286736022504,0.0045563363438002,0.032298254368402,0.0501590928360988,1.64609520470705e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.0846544058234145,0.00936697212751248,0.06629514045349,0.103013671193339,1.81780249830755e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.0317151761917313,0.00350855357740574,0.024838411180016,0.0385919412034465,1.83016352802016e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.0508351618677313,0.00562634584544526,0.0398075240106586,0.061862799724804,1.853558302423e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPM1F,Protein phosphatase 1F,39958,0.0520065777205768,0.00578048311837001,0.0406768308085716,0.0633363246325821,2.68902075768241e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,41843,0.0512583532415947,0.00569887405775108,0.0400885600884026,0.0624281463947868,2.69271056792011e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD83,CD83 antigen,42119,0.0336263997201844,0.00374219272817282,0.0262917019729657,0.0409610974674031,2.90628899296867e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0545392107155393,0.00607657887718972,0.0426291161162475,0.0664493053148312,3.27507075628197e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C7orf50,Uncharacterized protein C7orf50,39929,0.0221070932674633,0.00246967272620682,0.0172665347240979,0.0269476518108287,4.0548193588432e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NID2,Nidogen-2,42137,0.0707040553167293,0.00790103636421552,0.0552180240428669,0.0861900865905917,4.05892917297356e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0549773376626515,0.00614498416757029,0.0429331686942137,0.0670215066310892,4.14392796344424e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTC,Probetacellulin,41843,0.0711790641592298,0.00795597490945868,0.0555853533366908,0.0867727749817688,4.14705480800621e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DENR,Density-regulated protein,39657,0.0557259470507184,0.00623036584808834,0.0435144299884653,0.0679374641129716,4.34044083417283e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM4,Intercellular adhesion molecule 4,42119,-0.0509078028401954,0.00569548693817105,-0.0620709572390106,-0.0397446484413801,4.45932413811715e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,42119,0.0474125327720589,0.00530922033983793,0.0370064609059766,0.0578186046381413,4.79382553965864e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LBP,Lipopolysaccharide-binding protein,42217,-0.0566868957720782,0.00634869065732756,-0.0691303294604402,-0.0442434620837162,4.84658392620169e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK7,Kallikrein-7,39475,0.0382448527944655,0.00428863979126866,0.0298391188035789,0.0466505867853521,5.52121559723449e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,39699,0.0523847238027109,0.00588162692809132,0.0408567350236519,0.0639127125817699,6.0862167695375e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGH,Gamma-glutamyl hydrolase,41933,0.0327597272722436,0.00368198351281623,0.0255430395871238,0.0399764149573634,6.45136713258084e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDHB,Succinate dehydrogenase,39930,0.0631600496404987,0.00711240371875826,0.0492197383517325,0.0771003609292649,7.67253767332666e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.0459673942051802,0.00517745685231046,0.0358195787746517,0.0561152096357087,7.80350378560372e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,42070,0.0205988672548655,0.00232238506856723,0.0160469925204737,0.0251507419892573,8.24702598565984e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCRN1,Secernin-1,42119,0.0532271701590745,0.00600228525362656,0.0414626910619665,0.0649916492561826,8.3835066674685e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS22,Brain-specific serine protease 4,39657,0.0331743812740097,0.00375262554239166,0.025819235210922,0.0405295273370973,1.09899441800551e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPP1,Osteopontin,42286,-0.0421245594916875,0.00476769908138356,-0.0514692496911993,-0.0327798692921757,1.11747370856844e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENO2,Gamma-enolase,42249,0.0621666608068808,0.00705430162231651,0.0483402296271405,0.0759930919866212,1.36900743080856e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0410453636348845,0.00465760944427007,-0.0501742781456539,-0.0319164491241152,1.36997999463878e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.0830720906644419,0.00943569640638595,0.0645781257079255,0.101566055620958,1.51445031472774e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEL1L,Protein sel-1 homolog 1,39638,0.0299880085695139,0.00340653823157596,0.023311193635625,0.0366648235034028,1.52948244468729e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0515009209124447,0.0058534639937993,0.0400281314845981,0.0629737103402913,1.55460770994347e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0534512906240124,0.00607760604562315,0.041539182774591,0.0653633984734337,1.64233143067284e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGMN,Legumain,42185,0.034560622488643,0.00393500785667172,0.0268480070895664,0.0422732378877196,1.78239994589673e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PER3,Period circadian protein homolog 3,39657,0.116925740287083,0.0133174798631102,0.0908234797553874,0.143028000818779,1.87729546761308e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL14,C-C motif chemokine 14,42152,0.038433442171841,0.00438108895857853,0.029846507813027,0.0470203765306549,1.95250701272861e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XRCC4,DNA repair protein XRCC4,41839,0.0351115160387717,0.00400325647114816,0.0272651333553213,0.0429578987222221,1.9896998144002e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0308004707109981,0.00352651192349039,0.023888507340957,0.0377124340810393,2.74044442263269e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL1A1,Collagen alpha-1(I) chain,42310,-0.0222139616887951,0.00254455122906819,-0.0272012820977688,-0.0172266412798215,2.83767991002499e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.0411309693846338,0.00471650134999285,0.0318866267386478,0.0503753120306197,3.09263913211716e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRD1,Natural killer cells antigen CD94,42296,0.0445531013328051,0.00511232803663112,0.0345329383810081,0.0545732642846021,3.24274213532357e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0619816977725763,0.00712757785680747,0.0480116451732337,0.075951750371919,3.90943632205322e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VGF,Neurosecretory protein VGF,39934,0.0283943749155693,0.00326897160278984,0.0219871905741012,0.0348015592570373,4.26717790170946e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM3C,Protein FAM3C,42129,0.028555981100222,0.00329170111179991,0.0221042469210942,0.0350077152793499,4.59686550864899e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CORO1A,Coronin-1A,41883,0.0832677119083134,0.00961592175559289,0.0644205052673513,0.102114918549275,5.28654023413318e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPR,Nucleoprotein TPR,39575,0.0458359253542286,0.00529233284150799,0.035462952984873,0.0562088977235843,5.33939688807435e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNM1,Dynamin-1,39930,0.108452213350634,0.0125391074940643,0.083875562662268,0.133028864039,5.88807258478808e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACRBP,Acrosin-binding protein,39919,0.0373888281358998,0.00432734348863936,0.0289072348981667,0.0458704213736329,6.3674889080174e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0655494933893281,0.00758929047903647,0.0506744840504166,0.0804245027282396,6.55090024846613e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0866082548442632,0.0100350231516512,0.0669396094670269,0.106276900221499,6.91653412753046e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.0834483821762272,0.00966939382715396,0.0644963702750054,0.102400394077449,6.95852328130057e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SF3B4,Splicing factor 3B subunit 4,42070,0.0676301267788079,0.00784693126870218,0.0522501414921516,0.0830101120654641,7.52164686143625e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.0830148240597316,0.00964030382577761,0.0641198285612075,0.101909819558256,8.03460356426605e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.0328049841903548,0.00381176345969495,0.0253339278093527,0.0402760405713569,8.36352374038528e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMS,Spermine synthase,39586,0.0599562241587428,0.00696504674163551,0.0463047325451372,0.0736077157723484,8.43594448360219e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAA4,Serum amyloid A-4 protein,39979,0.0306984242801628,0.00357040622961398,0.0237004280701194,0.0376964204902062,9.16971167458437e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100P,Protein S100-P,41900,0.0498264588229034,0.00580016301402009,0.038458139315424,0.0611947783303828,9.61305592041588e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFA,Protransforming growth factor alpha,42119,0.0421529483053154,0.00490770189792583,0.0325338525853808,0.0517720440252501,9.7125922747525e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,39757,0.0690666220324265,0.00804085511094106,0.053306546014982,0.0848266980498709,9.89828079745653e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSL5,Insulin-like peptide INSL5,39930,0.0952566251491007,0.011099287130925,0.0735020223724878,0.117011227925714,1.05168882551938e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DMD,Dystrophin,39638,0.0477950982488225,0.00557806843148526,0.0368620841231114,0.0587281123745337,1.1888926095191e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.0669702664147407,0.00781960994731878,0.0516438309179959,0.0822967019114855,1.20396036613644e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPL,Periplakin,39657,0.0299709090519984,0.00349905040890236,0.0231127702505498,0.0368290478534471,1.21931750141849e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G15,Phospholipase A2 group XV,42181,0.0254634202828406,0.00297870186502459,0.0196251646273924,0.0313016759382888,1.37903430114646e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,42070,0.0340038861585873,0.00398154531909884,0.0262000573331536,0.0418077149840211,1.48016324460055e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VIT,Vitrin,39958,0.0355602853082639,0.00416619629223814,0.0273945405754771,0.0437260300410506,1.5735764925789e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD84,SLAM family member 5,42119,0.0294691377552513,0.00345605623699336,0.0226952675307443,0.0362430079797583,1.66271170557184e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0632198565380819,0.00741724856321065,0.048682049354189,0.0777576637219748,1.7492574973095e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.033107709099967,0.00388772384754808,-0.0407276478411612,-0.0254877703587728,1.86040024693462e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMA4,Laminin subunit alpha-4,42185,0.0315588015518683,0.00370726784139247,0.0242925565827391,0.0388250465209976,1.87626819326683e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAT,Catalase,39827,0.0482415436451325,0.00566678676454963,0.0371346415866152,0.0593484457036497,1.909779788324e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTA,Lymphotoxin-alpha,42119,0.0369173743668689,0.00434237654986923,0.0284063163291252,0.0454284324046126,2.06344726328509e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH15,Cadherin-15,42230,0.0636330185696885,0.00749743301702491,0.0489380498563197,0.0783279872830573,2.3312855319884e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCF2,Neutrophil cytosol factor 2,42097,0.0763623669403777,0.00901565499240851,0.058691683155257,0.0940330507254983,2.70618152563285e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.052520338265049,0.00620537349304273,0.0403578062186852,0.0646828703114127,2.85950523742317e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIMAP8,GTPase IMAP family member 8,39560,0.0460023022902798,0.00543454199684116,0.0353505999764711,0.0566540046040885,2.89265191244007e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C5,Complement C5,39979,0.0137821317645695,0.00162841885466975,0.0105904308094168,0.0169738327197222,2.91189060868119e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS7_LGALS7B,Galectin-7,42076,0.0403190172962786,0.00476811380340875,0.0309735142415974,0.0496645203509597,3.05018748714801e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTN2,Dynactin subunit 2,42070,0.086782143737754,0.0102816694311416,0.0666300716527165,0.106934215822791,3.48073953824263e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD101,Immunoglobulin superfamily member 2,39930,0.0395518622622028,0.00468561702598397,0.0303680528912743,0.0487356716331314,3.52497226746739e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STK4,Serine/threonine-protein kinase 4,42145,0.0797646523906622,0.00946619269686567,0.0612109147048055,0.0983183900765189,3.92563369394169e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.0394372432078856,0.00468306851319069,0.0302584289220318,0.0486160574937393,4.18592036029092e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BGN,Biglycan,41820,-0.10774581706672,0.0128048527804961,-0.132843328516492,-0.0826483056169475,4.34995452678959e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP1,Interstitial collagenase,41693,0.0821666606124108,0.00977095226629335,0.0630155941704758,0.101317727054346,4.54933681702633e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIF22,Kinesin-like protein KIF22,39575,0.113208329833919,0.0134619392449442,0.0868229289138285,0.13959373075401,4.62653708848471e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD46,Membrane cofactor protein,42107,0.0260723742650495,0.00310576366510447,0.0199850774814448,0.0321596710486543,5.12628791421674e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HLA_E,,42119,0.0267094094308976,0.00318302580029238,0.0204706788623246,0.0329481399994707,5.28599814703865e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.0301844874035148,0.00359924142760816,0.0231299742054028,0.0372390006016268,5.50526143734267e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FXN,"Frataxin, mitochondrial",42262,0.0660337351783168,0.00787766081123241,0.0505935199883013,0.0814739503683323,5.68879610357959e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LACRT,Extracellular glycoprotein lacritin,39895,0.0413385419307328,0.00493041710865334,0.0316749243977722,0.0510021594636933,5.70328202919035e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0572129280903493,0.00682866836733642,0.0438287380903699,0.0705971180903286,5.9979291220896e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.092683461690789,0.0110692241816241,0.0709877822948058,0.114379141086772,6.16618796775059e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA2,Integrin alpha-2,39736,0.0313841258737093,0.00375137758387646,0.0240314258093114,0.0387368259381072,6.66980216939814e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.0517021696814558,0.00618026610491243,0.0395888481158275,0.0638154912470842,6.68754821154905e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,39966,0.0244533791144896,0.00292701929356857,0.0187164212990952,0.030190336929884,7.34187146501074e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APLP1,Amyloid-like protein 1,42145,-0.045937445246383,0.00550580369982229,-0.0567288204980347,-0.0351460699947313,7.90763193329513e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,39930,0.02222564155274,0.0026664300464503,0.0169994386616974,0.0274518444437826,8.61741266394625e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA1,Carbonic anhydrase 1,41890,0.0508985179239463,0.00611252872317677,0.0389179616265199,0.0628790742213728,9.10355121788846e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDF1,Endothelial differentiation-related factor 1,39934,0.0597358681427769,0.00719393355617955,0.0456357583726649,0.0738359779128888,1.12418835390285e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENAH,Protein enabled homolog,41913,0.0432374992811362,0.00522624335515921,0.0329940623050242,0.0534809362572483,1.42782286587124e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17D,Interleukin-17D,41913,0.0305547560363446,0.00369747691732332,0.0233077012783909,0.0378018107942983,1.54525650909735e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD2,Sushi domain-containing protein 2,42137,-0.0253915183485441,0.00307450000606518,-0.0314175383604318,-0.0193654983366563,1.60770917195534e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAM,Integrin alpha-M,42137,-0.0282792680338489,0.0034241863996067,-0.0349906733770781,-0.0215678626906198,1.60857751053381e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.0319872793129437,0.00387516352097697,0.0243919588118288,0.0395825998140585,1.66979397640324e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,42310,0.0320603400026976,0.00388466946563754,0.0244463878500481,0.0396742921553472,1.6841142876818e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VCAM1,Vascular cell adhesion protein 1,42199,-0.0247034451076886,0.00300462491724434,-0.0305925099454875,-0.0188143802698896,2.18504273557694e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR3,Toll-like receptor 3,42296,0.0544122241165138,0.00662702959068951,0.0414232461187623,0.0674012021142652,2.39540437995767e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAPK2,Death-associated protein kinase 2,39657,0.0492983857307699,0.00600360163874111,0.0375313265188373,0.0610654449427025,2.42787327691885e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDGF,Hepatoma-derived growth factor,42243,0.0812942972417149,0.00990349830496958,0.0618834405639745,0.100705153919455,2.43636147532813e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYM,Ketimine reductase mu-crystallin,39586,0.0672491918384417,0.00820257372375348,0.0511721473398849,0.0833262363369985,2.70360286744357e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,39990,-0.0240741793342238,0.00293687223455401,-0.0298304489139496,-0.0183179097544979,2.72334579892696e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDZD2,PDZ domain-containing protein 2,39575,0.0522208406168773,0.00638532007972605,0.0397056132606142,0.0647360679731403,3.1968208065277e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSNK1D,Casein kinase I isoform delta,39657,0.0570324457182431,0.00697553655596386,0.0433603940685539,0.0707044973679323,3.25281625247813e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL1,Fc receptor-like protein 1,42145,0.0405513587617594,0.00496330510243182,0.030823280760993,0.0502794367625257,3.34905382211855e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIGR,Polymeric immunoglobulin receptor,41987,0.0328345813049163,0.00402189936254047,0.024951658554337,0.0407175040554956,3.53064963100911e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0354725720743191,0.00435394172230686,0.0269388462985976,0.0440062978500405,4.12728068148952e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0524744444322374,0.0064520487686972,0.0398284288455909,0.0651204600188839,4.62331519764889e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,0.0346558942970503,0.00426556827185296,0.0262953804842185,0.0430164081098821,4.96694897459126e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHRDL1,Chordin-like protein 1,42166,0.0287770010138395,0.00354573399376922,0.0218273623860518,0.0357266396416272,5.23240946477345e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DGKZ,Diacylglycerol kinase zeta,41913,0.0317927733267939,0.00391731292615371,0.0241148399915326,0.0394707066620551,5.23993761009876e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0433448293949567,0.005345422187738,0.0328678019069902,0.0538218568829232,5.54987799758975e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBS,Cystathionine beta-synthase,39638,0.04545088740153,0.00560894224527395,0.0344573606007931,0.056444414202267,5.91309384377528e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDK,Midkine,42129,0.0449286434808896,0.0055466646838918,0.0340571807004616,0.0558001062613175,5.95793873590452e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSL3,Insulin-like 3,39929,0.0790137018577343,0.00976079143156515,0.0598825506518666,0.098144853063602,6.31085902003244e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAS2,Growth arrest-specific protein 2,39757,0.0457412301279434,0.00565150896408513,0.0346642725583366,0.0568181876975503,6.39183854836159e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C2orf69,UPF0565 protein C2orf69,39649,0.0516926427788264,0.0063947860242183,0.0391588621713585,0.0642264233862943,6.94596367246195e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0549924195392432,0.00680371995999732,0.0416571284176485,0.068327710660838,6.98131974005506e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSHB,Thyrotropin subunit beta,42145,0.0595475171888516,0.00737697150542679,0.0450886530382151,0.0740063813394881,7.49025094293835e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,41820,0.0582435950378666,0.00724266676681313,0.0440479681749129,0.0724392219008203,9.60740882475012e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SBSN,Suprabasin,39954,-0.0309689459527397,0.00385056413800388,-0.0385160516632273,-0.0234218402422521,9.65970768720265e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA6,Integrin alpha-6,42119,0.0444139948409228,0.00552478852768555,0.0335854093266591,0.0552425803551864,9.80234082492896e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSC,Dipeptidyl peptidase 1,42123,0.0386133228352033,0.00481024178033435,0.029185248945748,0.0480413967246587,1.07806593454608e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,0.0294860089937058,0.00367356136628675,0.0222858287157838,0.0366861892716278,1.084666223751e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0640642410183778,0.00798653251587921,0.0484106372872546,0.0797178447495011,1.13168977763266e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.0302500003010423,0.00377217634466839,0.0228565346654923,0.0376434659365924,1.15081206713779e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0361387281113017,0.00450930651936185,0.0273004873333524,0.0449769688892509,1.20042510870645e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,39638,0.0448130415374724,0.00559239580513168,0.0338519457594143,0.0557741373155305,1.23000962563105e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.0271082515561172,0.00339119560241801,0.0204615081753779,0.0337549949368565,1.41490633450475e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.0412988682741529,0.00516606241710934,0.0311733859366186,0.0514243506116872,1.42988701678374e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL20,C-C motif chemokine 20,42296,0.0749257549363447,0.00938106116494717,0.0565388750530482,0.0933126348196411,1.49333433595971e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFHR5,Complement factor H-related protein 5,39864,0.0360965548069282,0.00451890675892776,0.0272394975594298,0.0449536120544266,1.50613164357433e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD302,CD302 antigen,42070,0.026875273898297,0.00337555759827782,0.0202591810056725,0.0334913667909216,1.83171742945626e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDA,Cytidine deaminase,39946,0.0411011901273011,0.00516568878349337,0.0309764401116541,0.0512259401429481,1.93667281766107e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1RL,Complement C1r subcomponent-like protein,39958,0.0169850985927566,0.00213798150246503,0.0127946548479251,0.021175542337588,2.13436902936953e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX7,Syntaxin-7,39657,0.042250262786227,0.00532109847688001,0.0318209097715422,0.0526796158009118,2.21493835260969e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APRT,Adenine phosphoribosyltransferase,42002,0.040490779591969,0.00510188751025367,0.0304910800718718,0.0504904791120662,2.24535490357896e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELOB,Elongin-B,39575,0.0337143399640206,0.0042514176737533,0.0253815613234641,0.0420471186045771,2.4013126250127e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADA,Adenosine deaminase,42296,0.030487214815986,0.00384978612741397,0.0229416340062546,0.0380327956257174,2.57368956509405e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0544431589706225,0.00687467952192298,0.0409687871076535,0.0679175308335916,2.57658297429211e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM3B,Protein FAM3B,42070,0.0301287852903543,0.0038136984001275,0.0226539364261044,0.0376036341546042,3.00076993558533e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CILP,Cartilage intermediate layer protein 1,39966,0.0473090976006,0.00598951174136411,0.0355696545875263,0.0590485406136737,3.07864775787097e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.102662283185497,0.0130120279261255,0.0771587084502913,0.128165857920703,3.30486496176709e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,39757,0.0301861134850728,0.00383011471812912,0.0226790886375397,0.0376931383326058,3.54235841166262e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BOLA1,BolA-like protein 1,39586,0.0465817240407825,0.00591246702267863,0.0349932886763324,0.0581701594052326,3.6241744759927e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,42114,0.0291422963901083,0.00370008892667043,0.0218901220938342,0.0363944706863823,3.63404676598508e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,41843,0.0493395622245808,0.00626566812108649,0.0370588527072513,0.0616202717419103,3.68372757411747e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSDE1,Cold shock domain-containing protein E1,39575,0.102642007938969,0.0130701556110271,0.0770245029413562,0.128259512936582,4.43492187156312e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSME2,Proteasome activator complex subunit 2,41955,0.0300123302349679,0.0038249008625207,0.0225155245444274,0.0375091359255085,4.59983414398395e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,42129,0.0648057405144522,0.00827075662479203,0.0485950575298599,0.0810164234990446,5.01579001507001e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSTB,Cystatin-B,41959,0.0368493417617536,0.00470435103407028,0.0276288137349758,0.0460698697885313,5.12050168322457e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECTIN2,Nectin-2,42129,0.0262342573402596,0.00335108459298804,0.019666131538003,0.0328023831425161,5.2992154421795e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CIT,Citron Rho-interacting kinase,39649,0.0388640721122797,0.00496868002584823,0.0291254592616172,0.0486026849629423,5.6808932571914e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.0399090478788478,0.0051038773255029,0.0299054483208621,0.0499126474368335,5.70934744092312e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AK1,Adenylate kinase isoenzyme 1,42145,0.0520509921271124,0.00666493604334777,0.0389877174821508,0.0651142667720741,6.1534385704297e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0514801416707728,0.00659406076253826,0.0385557825761978,0.0644045007653478,6.38686522477367e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0375595992508783,0.00481386610325858,0.0281244216884915,0.0469947768132651,6.62216889162661e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK6,Kallikrein-6,42158,0.0261167519011057,0.00334942598235788,0.0195518769756843,0.0326816268265272,6.78000227838751e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300LF,CMRF35-like molecule 1,42262,0.0507510715151,0.00651114810830917,0.037989221222814,0.0635129218073859,6.93272531437061e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGBL1,Integrin beta-like protein 1,39966,0.0332552313886626,0.00426936541419808,0.0248872751768344,0.0416231876004908,7.32550756568033e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0964521549160772,0.0124328126008346,0.0720838422184413,0.120820467613713,9.37730882227365e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMPA1,Inositol monophosphatase 1,42016,0.0514049874337917,0.00662965085117865,0.0384108717654816,0.0643991031021019,9.55893444003282e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.045371870215783,0.00585343352780882,0.0338991405012778,0.0568445999302883,9.89145321231252e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH1,Protocadherin-1,42264,0.0172934838278319,0.0022341794700156,0.0129144920666013,0.0216724755890625,1.0602645742048e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.0357830157827192,0.00463141314576026,-0.0448605855484093,-0.026705446017029,1.18659108669937e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.01851878987886,0.00239715797487182,-0.0232172195096088,-0.0138203602481112,1.19548598392395e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN1,Tetraspanin-1,41900,0.0609659002660032,0.00789886506983128,0.0454841247291339,0.0764476758028725,1.26267470326704e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,42145,0.0564980130327189,0.00732406010809771,0.0421428552208474,0.0708531708445904,1.30398646195509e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HPCAL1,Hippocalcin-like protein 1,42296,0.0614812025427787,0.00798250709408721,0.0458354886383678,0.0771269164471897,1.43129093251843e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPP1,Tripeptidyl-peptidase 1,42057,0.0395398053790378,0.0051344273067707,0.0294763278577672,0.0496032829003084,1.44500499770018e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL2A1,Collagen alpha-1(II) chain,39638,0.0657757510838292,0.0085478486054796,0.0490219678170892,0.0825295343505692,1.53544651078198e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN8,Tetraspanin-8,39930,0.0795612289587631,0.0103445377196172,0.0592859350283133,0.0998365228892129,1.57907686389241e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,41843,0.0310516716164105,0.00403964146402204,0.0231339743469273,0.0389693688858937,1.61539374027386e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.033758684579551,0.00439443874758901,0.0251455846342765,0.0423717845248254,1.69674023936364e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY75,Lymphocyte antigen 75,42119,0.0321282976426677,0.00419841269245805,0.0238994087654499,0.0403571865198855,2.10448217927317e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMBS,Porphobilinogen deaminase,42262,0.0333520332826805,0.0043597125038285,0.0248069967751766,0.0418970697901844,2.14305643168248e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.0313453755838808,0.00409919492035991,0.0233109535399753,0.0393797976277862,2.23302805039442e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.0279964293749106,0.00366941827126207,-0.0351884891865843,-0.020804369563237,2.54736923682277e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.0273228563650682,0.00358216428257461,0.0203018143712219,0.0343438983589144,2.55423795605078e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,41913,0.0542845189746983,0.00712013849772641,0.0403290475191546,0.0682399904302421,2.62395029479732e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB6,Integrin beta-6,41913,0.0254006532948092,0.00333380934705783,0.0188663869745759,0.0319349196150426,2.72659788322003e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANSC1,MANSC domain-containing protein 1,42181,-0.0229196606637849,0.00301334153329644,-0.0288258100690459,-0.0170135112585239,3.01113938219574e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPO,Erythropoietin,42119,0.0600859669221505,0.00791346060179566,0.044575584142631,0.07559634970167,3.33347851519087e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.0132784740563364,0.00174968744965612,0.00984908665501041,0.0167078614576624,3.42995114053575e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0310734665362859,0.00409930226210162,0.0230388341025667,0.0391080989700051,3.7198461141599e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.0661714287434338,0.00873373679786803,0.0490533046196125,0.0832895528672552,3.77952358761982e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.0462002242563503,0.00609877264243453,0.0342466298771786,0.058153818635522,3.81833252341977e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,39757,0.0586939419433839,0.00776464264406227,0.0434752423610218,0.0739126415257459,4.37573545239885e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPME1,Protein phosphatase methylesterase 1,42070,0.0476392589535497,0.00630391867274514,0.0352835783549693,0.0599949395521302,4.38765210528443e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA4,Carbonic anhydrase 4,42310,-0.0198558849622723,0.00263088948304488,-0.0250124283490403,-0.0146993415755044,4.72664793768785e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRCAM,Neuronal cell adhesion molecule,42145,0.0234629253180704,0.00311346566429698,0.0173605326160483,0.0295653180200924,5.1550563943623e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0437067955800944,0.0058148200244557,0.0323097483321612,0.0551038428280275,5.98335518015679e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.0372113364647324,0.00495078591133071,0.0275077960785243,0.0469148768509406,6.06287127280163e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.0436909479795901,0.00581620825665516,0.032291179796546,0.0550907161626342,6.26409324248698e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,39638,0.0201283892010437,0.00268149233397996,0.014872664226443,0.0253841141756444,6.54494254916419e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,39575,0.0355681234928156,0.00473963355729354,0.0262784417205203,0.044857805265111,6.64842010140838e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTGES2,Prostaglandin E synthase 2,39579,0.04536256312334,0.00604573624209066,0.0335129200888424,0.0572122061578377,6.70764378391384e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0247237285527589,0.00329859846004692,-0.0311889815344509,-0.018258475571067,7.03007668279746e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.0393686943623526,0.00525312302969547,0.0290725732241495,0.0496648155005558,7.08652194919391e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UMOD,Uromodulin,42274,-0.0437064709300664,0.00583572621167006,-0.0551444943049398,-0.0322684475551931,7.33866646344716e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRSF1,G-rich sequence factor 1,39486,0.0673636631139842,0.00902510301400343,0.0496744612065374,0.0850528650214309,9.03201055077349e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMM2,Phosphomannomutase 2,39575,0.0484945974534211,0.00650632134818953,0.0357422076109696,0.0612469872958726,9.77681976438868e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RCOR1,REST corepressor 1,41900,0.0360447081654197,0.00484136931499849,0.0265556243080227,0.0455337920228168,1.0278899906463e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0213890969725171,0.00287770915700158,0.015748787024794,0.0270294069202402,1.12738416591075e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX6,Syntaxin-6,41843,0.0528893026028718,0.00712095940004585,0.038932222178782,0.0668463830269617,1.17638986708086e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0355544387118052,0.00478710149625319,0.026171719779149,0.0449371576444615,1.19210575002785e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0534598243400938,0.00720174443611853,0.0393444052453015,0.0675752434348861,1.22490690225361e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB8,Serpin B8,42296,0.0470439457757623,0.00633924390599456,0.034619027720013,0.0594688638315116,1.23021515152255e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300A,CMRF35-like molecule 8,39736,0.0246111604621484,0.0033159830469299,0.0181118336901658,0.0311104872341311,1.23791075526089e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.040401683390239,0.00544419644281215,0.0297310583623272,0.0510723084181508,1.24504837928058e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP9,Caspase-9,39657,0.0513847201596841,0.00692588804494098,0.0378099795915997,0.0649594607277684,1.26443907078059e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0456618483434545,0.00617683046928841,-0.0577684360632598,-0.0335552606236492,1.52626401747952e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COLEC12,Collectin-12,42123,0.0219199371266373,0.00296931393005313,0.0161000818237332,0.0277397924295414,1.64841600682022e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAA10,N-alpha-acetyltransferase 10,39575,0.0405772515796319,0.00549750537678644,0.0298021410411305,0.0513523621181333,1.6843192966643e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRDT,Bromodomain testis-specific protein,39575,0.0292687089941431,0.00396641976563473,0.0214945262534991,0.0370428917347872,1.70846493226265e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OMD,Osteomodulin,42185,-0.0328200514366689,0.00445132113213935,-0.041544640855662,-0.0240954620176757,1.76341599818195e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.0324355880508016,0.00439847816640661,0.0238145708446446,0.0410566052569585,1.76761811729389e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.0209423664867518,0.00284419165458423,-0.0265169821297369,-0.0153677508437667,1.92215657107461e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA4,Annexin A4,42088,0.0578237348896082,0.00785578953590726,0.04242638739923,0.0732210823799865,1.93603403769757e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0352085873735727,0.00479149672258977,0.0258172537972968,0.0445999209498487,2.15177968502539e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.0281848698167193,0.00384282294476811,0.0206529368449738,0.0357168027884648,2.35399565520876e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.0568715196211307,0.00776973452984158,0.0416428399426412,0.0721001992996202,2.65514829838203e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL8,Interleukin-8,42035,0.0538345170332369,0.00735751468931612,0.0394137882421773,0.0682552458242965,2.68071377025358e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,41843,0.0376719878657967,0.00515025684797728,0.0275774844437612,0.0477664912878321,2.73021005043236e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.029660922883574,0.00405806497003095,0.0217071155423134,0.0376147302248347,2.86985939061738e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BSG,Basigin,42284,0.0165455459183126,0.00226538529007854,0.0121053907497586,0.0209857010868665,2.95572955884038e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A12,Protein S100-A12,41910,0.058103625112426,0.00796557704154927,0.0424910941109894,0.0737161561138625,3.17100426196802e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,41920,0.0226786531120218,0.00311497369471116,0.0165733046703879,0.0287840015536556,3.51163612505764e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THBS4,Thrombospondin-4,42189,0.0358653782793513,0.00492737556295246,0.0262077221759645,0.0455230343827382,3.55291214759734e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROBO1,Roundabout homolog 1,42144,0.0188966480955346,0.00259788565820079,0.013804792205461,0.0239885039856082,3.68555885449922e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD80,T-lymphocyte activation antigen CD80,39958,0.0270000699160265,0.00371520337810242,0.0197182712949457,0.0342818685371072,3.90346145234786e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.0410269006916316,0.00565460799624245,-0.0521099323642668,-0.0299438690189964,4.22009234821266e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHGA,Chromogranin-A,39966,-0.0668930748279703,0.00922097272226827,-0.0849661813636161,-0.0488199682923245,4.29535464539851e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.0441145101881512,0.00608412987306674,0.0321896156369404,0.056039404739362,4.42359911744068e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECE1,Endothelin-converting enzyme 1,41839,0.0277295511691307,0.00383615973426612,0.0202106780899691,0.0352484242482923,5.15258940015543e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MARCO,Macrophage receptor MARCO,42145,0.0202361640604839,0.00280084544481455,0.0147465069886474,0.0257258211323204,5.27809525092918e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.048934415678586,0.0067719722350857,0.035661350097818,0.062207481259354,5.30132737188003e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0308423031798052,0.00428845885288052,0.0224369238281594,0.039247682531451,6.79708117265166e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLC,Galectin-10,42119,-0.0522168390573421,0.00727749393900178,-0.0664807271777856,-0.0379529509368986,7.60106256234872e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.01839153908547,0.00256994254065163,0.0133544517057928,0.0234286264651472,8.70498422723841e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX5,Sorting nexin-5,39638,0.0230553344943035,0.00323278718160093,0.0167190716183657,0.0293915973702413,1.0532405738349e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINI2,Serpin I2,39930,0.0446789312354706,0.00626923605748275,0.0323912285628044,0.0569666339081368,1.09052419678573e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSTN3,Calsyntenin-3,39929,0.0233620848546298,0.00328101126556057,0.0169313027741311,0.0297928669351286,1.14135158642492e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD248,Endosialin,39966,-0.0312423494580591,0.00439157992400661,-0.0398498461091121,-0.0226348528070062,1.19375527685101e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0399332249019316,0.00563025574016002,0.028897923651218,0.0509685261526453,1.38285745707481e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.0522007687980651,0.00737180315916147,0.0377520346061086,0.0666495029900216,1.50049402620066e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CENPF,Centromere protein F,39757,0.0413996386857552,0.00584766955027164,0.0299382063672228,0.0528610710042877,1.53166975752996e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,42070,-0.0311915780385952,0.00440777514542202,-0.0398308173236224,-0.0225523387535681,1.55162345448584e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD93,Complement component C1q receptor,41654,-0.0241175270329137,0.00341390043179033,-0.0308087718792228,-0.0174262821866047,1.69360556184358e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0329270847661204,0.00467176839994886,0.0237704187022206,0.0420837508300202,1.90310949384836e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGFR,Epidermal growth factor receptor,42310,0.0121979880253618,0.00173185539427001,0.00880355145259258,0.015592424598131,1.96677887794394e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,42093,0.0313520601572015,0.00445366958715306,0.0226228677663815,0.0400812525480215,2.02109405948788e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,42016,-0.0279065467540906,0.00396473393120206,-0.0356774252592466,-0.0201356682489345,2.03481132917766e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGMB,RGM domain family member B,42249,0.0213883459584607,0.00304113118618126,0.0154277288335455,0.027348963083376,2.11725348209135e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.0251467228731143,0.00357820716216105,-0.03216000891095,-0.0181334368352787,2.21911471235083e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH5,Cadherin-5,42310,-0.0231456596443745,0.00329524822946316,-0.0296043461741223,-0.0166869731146267,2.25847887987625e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRELP,Prolargin,42123,0.0178347563286194,0.00253976450763386,0.012856817893657,0.0228126947635818,2.28816848872755e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPING1,Plasma protease C1 inhibitor,39959,0.0140949674214854,0.00200838637976512,0.0101585301171457,0.018031404725825,2.37787934294121e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0381416378803329,0.00543893671624654,0.0274813219164897,0.0488019538441762,2.4510254548481e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,0.030891453381062,0.00441114985595893,0.0222455996633825,0.0395373070987415,2.62396261799119e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F3,Tissue factor,42174,-0.0198391369461067,0.00283539284225176,-0.0253965069169202,-0.0142817669752933,2.7383621208204e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKK4,Dickkopf-related protein 4,41992,0.0350107416499393,0.00500431041129963,0.025202293243792,0.0448191900560866,2.756575959398e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.0356861715044637,0.00511001139663227,0.0256705491670645,0.045701793841863,3.042783388652e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACTN2,Alpha-actinin-2,39575,-0.048923882276427,0.00700601381554075,-0.0626556693548869,-0.0351920951979671,3.05371568110265e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,39990,0.0199909905828824,0.0028659776193905,0.014373674448877,0.0256083067168878,3.22179767778715e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP8,Caspase-8,42224,0.0460580094006829,0.00662708772176929,0.0330689174660151,0.0590471013353508,3.81997374242683e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0181490325230498,0.00261305514223083,0.0130274444442774,0.0232706206018223,3.94275573911578e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPM3,Tropomyosin alpha-3 chain,39575,-0.034822475934729,0.00502077918740631,-0.0446632031420453,-0.0249817487274126,4.2703655651309e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPM1A,Protein phosphatase 1A,41843,0.0236016858035724,0.00340489180503655,0.0169280978657008,0.030275273741444,4.35072835238389e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0306694558030066,0.00443249361241102,0.021981768322681,0.0393571432833322,4.75011934664814e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.0207248328320465,0.00299609302214602,0.0148524905086403,0.0265971751554527,4.80978943609227e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAST,Gastrin,39929,0.0981849938998407,0.0141949573769128,0.0703628774410917,0.12600711035859,4.86522433831319e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRP2,Neuropilin-2,42137,-0.0210901357706549,0.00305158029805793,-0.0270712331548484,-0.0151090383864613,5.02015428232383e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPOCK1,Testican-1,42016,0.0195731378943808,0.00283373492653033,0.0140190174383814,0.0251272583503803,5.1663259500991e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.0195953860349798,0.00283831973765778,0.0140322793491706,0.0251584927207891,5.33098831758508e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0689123214909429,0.00999130227390362,0.0493293690340918,0.088495273947794,5.59254890133968e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.0322797746171082,0.00469677252379182,0.0230741004704763,0.0414854487637402,6.5727295758015e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0436939792434595,0.0063571831411155,0.0312339002868731,0.0561540582000459,6.61719642930157e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA7A,Semaphorin-7A,42272,0.0212668473297626,0.00309910640018818,0.0151925987853938,0.0273410958741315,7.07024164880372e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,0.0309802292075777,0.00452178892905547,0.022117522906629,0.0398429355085265,7.69638766891075e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGT,Angiotensinogen,39990,0.0161750228654243,0.00236113450050034,0.0115471992444437,0.020802846486405,7.73682063327838e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0298414255013924,0.0043597696815644,0.0212962769255261,0.0383865740772586,8.05790124215054e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MET,Hepatocyte growth factor receptor,42158,-0.0142314518293406,0.00208072945764278,-0.0183096815663205,-0.0101532220923608,8.2792051462602e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.0248736066108981,0.00363692095796292,0.0177452415332907,0.0320019716885054,8.30262235796222e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,39934,0.0215690305881536,0.00315757765095062,0.0153801783922903,0.0277578827840168,8.87166819290729e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CR2,Complement receptor type 2,42217,0.0345345871362657,0.00505927908543151,0.02461840012882,0.0444507741437115,9.10176146775862e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALB2,Calretinin,41839,0.0217944918942701,0.0031945684127898,0.0155331378052021,0.0280558459833381,9.34507869388665e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZBP1,Z-DNA-binding protein 1,39657,0.0305347428317035,0.00448640578225089,0.0217413874984918,0.0393280981649153,1.05499138339393e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0386741951177918,0.00569750684671694,0.0275070816982265,0.049841308537357,1.19599722812831e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIMAP7,GTPase IMAP family member 7,39736,-0.0236954120225523,0.00349132690273243,-0.0305384127519079,-0.0168524112931967,1.20358051032453e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXN,Thioredoxin,39854,0.0316055778026901,0.00466231119703202,0.0224674478565073,0.0407437077488728,1.27106061148318e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.0278407422423368,0.00410867442190049,0.0197877403754118,0.0358937441092617,1.28586207166066e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.0302699488067537,0.00447371756117542,0.0215014623868499,0.0390384352266575,1.37677195508353e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPCAM,Epithelial cell adhesion molecule,42125,-0.068541155888492,0.0101496823155574,-0.0884345332269846,-0.0486477785499994,1.50696546474254e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSF,Cathepsin F,42181,0.0295249592515239,0.00437296168319698,0.0209539543524578,0.03809596415059,1.52051769318853e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.0390302303701094,0.00579276416394471,0.0276764126087778,0.0503840481314411,1.67387782676361e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFHR2,Complement factor H-related protein 2,39904,0.0416660168303993,0.00618831026753666,0.0295369287060275,0.0537951049547712,1.74228452938561e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0242295498248877,0.00360689256213404,0.017160040403105,0.0312990592466704,1.92094343462766e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHCHD6,MICOS complex subunit MIC25,39919,0.0211577914488973,0.00315020935060881,0.014983381121704,0.0273322017760906,1.9530906139306e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.0220218714812073,0.00328324329671085,0.015586714619654,0.0284570283427605,2.07858672953411e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCAM2,Neural cell adhesion molecule 2,42137,-0.0195957014087411,0.0029238250484614,-0.0253263985037255,-0.0138650043137568,2.13610695750833e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,0.0202623082389854,0.00302530159675612,0.0143327171093434,0.0261918993686274,2.20180334813205e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C7,Complement component C7,39722,-0.0242509074006844,0.00362179543871431,-0.0313496264605644,-0.0171521883408043,2.24791038314224e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN4B,Sodium channel subunit beta-4,39638,0.031620485563967,0.00472356346633913,0.0223623011699423,0.0408786699579917,2.27371140639297e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.0355200505597911,0.0053099179082835,0.0251126114595554,0.0459274896600268,2.34960298309161e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.0273241487344724,0.0040884220010531,0.0193108416124083,0.0353374558565364,2.42922470960256e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASET2,Ribonuclease T2,42258,0.0194047675996732,0.00290849634164587,0.0137041147700473,0.0251054204292991,2.62504100205376e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.020228027638468,0.00303443814572801,0.0142805288728411,0.0261755264040949,2.72650879808956e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH1,Cadherin-1,41697,0.0290504800661749,0.00435912687254078,0.0205065913959949,0.0375943687363548,2.76594406162148e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRN,Progranulin,42077,0.0181620855148809,0.00272742664731782,0.0128163292861379,0.0235078417436238,2.86273166317102e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA3,Protein disulfide-isomerase A3,39736,0.0177603322840035,0.0026669108298008,0.012533187057594,0.0229874775104131,2.87667712073124e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRR3,Small proline-rich protein 3,39929,0.0454292059302348,0.00683434875535593,0.0320338823697371,0.0588245294907324,3.12462693427815e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0460713305013344,0.00693274438961124,0.0324831514976964,0.0596595095049724,3.16493995836606e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.0269588910773078,0.00405845729978878,0.0190043147697218,0.0349134673848938,3.22567474956519e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,39919,0.0417794189282687,0.00629039626320276,0.0294502422523913,0.0541085956041461,3.24118948875434e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNC,Tenascin,42217,-0.0347217327716157,0.00523713255295082,-0.0449865125753993,-0.0244569529678321,3.48542720001481e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0248657794361809,0.00375353382437781,-0.0322227057319614,-0.0175088531404004,3.61508841576233e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHI3L1,Chitinase-3-like protein 1,41907,0.0599058779536529,0.00908246683649113,0.0421042429541303,0.0777075129531755,4.39037403823452e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DGCR6,Protein DGCR6,39586,0.0298498544111832,0.00454453479613215,0.0209425662107642,0.0387571426116022,5.31931446035754e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWC2,Brorin,41973,0.0291691751066418,0.00444340101881221,0.0204601091097699,0.0378782411035137,5.40958860226134e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST5,Cystatin-D,41846,0.0399832048968416,0.00610500201714673,0.028017400943234,0.0519490088504492,5.99600431096801e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RALY,RNA-binding protein Raly,39919,0.0340781040475172,0.00522111052091196,0.0238447274265298,0.0443114806685047,6.99749275415966e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.0598834674002878,0.00918001825182974,0.0418906316267015,0.0778763031738741,7.17349237876283e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.0232600420937794,0.00357251192419431,-0.0302621654652003,-0.0162579187223586,7.73680099443264e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.0181797612218452,0.0027948099317619,0.0127019337555919,0.0236575886880985,8.05453291441992e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.0265217437039823,0.0040798325523604,0.0185252719013559,0.0345182155066087,8.34194801964616e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOM2,Myomesin-2,39575,-0.0392987005906115,0.00604613747268441,-0.051149130037073,-0.0274482711441501,8.39133994287331e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,39945,-0.0349152928949324,0.00537797461544142,-0.0454561231411976,-0.0243744626486672,8.80781791851793e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTB,Lymphotoxin-beta,39919,0.0241733106477172,0.00373353066953823,0.0168555905354222,0.0314910307600121,9.89635128416896e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.0145818375203011,0.00225477252553873,0.0101624833702452,0.019001191670357,1.03350148610239e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AFAP1,Actin filament-associated protein 1,39736,0.0586553003030916,0.00907085065042781,0.0408764330282531,0.0764341675779301,1.04600695689111e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLU,Clusterin,39979,0.0210418024720961,0.00326618004156601,0.0146400895906267,0.0274435153535655,1.22401938315964e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0492518026554025,0.00764515632943783,0.0342672962497044,0.0642363090611007,1.22582327308234e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSC2,Desmocollin-2,41984,-0.0245372229127374,0.0038172458234197,-0.0320190247266401,-0.0170554210988348,1.33686072517758e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.0400856992598373,0.00624301487956276,0.0278493900958943,0.0523220084237803,1.41046636431905e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMPD3,AMP deaminase 3,39929,0.0478466300642436,0.00747417913558482,0.0331972389584974,0.0624960211699899,1.59843777644944e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0437405410015911,0.00686659237629802,-0.0571990620591352,-0.030282019944047,1.94998898560917e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD14,Monocyte differentiation antigen CD14,41932,0.028488217631704,0.00447433749401254,0.0197185161434395,0.0372579191199686,1.99048340561997e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTRK3,NT-3 growth factor receptor,42249,-0.0146456559296933,0.00230192547301812,-0.0191574298568089,-0.0101338820025778,2.0503160056709e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.0350644719304554,0.00552541670545991,0.0242346551877539,0.0458942886731568,2.28105351403612e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD6,Programmed cell death protein 6,42145,-0.0484231181273699,0.00765312494816155,-0.0634232430257665,-0.0334229932289732,2.57447796252174e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300C,CMRF35-like molecule 6,42249,0.0241784705385603,0.00382323176237846,0.0166849362842985,0.0316720047928221,2.6266369230462e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.0307177367859109,0.00485975419210077,0.0211926185693934,0.0402428550024284,2.69925488848753e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0161287641594725,0.00255223191286118,0.0111263896102646,0.0211311387086804,2.70686961317457e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A13,Protein S100-A13,39657,0.024336520788893,0.00386474463641568,0.0167616213015182,0.0319114202762677,3.14856837904729e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSAP,Prosaposin,39886,0.0194644798731204,0.00309726445399431,0.0133938415432916,0.0255351182029493,3.41232254760294e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCT,Secretin,39649,0.0328300319357265,0.00522717615029043,0.0225847666811573,0.0430752971902958,3.49843188128857e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,41843,0.0363081020504068,0.0057933346416798,0.0249531661527144,0.0476630379480992,3.78946051902585e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,0.0186334261308165,0.00297416575392733,0.012804061253119,0.0244627910085141,3.83847398614628e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.0347772312991331,0.00555314950053395,-0.0456614043201796,-0.0238930582780865,3.89989141318724e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIF1C,Kinesin-like protein KIF1C,39575,0.0236633670619078,0.00378314972110329,0.0162483936085453,0.0310783405152702,4.12475909371127e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.0363706239531217,0.00581805150937312,0.0249672429947504,0.047774004911493,4.19045499988202e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0365806411230178,0.0058528770813568,0.0251090020435585,0.0480522802024771,4.25138735532369e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR15L,Protein GPR15L,39930,0.0422364573275205,0.00676831003349592,0.0289705696618685,0.0555023449931725,4.52252188358406e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,0.0229167026123351,0.00367866802330812,0.0157065132866512,0.030126891938019,4.81538642804343e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0170292467234367,0.00273433140839959,0.0116699571629736,0.0223885362838999,4.86583055382591e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB37,Ras-related protein Rab-37,41913,0.0548915529159844,0.00881828677859266,0.0376077108299427,0.072175395002026,4.96830940517313e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0740714972555195,0.0119114885576949,0.0507249796824374,0.0974180148286015,5.16663426596477e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSM,Oncostatin-M,42051,0.0465451924137582,0.00750208594759612,0.0318411039564698,0.0612492808710466,5.65518562465439e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLR2,Folate receptor beta,42249,-0.0195231363584484,0.00315266493588369,-0.0257023596327804,-0.0133439130841164,6.0883769038353e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.0259112118050118,0.00418420430181935,0.0177101713734458,0.0341122522365777,6.12866692032554e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CABP2,Calcium-binding protein 2,39649,0.0438098455285144,0.0071041122963287,0.0298857854277101,0.0577339056293186,7.2107770472388e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0386604656237851,0.00627794942923445,0.0263556847424855,0.0509652465050846,7.56894510365496e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NXPH1,Neurexophilin-1,41839,0.0259603381737675,0.00421831845791835,0.0176924339962475,0.0342282423512874,7.76392347058514e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0206699818731592,0.00336044503899551,0.014083509596728,0.0272564541495904,7.96029712641927e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP6,Gastrotropin,41881,0.037879413120485,0.00616717631530459,0.025791747542488,0.049967078698482,8.37620040710471e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.025304617435981,0.00412189700088626,-0.0333835355577181,-0.017225699314244,8.57821325481914e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GC,Vitamin D-binding protein,39979,0.0171863611171095,0.002802983057425,0.0116925143245565,0.0226802079096625,8.99665407816961e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN3,CCN family member 3,42299,0.0226016213169692,0.00368697140391837,0.0153751573652891,0.0298280852686492,9.02163547129612e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARF2,Scavenger receptor class F member 2,42249,-0.0189091058140081,0.00308656625860912,-0.024958775680882,-0.0128594359471342,9.24415313294169e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD209,CD209 antigen,42171,-0.0258521780175558,0.00423193394816756,-0.0341467685559642,-0.0175575874791474,1.03105352701276e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.0336709215831629,0.00551245041786218,0.022866518764153,0.0444753244021728,1.03524767575871e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX2,Sorting nexin-2,39919,0.0565508727875269,0.00927309412526541,0.0383756083020067,0.0747261372730471,1.10642911453589e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD276,CD276 antigen,42123,-0.0237669160065489,0.00389842155055319,-0.0314078222456331,-0.0161260097674646,1.11332527252599e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDM1,Nuclear protein MDM1,39649,0.0207636481881268,0.00341552119747312,0.0140692266410795,0.0274580697351741,1.24769107331733e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL25,C-C motif chemokine 25,42296,0.0323421328898702,0.00533028214096675,0.0218947798935753,0.042789485886165,1.33241418655505e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LUZP2,Leucine zipper protein 2,39919,0.029574041120538,0.00487856187620853,0.0200120598431693,0.0391360223979067,1.38687535913044e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFB,Vascular endothelial growth factor B,39657,0.0194124506725897,0.0032056322317663,0.0131294114983278,0.0256954898468517,1.44322227488175e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XG,Glycoprotein Xg,42261,0.0227516755226275,0.00375789920598455,0.0153861930788977,0.0301171579663572,1.44671369705858e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JAM2,Junctional adhesion molecule B,42249,0.0179294376456182,0.00296489589641881,0.0121182416886373,0.0237406336025991,1.51195058621051e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL34,Interleukin-34,41814,0.0239895240178044,0.00397023679594907,0.0162078598977442,0.0317711881378646,1.55978861577386e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.0263583559186221,0.00436232220408252,0.0178082043986204,0.0349085074386239,1.56032116091258e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0206151276361162,0.00341232432565594,-0.0273032833144018,-0.0139269719578305,1.5688708902419e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SATB1,DNA-binding protein SATB1,39934,0.0191772302160145,0.0031755618219863,0.0129531290449213,0.0254013313871076,1.59928933606128e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOB,Apolipoprotein B-100,39990,0.0149276272955953,0.0024737799235158,0.0100790186455043,0.0197762359456862,1.64577234568612e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AZU1,Azurocidin,41751,0.0491719002870987,0.00817403979204422,0.0331507822946921,0.0651930182795054,1.83960263582158e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKD1,Polycystin-1,39958,0.0177594292944376,0.00295271508950604,0.0119721077190058,0.0235467508698695,1.8587074007823e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNU13,NHP2-like protein 1,39575,0.0411661419438509,0.00684536964601004,0.0277492174376712,0.0545830664500306,1.87087524330366e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH3,Cadherin-3,42249,0.0240006759578757,0.00399738157907339,0.0161658080628919,0.0318355438528596,1.97280297160972e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA7,Carbonic anhydrase 7,39757,-0.0218574406087825,0.00364153644409677,-0.0289948520392122,-0.0147200291783528,2.00641952456252e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPHS1,Nephrin,39657,0.021675024670374,0.00361449801705661,0.014590608556943,0.0287594407838049,2.07674598551535e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COPB2,Coatomer subunit beta',39575,0.0279961708033373,0.00466929851471446,0.0188443457144969,0.0371479958921776,2.08862230959098e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.023531468162659,0.00392523937519241,0.0158379989872819,0.0312249373380361,2.09999270324451e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.0292455309023653,0.00487961819091515,0.0196814792481716,0.038809582556559,2.1074027901726e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.0228913257223022,0.00382182509541223,0.0154005485352942,0.0303821029093101,2.15585766535338e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIL1,Nucleotide exchange factor SIL1,39638,0.0213289143076586,0.00356181571271138,0.0143477555107443,0.0283100731045729,2.18764217731041e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,0.0257898134339367,0.00431106263965872,0.0173401306602057,0.0342394962076678,2.25576416533832e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN8,Septin-8,39906,0.0211751211245874,0.00353964186289163,0.0142374230733198,0.028112819175855,2.26699490448295e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.0337176912650896,0.0056377969654486,0.0226676092128103,0.0447677733173688,2.27975636876438e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0476685292723997,0.0079817216696968,0.0320243547997939,0.0633127037450054,2.39921514830358e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,39638,0.0204821326864754,0.00343523745751267,0.0137490672697506,0.0272151981032002,2.56226394036651e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE3,Eosinophil cationic protein,42081,0.0704204634868311,0.0118149530051745,0.047263155596689,0.0935777713769731,2.58088996312883e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EBI3_IL27,Interleukin-27,42247,-0.0198022551518433,0.00332392434414984,-0.026317146866377,-0.0132873634373096,2.62442604435108e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0253905298816527,0.0042654168123668,0.0170303129294138,0.0337507468338916,2.71852730267405e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDC1,Syndecan-1,42145,0.0260739354829966,0.00439065130934438,0.0174682589166816,0.0346796120493116,2.94665936247631e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.01579493471248,0.00266009394841408,-0.0210087188513716,-0.0105811505735884,2.95974569496665e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0302612281166593,0.00510584514203667,0.0202537716382674,0.0402686845950512,3.16624894119363e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFIC,Nuclear factor 1 C-type,39934,0.0293490218907564,0.00496269642679952,0.0196221368942293,0.0390759068872834,3.43686563910253e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.062678328513144,0.0105986544789068,0.0419049657344866,0.0834516912918013,3.4426834591415e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THBD,Thrombomodulin,42145,0.0189498997814556,0.00320591118755762,0.0126663138538427,0.0252334857090686,3.4837412008841e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STC2,Stanniocalcin-2,42113,0.015399175541804,0.00260539054729218,0.0102926100691114,0.0205057410144967,3.4927902324762e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LXN,Latexin,41960,-0.0437791786152255,0.00744655121469903,-0.0583744189960356,-0.0291839382344154,4.22296717284087e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBC1D17,TBC1 domain family member 17,41839,0.0275110017483678,0.00467990517199104,0.0183383876112653,0.0366836158854702,4.23874077891731e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB2A2,Mammaglobin-A,39575,-0.0198503804606995,0.00337897361954831,-0.0264731687550141,-0.0132275921663848,4.35970333815332e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0430980351388791,0.00734008027548059,0.0287114777989371,0.057484592478821,4.41636764037749e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.0259450698775574,0.00443221207010989,-0.0346322055349728,-0.017257934220142,4.9388802041778e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,39906,0.0242996671985574,0.00416016015233397,0.0161457532999829,0.032453581097132,5.33046488411416e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA9,Carbonic anhydrase 9,42262,-0.0295379546880848,0.00506781612990676,-0.039470874302702,-0.0196050350734676,5.71768669833308e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.032473967647293,0.00557413379899682,0.0215486654012593,0.0433992698933268,5.81494092486193e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYZL2,Lysozyme-like protein 2,39560,0.0229746376644186,0.00394842459562075,0.0152357254570019,0.0307135498718352,6.09733968485385e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0410699103532673,0.00707998904768957,0.0271931318197957,0.0549466888867388,6.7748937628786e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.0231634305051179,0.00399614501708188,0.0153309862716374,0.0309958747385984,6.92274747845015e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.027210615730502,0.00470924560962549,0.017980494335636,0.0364407371253679,7.72277226833842e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREML1,Trem-like transcript 1 protein,39990,0.0331816220477281,0.00575079029810709,0.0219100730634382,0.044453171032018,8.13737574620928e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,39638,0.0251658188060027,0.00436737169901549,0.0166057702759323,0.0337258673360731,8.52285453347561e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.018979019155349,0.00329513017909197,0.0125205640043288,0.0254374743063693,8.60741287728032e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1B,Interleukin-1 beta,41825,0.0352736236735223,0.00612700390335112,0.0232646960229541,0.0472825513240905,8.74845456361934e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CX3CL1,Fractalkine,42016,-0.0208782570934508,0.00362766740412784,-0.0279884852055413,-0.0137680289813602,8.83873487409981e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACHE,Acetylcholinesterase,39736,0.0213990163874891,0.00371791539163832,0.0141119022198779,0.0286861305551002,8.85878850368074e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.0193777042372924,0.003378466752197,0.0127559094029863,0.0259994990715985,9.96864826896332e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CR1,Complement receptor type 1,39970,0.0220784484287106,0.00384987998209748,0.0145326836637996,0.0296242131936217,1.00091276105895e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.0277671417265437,0.00485776571419621,-0.0372883625263683,-0.0182459209267191,1.11340565881459e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.0145184030339485,0.0025428046710565,-0.0195023001892192,-0.00953450587867774,1.15610880229219e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0487087579425853,0.00853430251172147,0.0319815250196112,0.0654359908655594,1.17167842421795e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.0370488442116309,0.00653293517862615,0.0242442912615236,0.0498533971617381,1.44762655356055e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VIM,Vimentin,41900,0.0706217967463856,0.0124672255026047,0.0461860347612803,0.0950575587314908,1.50425432147745e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL3,Myosin light chain 3,39638,-0.0483209162411422,0.00853305028877331,-0.0650456948071379,-0.0315961376751465,1.52647739288881e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TK1,"Thymidine kinase, cytosolic",39757,0.0289536629207292,0.00512131055497369,0.0189158942329808,0.0389914316084776,1.6101278638031e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A11,Protein S100-A11,42027,0.0283910853973167,0.00502322571262964,0.0185455630005626,0.0382366077940708,1.61853493459471e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.0190196138364733,0.00338637138763898,-0.0256569017562457,-0.0123823259167009,1.99592232378183e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.0397972313767181,0.00710059336438232,0.0258800683825288,0.0537143943709075,2.13557532013124e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,42119,0.0375415177997094,0.00672285250805925,0.0243647268839133,0.0507183087155055,2.39351851598506e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.0407346278853642,0.00730195772625435,0.0264227907419056,0.0550464650288227,2.48229231713891e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLVRB,Flavin reductase,42137,0.0385459847028334,0.0069175224747636,0.0249876406522968,0.0521043287533701,2.56308584642021e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.0167230895831998,0.0030076002297763,0.0108281931328382,0.0226179860335613,2.75610989768432e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX3,Syntaxin-3,39929,0.0229481661129406,0.00413875381356124,0.0148362086383606,0.0310601235875207,3.01048422975426e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL3,Fc receptor-like protein 3,41913,0.032202122579646,0.00581650412810919,0.020801774488552,0.04360247067074,3.14710262680987e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAPG,Macrophage-capping protein,42015,0.0353516146903578,0.00639041565045203,0.0228264000154718,0.0478768293652438,3.22575391594847e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENSA,Alpha-endosulfine,39919,0.0318251822565418,0.00575513229310958,0.020545122962047,0.0431052415510366,3.27563707750839e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRTAP,Cartilage-associated protein,39649,0.0296030902480859,0.00535726306905629,0.0191028546327355,0.0401033258634362,3.35450152384922e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUC16,Mucin-16,42070,0.11437695085868,0.0207205395487897,0.0737646933430518,0.154989208374307,3.45308124108511e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.0166451947801347,0.00301932549525146,0.0107273168094419,0.0225630727508276,3.59606730787297e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.0285505311913775,0.00517951240346638,-0.0387023755021716,-0.0183986868805834,3.60786016835255e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HGFAC,Hepatocyte growth factor activator,39897,0.0160676827540049,0.00293584696831487,0.0103134226961077,0.021821942811902,4.52107859059015e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA1,Alpha-1-antitrypsin,39795,-0.00486019701288414,0.000888146260635691,-0.0066009636837301,-0.00311943034203819,4.5381607515454e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,42199,-0.0172202321003896,0.00315706847531479,-0.0234080863120066,-0.0110323778887726,4.99690063935226e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSH,Pro-cathepsin H,41865,0.044139991028444,0.00810412867335355,0.028255898828671,0.0600240832282169,5.22550751606382e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFHD1,EF-hand domain-containing protein D1,39934,0.021194318079334,0.00390644228165926,0.0135376912072819,0.0288509449513861,5.89883133553902e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNG,Interferon gamma,41913,0.0670479646358019,0.0124044715321983,0.0427352004326932,0.0913607288389107,6.58720212523069e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP13,Collagenase 3,41839,-0.0189542604371149,0.00350750139480583,-0.0258289631709343,-0.0120795577032954,6.63286002226458e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.0279532375537987,0.005197991425827,0.0177651743591778,0.0381413007484196,7.6991829312377e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.0157454203702384,0.00293026401351358,0.0100021029037518,0.021488737836725,7.85510669866498e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB6A,Ras-related protein Rab-6A,42119,0.0258355864743603,0.00482128619822296,0.0163858655258433,0.0352853074228773,8.52215866471815e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST1,Cystatin-SN,38503,0.0620228604065459,0.0115727128566471,0.0393403432075176,0.0847053776055741,8.5371976984309e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPQ,Carboxypeptidase Q,39960,0.0217524731430656,0.00406431970586282,0.0137864065195745,0.0297185397665567,8.86515577209091e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBR2,TGF-beta receptor type-2,42181,0.0198094295288416,0.0037186939140976,0.0125207894572103,0.0270980696004729,1.01449453124951e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.0199807221400491,0.00375464439186184,0.0126216191319999,0.0273398251480983,1.04500008109903e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0307148086849018,0.00577789124044323,0.0193901418536331,0.0420394755161705,1.07804899110008e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMOX1,Heme oxygenase 1,42007,-0.0284490559032127,0.00535221804203268,-0.0389394032655968,-0.0179587085408287,1.08142905122205e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNLY,Granulysin,42137,0.0310664665186521,0.00585859528199434,0.0195836197659432,0.042549313271361,1.15886760071195e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP12,Macrophage metalloelastase,42146,0.0314282567427883,0.00593453733767298,0.0197965635609493,0.0430599499246274,1.20334584620911e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALM,Paralemmin-1,39859,0.0176003186016805,0.00332374692899054,0.011085774620859,0.0241148625825019,1.21042492884063e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,41900,0.0297857249074192,0.00562783898676481,0.0187551604933602,0.0408162893214783,1.2252662305836e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,0.0321051109340348,0.00607363751182957,0.0202007814108488,0.0440094404572207,1.27434681142449e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,42185,0.0156142142707532,0.00295554996726049,0.00982133633492259,0.0214070922065837,1.29037876582482e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QA,Complement C1q subcomponent subunit A,42230,-0.0128127723277714,0.00242909978522249,-0.0175738079068075,-0.00805173674873531,1.35008049092051e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.0217614415342331,0.00413269840522861,0.013661352659985,0.0298615304084811,1.42296793009151e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF7,SLAM family member 7,42119,-0.0341351815769962,0.00648472574022769,-0.0468452440278425,-0.0214251191261499,1.43161486691855e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRTG,Protogenin,42262,0.0140331861209364,0.00266719514303546,0.00880548364058685,0.0192608886012859,1.45121834438008e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PVALB,Parvalbumin alpha,42208,0.0637988376575409,0.0121283950420282,0.0400271833751655,0.0875704919399162,1.46011655612324e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA7,Thyroxine-binding globulin,39979,0.0104506457936758,0.00199320371665772,0.00654396650902666,0.0143573250783249,1.60696598337522e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS3,Galectin-3,42196,0.0168595316987105,0.00321683821152206,0.0105545288041272,0.0231645345932937,1.62075528081025e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.0178446061666882,0.0034181289321335,0.0111450734597066,0.0245441388736699,1.81608072470206e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,42166,-0.02522270812486,0.00484096805076105,-0.0347110055043516,-0.0157344107453683,1.91338389778233e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,39929,0.0217852334708186,0.00419802682076137,0.0135571009021263,0.0300133660395109,2.1462370829634e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,0.0188464339250644,0.00363785095413159,0.0117162460549665,0.0259766217951623,2.24260423308918e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKK3,Dickkopf-related protein 3,42310,-0.0165446651936605,0.00320068364895608,-0.0228180051456144,-0.0102713252417066,2.38526535765247e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTP1,Glutathione S-transferase P,41759,-0.0392347322884693,0.00759890270344411,-0.0541285815872197,-0.0243408829897188,2.46291089365127e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0475693707456506,0.00924287468412154,0.0294533363647724,0.0656854051265289,2.69049005571378e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.0193422764006348,0.00376080922343424,0.0119710903227037,0.0267134624785659,2.74736895009364e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,41963,0.0654003768788837,0.0127638520140873,0.0403832269312727,0.0904175268264948,3.03493177607184e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTF4,Neurotrophin-4,41843,0.0210770388569262,0.00411570832112839,0.0130102505475146,0.0291438271663379,3.07989379581223e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.0282120629664623,0.0055182292534423,0.0173963336297154,0.0390277923032092,3.23244064306207e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,-0.0139319500714037,0.00273001455807311,-0.019282778605227,-0.0085811215375804,3.38333084310139e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,41814,0.0297523586730894,0.00585233180199853,0.0182817883411723,0.0412229290050065,3.74924750552232e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.0157157121446469,0.00309222026767119,-0.0217764638692824,-0.00965496042001135,3.77782871062336e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.018897384339192,0.00372286754246088,0.0116005639559687,0.0261942047224153,3.91505443175442e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KEL,Kell blood group glycoprotein,41839,0.0199666511800816,0.00393449190052351,0.0122550470550555,0.0276782553051077,3.93219291809387e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG1A,Lithostathine-1-alpha,42105,-0.0274629680445708,0.00541437834237793,-0.0380751495956316,-0.0168507864935101,3.9839681315639e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLIC5,Chloride intracellular channel protein 5,39649,-0.0173433816735557,0.00342213893931144,-0.0240507739946062,-0.0106359893525053,4.08532321304685e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PADI4,Protein-arginine deiminase type-4,41814,0.0402002510265292,0.00794311668096021,0.0246317423318472,0.0557687597212112,4.226300941606e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.0300181827563962,0.00593487655579436,0.0183858247070392,0.0416505408057531,4.30638215369798e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.0167295469346585,0.00331857648653474,0.0102251370210504,0.0232339568482665,4.68598271463576e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,41802,0.01593984093152,0.00316231959637008,0.00974169452263462,0.0221379873404053,4.70334344767606e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMS1,PMS1 protein homolog 1,39649,0.0270020581658218,0.00536939492417753,0.0164780441144338,0.0375260722172098,5.01089681816617e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.0235627640730625,0.00468868715421304,0.014372937250805,0.0327525908953201,5.08625318584644e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0208199958123665,0.00414295848239205,0.0126997971868781,0.0289401944378549,5.08811505218846e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0141729833258038,0.00282112949593331,0.00864356951377449,0.0197023971378331,5.12888129307338e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UROS,Uroporphyrinogen-III synthase,39649,0.0360025706273923,0.00718102887586463,0.0219277540306976,0.050077387224087,5.42589209394197e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPO,Myeloperoxidase,42137,0.024470760953012,0.00488477007963021,0.0148966115969367,0.0340449103090872,5.52299757587099e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX2,Peroxiredoxin-2,39819,0.0328549206792632,0.00655868310269505,0.0199999017979809,0.0457099395605455,5.54377692064158e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,0.0274023160518335,0.00548011665537755,0.0166612874072935,0.0381433446963735,5.80932300523691e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRUNE2,Protein prune homolog 2,39757,0.0156055317696097,0.00313554356400426,0.00945986638416133,0.021751197155058,6.55488957213219e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS53,Serine protease 53,39929,0.0205273475794304,0.00414644862037824,0.0124003082834891,0.0286543868753718,7.50562622740296e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.018566523205792,0.00375077253825522,0.0112150090308118,0.0259180373807722,7.50973050635192e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.0126839286554063,0.00256492650002257,-0.0177111845954506,-0.00765667271536211,7.72080623873005e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL2,Fc receptor-like protein 2,42229,0.0267485361191224,0.005436533716068,0.0160929300356291,0.0374041422026156,8.74898783381774e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDI2,Protein DDI1 homolog 2,39736,0.0399919637923508,0.00813411972061543,0.0240490891399445,0.055934838444757,8.93305523421086e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THY1,Thy-1 membrane glycoprotein,42249,0.0155603832288243,0.00317362294320363,0.00934008226014523,0.0217806841975034,9.54529975182505e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PODXL,Podocalyxin,42070,0.00805310769585441,0.00164306891955806,0.00483269261352062,0.0112735227781882,9.63326021874367e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUC2,Mucin-2,39966,0.049359483755216,0.0100726149421874,0.0296171584685287,0.0691018090419034,9.69790617055866e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAM,Signal transducing adapter molecule 1,39919,0.0192373668464765,0.00392809731909253,0.0115382961010551,0.0269364375918978,9.84678758167427e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG4,Regenerating islet-derived protein 4,42144,0.0270959297880812,0.00553623903553694,0.0162449012784288,0.0379469582977336,9.97999964132701e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYGD,Gamma-crystallin D,39929,0.0520860898883013,0.010643833719842,0.031224175797411,0.0729480039791916,1.00398857066703e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,0.0142665361001427,0.00291788112393766,0.00854748909722491,0.0199855831030605,1.02337136499834e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ULBP2,UL16-binding protein 2,42016,0.0208839649981386,0.0042747489698145,0.0125054570173022,0.029262472978975,1.04397408996648e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHCY,Adenosylhomocysteinase,42145,0.0356380926515219,0.00729753237629677,0.0213349291939803,0.0499412561090636,1.05365484689791e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDHR1,Cadherin-related family member 1,41839,0.0219203146673584,0.00449680697426614,0.0131065729977968,0.0307340563369201,1.10271486960138e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0545404224944164,0.0112963629772547,0.0323995510589972,0.0766812939298356,1.3961537496018e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGR2,Anterior gradient protein 2 homolog,41740,0.0525549962723111,0.0109023856412234,0.0311863204155131,0.0739236721291091,1.44798576907431e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.0207900892817867,0.00431971469619192,0.0123234484772505,0.0292567300863228,1.50409739970764e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.0183819562242011,0.00381951377162344,0.0108957092318192,0.0258682032165831,1.5087176125935e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSB,Cathepsin B,42153,-0.0265238350686463,0.00551334137399279,-0.0373299841616722,-0.0157176859756204,1.5191108927497e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSG3,Desmoglein-3,42196,0.0183467574711439,0.00381462388539038,0.0108700946557788,0.0258234202865091,1.52865601925865e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICOSLG,ICOS ligand,42070,0.00995652971615555,0.0020759416295977,0.00588768412214406,0.014025375310167,1.63474906680528e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFHR4,Complement factor H-related protein 4,39945,0.0380031643559239,0.00794024302161075,0.0224402880335668,0.053566040678281,1.72159591326735e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.017375679636915,0.00363677849565738,0.0102475937854265,0.0245037654884035,1.79477559256022e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEO1,Neogenin,39934,0.0116900187004553,0.00245220584998948,0.00688369523447587,0.0164963421664346,1.89179866191865e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH12,Protocadherin-12,39934,0.0131859160029529,0.00276782045790587,0.00776098790545735,0.0186108441004484,1.92140595607451e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAFB2,Scaffold attachment factor B2,39934,0.014065004847593,0.00295786760033119,0.0082675843509439,0.0198624253442422,2.00775081606948e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD55,Complement decay-accelerating factor,41714,0.0136055634029699,0.0028622551221361,0.00799554336358313,0.0192155834423566,2.02107297933606e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL9,C-X-C motif chemokine 9,42185,0.0335016492671568,0.00705545687286331,0.0196729537963447,0.0473303447379689,2.07196015533383e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0291612223418486,0.00614270309386309,0.017121524277877,0.0412009204058203,2.08276925147624e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSV,Cathepsin L2,42200,0.0206254610797031,0.00434840281277162,0.0121025915666708,0.0291483305927355,2.12477227927454e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL21,C-C motif chemokine 21,42185,0.0196466307166425,0.00415618079574747,0.0115005163569774,0.0277927450763075,2.3004906781091e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.00986351556683223,0.0020878436204042,-0.0139556890628245,-0.00577134207084,2.33260153807028e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.0268676813005378,0.00570605828486284,0.0156838070622066,0.0380515555388689,2.52346347984149e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.0321505726668976,0.00684720459911252,0.0187300516526371,0.0455710936811582,2.69216810550065e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.0226185694382931,0.00485434204868101,0.0131040590228783,0.0321330798537079,3.20755363880369e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOSB,Protein fosB,41839,0.0194598889908253,0.00418238065361173,0.0112624229097463,0.0276573550719043,3.30589503231867e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2,Apoptosis regulator Bcl-2,39930,0.0269497881071827,0.00579680081575502,0.0155880585083028,0.0383115177060625,3.37185665004271e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.0262500841306063,0.00564769029290068,0.015180611156521,0.0373195571046917,3.39065471085587e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD99,CD99 antigen,42137,-0.0100452791254939,0.00216476445932042,-0.0142882174657619,-0.00580234078522585,3.5107046052847e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0382742029086091,0.00826444132531305,0.0220758979109955,0.0544725079062227,3.67752236040699e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,42185,0.0145435906168388,0.00314461056243999,0.00838015391445645,0.0207070273192212,3.78189961602892e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.0319730927738067,0.00693055602923875,0.0183892029564988,0.0455569825911146,4.0057170055387e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0160920891598964,0.00348886606375985,-0.0229302666448657,-0.00925391167492707,4.01669484652201e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSR,Insulin receptor,39657,0.00856299814629239,0.00186136026907736,0.00491473201890076,0.012211264273684,4.26371521661526e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROCR,Endothelial protein C receptor,39575,-0.017289986514408,0.00376077859006281,-0.0246611125509312,-0.00991886047788494,4.32473786021721e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE1,Ribonuclease pancreatic,39990,0.0123220466295251,0.00268343651998565,0.00706251105035322,0.017581582208697,4.43954252470413e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YAP1,Transcriptional coactivator YAP1,39929,0.0137508683690475,0.00299630011026319,0.00787812015293164,0.0196236165851634,4.49551512975759e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK4,Kallikrein-4,42262,-0.0310568665774254,0.00679735993859667,-0.0443796920570749,-0.0177340410977759,4.94441060615188e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD59,CD59 glycoprotein,41638,0.0116897286354597,0.00256383399535286,0.00666461400456806,0.0167148432663513,5.17492325010481e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF16,Fibroblast growth factor 16,39657,0.0229758156763385,0.00505078646247631,0.013076274209885,0.0328753571427921,5.44860610359752e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,39929,0.118739839888954,0.026197561522139,0.0673926193055614,0.170087060472346,5.8893262854341e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLASP1,CLIP-associating protein 1,39560,0.0369418137106505,0.00816255548860251,0.0209432049529896,0.0529404224683114,6.0810891839953e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHB6,Ephrin type-B receptor 6,41997,0.0161087723127133,0.00356010999336818,0.00913095672571162,0.0230865878997149,6.09736961585758e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.0139312411589875,0.00308194428318615,-0.0199718519540323,-0.00789063036394262,6.2275882435735e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0278967858338705,0.00618461384757504,0.0157749426926234,0.0400186289751176,6.51771262875418e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH17,Protocadherin-17,42145,0.018300167379441,0.0040657561043907,0.0103312854148352,0.0262690493440468,6.8182641318784e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCN2,Transcobalamin-2,42286,-0.0147781026646532,0.00328576056103311,-0.0212181933642781,-0.00833801196502831,6.92836627270272e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0202562551985909,0.00450693563920065,-0.0290898490514242,-0.0114226613457577,7.03189750255814e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOBR,Apolipoprotein B receptor,39638,-0.0209590477710734,0.004666141809943,-0.0301046857185617,-0.0118134098235851,7.13645701488468e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHISA5,Protein shisa-5,39966,0.012655959611878,0.00281889614101633,0.007130923175486,0.01818099604827,7.20303384958679e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCC,Netrin receptor DCC,39649,0.0108909441702279,0.00242901573675181,0.00613007332619435,0.0156518150142614,7.41038195560139e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00893354801131044,0.00199327528659354,0.0050267284495871,0.0128403675730338,7.47238166520514e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.0344477268237793,0.00770103345969391,0.0193537012427792,0.0495417524047793,7.78449973166721e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B2M,Beta-2-microglobulin,39979,0.0147786284211746,0.0033058788403517,0.00829910589408527,0.0212581509482639,7.88255279789235e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN4,Contactin-4,42137,-0.0114063612988374,0.00255287752605001,-0.0164100012498954,-0.00640272134777934,7.95793461817825e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECTIN1,Nectin-1,39657,0.0159336657765212,0.0035845873897693,0.00890787449257334,0.022959457060469,8.87278244227971e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB1A1,Uteroglobin,42165,0.0258518197486894,0.00581877744652476,0.0144470159535008,0.0372566235438779,8.94877467197515e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMNB2,Lamin-B2,39929,0.0138197365131613,0.00311435821601624,0.00771559440976946,0.0199238786165531,9.19003923798602e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.0144966969859596,0.00328384080401059,0.00806036901009888,0.0209330249618204,1.02019282540612e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0341868794374985,0.00775581053855361,0.0189854907819335,0.0493882680930636,1.05361231416854e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.0417298392076178,0.00947955504333103,0.023149911322689,0.0603097670925466,1.08227505643667e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0116856953157797,0.0026608994193701,0.00647033245381429,0.0169010581777451,1.13518614851254e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP4,Guanylate-binding protein 4,41839,0.0234138283933875,0.0053324999022624,0.0129621285849532,0.0338655282018218,1.13821320973548e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,41839,0.0409063093855973,0.00933868462457904,0.0226024875214224,0.0592101312497722,1.19422821152506e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LIPF,Gastric triacylglycerol lipase,39638,0.0299116474065217,0.00683031236869782,0.016524235163874,0.0432990596491694,1.20185662184016e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GZMB,Granzyme B,42119,0.032231879431432,0.00737191554309431,0.0177829249669671,0.0466808338958968,1.23889896313015e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.0140399991905135,0.00321739250861326,0.00773390987363152,0.0203460885073955,1.29003413644757e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGA,Fibrinogen alpha chain,39735,0.0147125630701522,0.0033807781319669,0.0080862379314971,0.0213388882088073,1.36211364660705e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.0201330613842585,0.00463085652602892,0.0110565825932418,0.0292095401752752,1.38664342854489e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUCA2A,Guanylin,42083,-0.0166035126001206,0.00382424127078739,-0.0240990254908639,-0.00910799970937737,1.42448975396611e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN2,Ataxin-2,39586,0.0499666975057353,0.0115175116338283,0.0273923747034317,0.0725410203080389,1.44855691860599e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18BP,Interleukin-18-binding protein,42217,0.0147280108035147,0.00340671542961086,0.00805084856147737,0.021405173045552,1.54854609808521e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRTN,Neurturin,41913,0.0232499773312717,0.00538489397724775,0.0126955851358662,0.0338043695266773,1.58854517245724e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB44,Ras-related protein Rab-44,39919,0.0210465165030511,0.00487481762528289,0.0114918739574966,0.0306011590486055,1.59224391367098e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,42145,0.0082073508992415,0.00190485187512722,0.00447384122399215,0.0119408605744909,1.65408115967541e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECM1,Extracellular matrix protein 1,39720,0.0170235467227625,0.00396383298129543,0.00925443407942346,0.0247926593661015,1.76400004704523e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300E,CMRF35-like molecule 2,42232,0.0194479322566618,0.00453759944314565,0.0105542373480964,0.0283416271652273,1.83207962019244e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFD,Vascular endothelial growth factor D,42275,-0.0179403137768129,0.00419190145544056,-0.0261564406294764,-0.00972418692414939,1.88372311354711e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERC2,ERC protein 2,39649,0.0341805810590076,0.00801138570468378,0.0184782650778274,0.0498828970401878,2.00217296659746e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,39889,-0.01261250343155,0.00296149700710891,-0.0184170375654834,-0.00680796929761654,2.07166487867299e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA12,Carbonic anhydrase 12,42070,-0.0151247257024098,0.00355432843433896,-0.0220912094337142,-0.00815824197110545,2.10182672369176e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,0.0200202434106554,0.00470921561896998,0.0107901807974743,0.0292503060238366,2.14240156957169e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAX,Apoptosis regulator BAX,41814,0.0423372960697839,0.00997778619160709,0.022780835134234,0.0618937570053338,2.21901557990271e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,QSOX1,Sulfhydryl oxidase 1,39767,0.0183596075867371,0.00433075957486271,0.00987131882000615,0.026847896353468,2.25970706271491e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.02440979174593,0.00575924075803913,-0.0356979036316867,-0.0131216798601733,2.26640933498258e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FSTL3,Follistatin-related protein 3,42084,0.0150638194545873,0.00355438290665472,0.00809722895754407,0.0220304099516306,2.26921688717671e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WIF1,Wnt inhibitory factor 1,42262,-0.0154863781245022,0.00365474701134631,-0.022649682266741,-0.00832307398226348,2.2767482221746e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDN1,Endothelin-1,39638,0.0135239705557379,0.00319290167417109,0.00726588327436257,0.0197820578371133,2.29753907550636e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.035224350012261,0.0083185676701254,0.0189199573788153,0.0515287426457068,2.30993915087066e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPARCL1,SPARC-like protein 1,42169,-0.0125621149439874,0.00296832548532907,-0.0183800328952324,-0.0067441969927424,2.33088544020081e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BOC,Brother of CDO,41900,-0.010648911517092,0.00252535287957446,-0.0155986031610579,-0.00569921987312604,2.49431156404285e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.0163683899117319,0.0038863335207988,0.00875117621096627,0.0239856036124976,2.55002997553902e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.04804165846593,0.0114174377308732,0.0256634805134185,0.0704198364184416,2.59610086576325e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGFLAM,Pikachurin,39930,0.0141182225091477,0.00335786189758733,0.00753681318987656,0.0206996318284189,2.63638121063138e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRD1,Bromodomain-containing protein 1,39757,-0.0138942672391515,0.00330460874823076,-0.0203713003856838,-0.00741723409261918,2.63687317285268e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.0142875038481174,0.00340144588142485,-0.0209543377757101,-0.00762066992052466,2.68524686710319e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LIF,Leukemia inhibitory factor,41839,0.0228587004640288,0.00544427782717611,0.0121879159227636,0.033529485005294,2.70247970846996e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD1,Programmed cell death protein 1,42232,0.0191091733328533,0.00455349876407507,0.0101843157552662,0.0280340309104404,2.72679133205185e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPEP1,Dipeptidase 1,41997,-0.0208453478570261,0.00498952467498971,-0.0306248162200059,-0.0110658794940462,2.96178824619703e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPE,Carboxypeptidase E,42134,-0.0176706617574445,0.00424486147502677,-0.025990590248497,-0.00935073326639205,3.16264515956749e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.019987462751114,0.00481414497865977,0.0105517385929409,0.0294231869092872,3.32316611382559e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.010002688568985,0.00240948610668898,0.00528009579987464,0.0147252813380954,3.32503951318856e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.0864679352536875,0.0208506162530838,0.0456007273976431,0.127335143109732,3.3889180732507e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNPEP,Aspartyl aminopeptidase,39929,0.0256362135511954,0.00618223930435301,0.0135190245146635,0.0377534025877273,3.39682688919817e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPB6,Heat shock protein beta-6,42262,0.0183133950092625,0.00441753171430036,0.00965503284923376,0.0269717571692912,3.40944895647211e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,39657,0.0289633858020217,0.00700562905181001,0.0152323528604741,0.0426944187435693,3.58663741409243e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.0252896353617671,0.00612431594604274,0.0132859761075233,0.0372932946160108,3.66349592053739e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE6,Ribonuclease K6,39937,0.0144161616024628,0.00350483299286601,0.00754668893644545,0.0212856342684802,3.92927379698515e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.0172992944461556,0.00421271703654236,0.0090423690545326,0.0255562198377786,4.04689620408909e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.0164416251740982,0.00400612033093542,0.00858962932546482,0.0242936210227317,4.08264199069882e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PEPD,Xaa-Pro dipeptidase,39990,0.0117492942229915,0.0028634926667101,0.00613684859623974,0.0173617398497433,4.10429037946897e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA1,Annexin A1,39699,0.0197894536342239,0.00482766709389094,0.0103272261301977,0.0292516811382501,4.17577025519791e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP9,Fatty acid-binding protein 9,42119,0.0250664713003362,0.00612635206066932,0.0130588212614243,0.037074121339248,4.30926213300049e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRG3,Proteoglycan 3,39966,-0.0221086925207385,0.00540445803303393,-0.032701430265485,-0.011515954775992,4.32806484347366e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCP1,Plastin-2,39966,0.0212589901481458,0.00520253663254548,0.0110620183483566,0.0314559619479349,4.41367298082463e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARG1,Arginase-1,42015,0.0223992108443279,0.0054885532062591,0.01164164656006,0.0331567751285957,4.50869532318265e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0210462678704341,0.00516049324889765,-0.0311608346382735,-0.0109317011025947,4.56173099817686e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,0.0153146902020071,0.00375769589762929,0.00794960624265373,0.0226797741613605,4.61683874973268e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0362504887442504,0.00892405290773121,0.0187593450450972,0.0537416324434036,4.89670605950033e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF5,Fibroblast growth factor 5,41913,-0.0149587333979959,0.00370510815970078,-0.0222207453910095,-0.00769672140498238,5.43664424730094e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPESP1,Sperm equatorial segment protein 1,39958,0.0146660356558586,0.00364401901931427,0.00752375837800261,0.0218083129337146,5.74213520450567e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.0160541569318018,0.00399423481922997,0.00822545668611106,0.0238828571774925,5.87476316562334e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.0452730997428491,0.011272801302546,0.0231784091898589,0.0673677902958393,5.95516567553778e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.0156371688238925,0.00389494381528212,-0.0232712587018455,-0.00800307894593958,5.99057883522561e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.0170756799536642,0.00425371089641515,0.00873840659669054,0.0254129533106379,6.00058846777703e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPA4,Carboxypeptidase A4,39518,0.0191677377426333,0.00477801746146603,0.00980282351815991,0.0285326519671068,6.06976931543373e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.0161826413663881,0.00403655648557138,-0.024094292078108,-0.00827099065466817,6.13743298325106e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMNB1,Lamin-B1,39908,0.0265915716694097,0.00663800202696437,0.0135810876965595,0.0396020556422599,6.21615503862051e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0153290054584096,0.00382869582118107,-0.0228332492679245,-0.00782476164889468,6.26861383026825e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,39757,0.019374991029192,0.00484572420764234,0.00987737158221298,0.028872610476171,6.41915600578295e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OLFM4,Olfactomedin-4,39347,0.0537779805221935,0.0134591704989733,0.0273980063442058,0.0801579547001812,6.49506151098921e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,39736,0.022757884503743,0.00569718815108844,0.0115913957276096,0.0339243732798763,6.5225395827897e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CENPJ,Centromere protein J,39757,0.0304680513701757,0.00763240692809969,0.0155085337911003,0.0454275689492511,6.59568026846682e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANPEP,Aminopeptidase N,42187,0.0118105820557858,0.00296101364266836,0.00600699531615582,0.0176141687954158,6.67857750089917e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK8,Kallikrein-8,41668,0.0158485136084561,0.00398564614130569,0.00803664717149697,0.0236603800454153,7.03439282497832e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.038769019554043,0.00975739921640567,0.0196445170898879,0.0578935220181981,7.12519798561174e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,0.0267130949046234,0.00673980729358606,0.0135030726091947,0.0399231172000521,7.43186669010776e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.016158231955931,0.00407775908185092,0.00816582415550315,0.0241506397563588,7.46282244776445e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A14,Protein S100-A14,39934,0.0222696922389985,0.00562356003215149,0.0112475145759816,0.0332918699020154,7.53859428996592e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINI1,Neuroserpin,39713,0.0124043158174696,0.00314510265609066,0.00623991461153191,0.0185687170234073,8.06225050037689e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.0122986864796483,0.00312355153767062,0.00617652546581386,0.0184208474934827,8.28594389155749e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AOC3,Membrane primary amine oxidase,42217,-0.0126696773667503,0.00321982794361792,-0.0189805401362414,-0.00635881459725916,8.36472746512545e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,0.0182194580237989,0.00463268705711822,0.00913939139184722,0.0272995246557507,8.43787288132966e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.0134000516846641,0.00341072136447126,0.00671503781030046,0.0200850655590278,8.58764065672275e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C9orf40,Uncharacterized protein C9orf40,39930,0.0331385866919028,0.0084472072284459,0.0165820605241488,0.0496951128596567,8.7961079873962e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,0.0126910737538626,0.00323747892518097,0.00634561506050788,0.0190365324472173,8.89769405210703e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.0111018354787747,0.00283353698989222,-0.0166555679789635,-0.00554810297858599,8.98240568962145e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.0243722557654143,0.00622358441398478,0.0121740303140042,0.0365704812168245,9.05242189609693e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM3,Intercellular adhesion molecule 3,42310,-0.0115055124353712,0.00294087422917061,-0.0172696259245456,-0.00574139894619678,9.18715117115074e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,42100,0.0201192808589139,0.00518854524608582,0.00994973217658568,0.0302888295412421,0.000105977022966839
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLMP,CXADR-like membrane protein,42262,0.00931144959146362,0.00240390089158054,0.00459980384396576,0.0140230953389615,0.000107794938196243
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRH,Corticoliberin,41830,0.036101642734516,0.00932237833413394,0.0178297811996135,0.0543735042694186,0.000108208199355916
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGN,Mimecan,42137,0.0181190734272603,0.00469836758605381,0.00891027295859483,0.0273278738959258,0.000115572836816629
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOD3,Extracellular superoxide dismutase,39990,-0.0254154130515197,0.00659484402685931,-0.038341307344164,-0.0124895187588755,0.000116922353491695
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,METAP1,Methionine aminopeptidase 1,41839,0.0121524512564592,0.00315790244269798,0.00596296246877113,0.0183419400441472,0.000119515083140955
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTPN,Myotrophin,41900,0.0135652647780307,0.00352974435124948,0.00664696584958168,0.0204835637064796,0.000122040302810898
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.0192321649560461,0.00501441364245147,0.00940391421684125,0.029060415695251,0.000126073535349946
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL15,Interleukin-15,42119,0.0135698543471705,0.00358011315731311,0.00655283255883676,0.0205868761355042,0.000151093174484933
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GZMH,Granzyme H,41900,0.0323925544637699,0.00854899537775513,0.0156365235233698,0.0491485854041699,0.000151892388992508
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,0.0157807119458654,0.00416489895468344,0.00761750999468587,0.023943913897045,0.000151916236071494
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RCC1,Regulator of chromosome condensation,39919,0.0214346591530941,0.00566392224979483,0.0103333715434963,0.032535946762692,0.000154862306406571
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWF,von Willebrand factor,42310,-0.0303898035710475,0.00804251681642026,-0.0461531365312313,-0.0146264706108638,0.000158352443789733
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,0.0167309960135758,0.00443156958202895,0.00804511963279907,0.0254168723943525,0.000160555629692247
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA5,Protein disulfide-isomerase A5,39560,0.0252433210325273,0.00669743443800275,0.0121163495340419,0.0383702925310127,0.000164694752570382
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX18,Sorting nexin-18,39930,0.0178918914645381,0.00475219468297846,0.00857758988590032,0.0272061930431759,0.00016740794054051
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0232163066802766,0.00617297943960716,0.0111172669786465,0.0353153463819066,0.000170145749753643
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDRG1,Protein NDRG1,41839,0.0268685948254299,0.00718047695106869,0.0127948600013353,0.0409423296495246,0.000183409086721171
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHB4,Ephrin type-B receptor 4,42310,-0.0103060144489384,0.00275497850994361,-0.0157057723284279,-0.00490625656944898,0.000184132290926342
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THBS2,Thrombospondin-2,42137,0.0156864721482109,0.00419666847187414,0.00746100194333762,0.0239119423530842,0.000186372355468203
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFDN2,Prefoldin subunit 2,41839,0.02240976611029,0.00600137205135294,0.0106470768896383,0.0341724553309418,0.000189172028373965
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FMR1,Synaptic functional regulator FMR1,41843,0.0146684442130579,0.00392864680566325,0.00696829647395793,0.0223685919521579,0.000189467017419361
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA11,Serpin A11,42310,-0.0169185308682023,0.00453692937530903,-0.025810912443808,-0.00802614929259657,0.000192961164132964
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.0165867073078181,0.00444848757224214,0.00786767166622348,0.0253057429494127,0.000193322237130608
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,42212,0.0338129031586303,0.00908567708713334,0.016004976067849,0.0516208302494116,0.000198791962811655
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM26,Tripartite motif-containing protein 26,39560,0.0232190124108338,0.00623917672827189,0.0109902260234209,0.0354477987982467,0.000199043895601135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.0172349301060566,0.00463655236121653,-0.026322572734041,-0.00814728747807222,0.000202455441241925
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALB1,Calbindin,42070,0.0182520859512689,0.00491445962674293,0.00861974508285272,0.027884426819685,0.000204868173628541
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.0245541432885126,0.00662120853951677,0.0115765745510598,0.0375317120259655,0.000209414336209349
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP112,Centrosomal protein of 112 kDa,39575,0.0178792764181691,0.00482255385880107,0.00842707085491904,0.0273314819814193,0.000210404917281395
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,0.0210224890581149,0.00567147040228327,0.00990640706963966,0.0321385710465901,0.00021082606928457
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRD3,Bromodomain-containing protein 3,39575,0.0191157088230942,0.0051588753363843,0.00900431316378098,0.0292271044824074,0.000212092463544419
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPON1,Spondin-1,42144,0.0131201984865956,0.00354261414930327,0.00617667475396123,0.02006372221923,0.000213459800931739
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP3,"Fatty acid-binding protein, heart",39958,0.0218708932027404,0.00590829002850965,0.0102906447468615,0.0334511416586193,0.000215147444949462
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.0110415661668402,0.00298510998848168,0.00519075058941611,0.0168923817442643,0.000217398104687019
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK14,Kallikrein-14,42262,-0.0185593098086924,0.00503125638368158,-0.0284205723207083,-0.00869804729667647,0.000226186444217903
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.0201042663194364,0.00547002939945793,0.00938300869649882,0.0308255239423739,0.000238462704162057
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM5,Intercellular adhesion molecule 5,42145,0.0183612506962777,0.00499720186393281,0.00856673504296936,0.028155766349586,0.000239416047862029
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.0206707314090443,0.00563883186107585,0.00961862096133565,0.031722841856753,0.000247748606871937
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALCAM,CD166 antigen,42310,0.00783260237628084,0.00213787840768012,0.0036423606972278,0.0120228440553339,0.000249508665356567
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC12A2,Solute carrier family 12 member 2,39575,-0.0105034976893775,0.0028689471538554,-0.0161266341109341,-0.00488036126782091,0.000252315750655093
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.0107802074716838,0.00294632968950013,0.00500540128026351,0.016555013663104,0.000254489195091642
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.0125088766307894,0.00342103730952447,0.0058036435041214,0.0192141097574573,0.000256711101185495
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST7,Cystatin-F,42148,0.0374791402576515,0.0102591008083704,0.0173713026732456,0.0575869778420574,0.000259910917195844
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.00948095668194097,0.00260492433937469,0.00437530497676658,0.0145866083871154,0.000274042781111645
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,42247,0.0111714218044034,0.00308237338691257,0.00512996996605475,0.017212873642752,0.000290807198467083
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.0116339577046472,0.00321030049869447,0.00534176872720607,0.0179261466820884,0.000291443172140904
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,39575,0.0167264822453544,0.00462267652178285,0.00766603626265999,0.0257869282280488,0.000297814484340241
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMEM25,Transmembrane protein 25,39934,-0.0183877675271942,0.00508930429366536,-0.0283628039427783,-0.00841273111161005,0.000303958860371437
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN3,Neuronal-specific septin-3,39934,-0.0306905460660895,0.00850467298235413,-0.0473597051115036,-0.0140213870206754,0.000309098320553766
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,0.0121517707379447,0.00336887681210802,0.00554877218621302,0.0187547692896765,0.000310790270555026
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGN,Secretagogin,41913,-0.0173632793970098,0.0048282064065645,-0.0268265639538763,-0.00789999484014341,0.000324046763540458
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.0114872600459628,0.0031978906560585,0.00521939436008811,0.0177551257318374,0.000329141537529131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROBO4,Roundabout homolog 4,39638,-0.00711810573505609,0.00198273845715564,-0.0110042731110811,-0.00323193835903104,0.000332064614198878
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",39586,0.0326668240334393,0.00911841540544359,0.0147947298387699,0.0505389182281088,0.000341778995612646
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17RA,Interleukin-17 receptor A,42137,0.0172244377128165,0.00482086345519347,0.0077755453406373,0.0266733300849957,0.00035428314820119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.0140704659026097,0.00394402442320615,0.00634017803312566,0.0218007537720938,0.000361872381339086
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNPY2,Protein canopy homolog 2,41900,0.0235532558118901,0.00661540265448847,0.0105870666090927,0.0365194450146875,0.000371630351204685
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.0289218202874283,0.00813316930226853,0.0129808084549819,0.0448628321198746,0.000378028243106707
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.0214670920021183,0.00604529127739926,0.0096183210984158,0.0333158629058209,0.000385263961098177
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.0140002182553504,0.00395133684615688,0.00625559803688292,0.0217448384738179,0.000396956772538657
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPA2,Replication protein A 32 kDa subunit,39657,0.0118817927821151,0.00336407491395143,0.00528820595077031,0.0184753796134599,0.000414165586419643
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.014840739516503,0.00422196535585238,0.00656568741903239,0.0231157916139737,0.000441014627506276
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.0185635962962066,0.00530365499857342,-0.0289587600934105,-0.00816843249900271,0.000466484922345249
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.0128527341574967,0.00367288502966281,0.00565387949935761,0.0200515888156358,0.000467887592773895
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD7,T-cell antigen CD7,39636,0.0169988322944574,0.00486443834820201,0.00746453313198142,0.0265331314569333,0.000476794503649138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,0.0139572629542614,0.00401116050245777,0.00609538836944415,0.0218191375390786,0.00050403176339425
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN10,Ataxin-10,41839,0.0276987225012532,0.00797820868660591,0.0120614334755057,0.0433360115270008,0.000518636356244386
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.0173467743863265,0.00501455314481997,0.00751825022247932,0.0271752985501736,0.000543603740045368
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PI3,Elafin,41966,0.0211134357716051,0.00610813126940911,0.00914149848356329,0.033085373059647,0.000548713982325867
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.0208531686961815,0.00607950295169092,0.00893734291086733,0.0327689944814957,0.000605559184305831
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.0249293604149271,0.00727101863188642,0.0106781638964297,0.0391805569334244,0.000608567261064764
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,41960,0.011311037077173,0.00330283110425162,0.00483748811283986,0.0177845860415062,0.000617444037873915
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDK1,Cyclin-dependent kinase 1,39560,0.0135770838405275,0.00396496055681775,0.0058057611491647,0.0213484065318903,0.000618717571841366
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RSPO1,R-spondin-1,42016,0.0126581128297176,0.00370285618110049,0.00540051471476064,0.0199157109446746,0.000631608025189247
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAM,Basal cell adhesion molecule,42137,-0.00911134458020679,0.00266728223930832,-0.0143392177692511,-0.00388347139116247,0.000637429600427397
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REN,Renin,42145,-0.0300860523382304,0.00881106099678146,-0.047355731891922,-0.0128163727845387,0.000640682340411978
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP1,Caspase-1,41839,0.025586762617462,0.00749401457402217,0.0108984940523785,0.0402750311825455,0.000641394658617527
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.0263647743345924,0.0077263707155765,-0.0415084609371223,-0.0112210877320624,0.000646399891494993
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HCG22,Protein PBMUCL2,39575,-0.0215123846296514,0.0063092555516722,-0.0338785255109289,-0.00914624374837389,0.000652792231120583
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYTL1,Cytokine-like protein 1,39966,0.00944106867664988,0.00277321224632169,0.00400557267385937,0.0148765646794404,0.000665435369939871
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.0266742843558177,0.0078548259961499,-0.0420697433082715,-0.0112788254033639,0.000686356891894555
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.0149029023375343,0.00440344910899259,-0.0235336625911597,-0.00627214208390877,0.000715914834637509
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,42185,0.00991741469229133,0.00293277657032911,0.00416917261444627,0.0156656567701364,0.000722737674676086
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.023384705154397,0.00698697720500167,0.00969022983259377,0.0370791804762003,0.000819861149398644
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCAN,Neurocan core protein,42249,0.0135837679303198,0.00407019554734646,0.00560618465752071,0.0215613512031188,0.00084799811804434
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.0114366311318232,0.00344839199603024,0.00467778281960399,0.0181954794440425,0.000914445854744913
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHNAK2,Protein AHNAK2,39638,0.011212151810501,0.00338583675012781,0.00457591178025048,0.0178483918407515,0.000930997610426035
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2L15,Bcl-2-like protein 15,39657,0.0202930861250574,0.00615246061026798,0.00823426332893212,0.0323519089211826,0.000975553468286477
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.0107461824904108,0.00326198983304404,-0.0171396825631771,-0.0043526824176445,0.00098894693645631
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRAL,GDNF family receptor alpha-like,39574,-0.0226173797538785,0.00686653693979551,-0.0360757921558777,-0.00915896735187931,0.00099136215526614
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,L1CAM,Neural cell adhesion molecule L1,42181,0.010599059908003,0.00322456515661976,0.00427891220102827,0.0169192076149777,0.0010152744225556
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.019745245417548,0.00602342336628116,0.00793933561963692,0.0315511552154591,0.00104836641773743
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,0.020537316513138,0.00626719713903383,0.00825361012063168,0.0328210229056443,0.00105197526339744
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A16,Protein S100-A16,41814,-0.0216851334288215,0.00662162038821819,-0.0346635093897292,-0.0087067574679139,0.00105972027905424
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOH,Beta-2-glycoprotein 1,42137,-0.0129941905749851,0.00397627204086713,-0.0207876837750846,-0.00520069737488549,0.00108606017901919
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NXPH3,Neurexophilin-3,39657,0.0106468244862076,0.00326066324678488,0.00425592452250925,0.017037724449906,0.00109706923627424
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMOD1,Leiomodin-1,39934,-0.0122895972023678,0.00376792753187048,-0.019674735164834,-0.00490445923990171,0.00111099850869058
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.0207692379954268,0.00639443919358351,0.00823613717600311,0.0333023388148505,0.00116496392567209
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.0122403791942875,0.00377472919048248,0.00484190998094182,0.0196388484076332,0.00118678799560529
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDS,Iduronate 2-sulfatase,42296,0.00323761702231864,0.00099929396010004,0.00127900086052257,0.00519623318411472,0.00119855037689097
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP152,Centrosomal protein of 152 kDa,39560,0.0147981732247529,0.00457006272682655,0.00584085028017288,0.023755496169333,0.00120700328925667
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,39757,0.018461840657282,0.00570510863252717,0.00727982773752879,0.0296438535770353,0.0012156278666772
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MILR1,Allergin-1,41913,-0.0179614484560006,0.00555988759178961,-0.0288588281359082,-0.00706406877609292,0.0012385598266061
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.0101622788538312,0.00314591045487508,0.00399629436227608,0.0163282633453864,0.00124007475540052
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUK1,Guanylate kinase,39575,-0.0141155874850834,0.00437247366355201,-0.0226856358656453,-0.00554553910452141,0.00124901201348142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP7,Retinoid-binding protein 7,39930,0.0218853096592617,0.00678609863550316,0.00858455633367552,0.0351860629848479,0.00126320745876707
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,41843,0.0165951718921631,0.0051539187582446,0.00649349112600372,0.0266968526583225,0.00128538637112255
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA6,Corticosteroid-binding globulin,39979,0.00539263977598721,0.00167499880078002,0.00210964212645837,0.00867563742551605,0.00128779764559217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,39929,0.0164616747869113,0.00511827287371448,0.00642985995443091,0.0264934896193917,0.00130239713941202
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLPS,Colipase,42115,0.0257547170169567,0.0080140342304609,0.0100472099252534,0.0414622241086601,0.0013134313686997
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,0.0169713865342573,0.00528259479844925,0.00661750072929681,0.0273252723392179,0.00131807266537138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MST1,Hepatocyte growth factor-like protein,39854,0.0235305353410342,0.007325681797844,0.00917219901725994,0.0378888716648084,0.00132157225845035
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TERF1,Telomeric repeat-binding factor 1,39657,-0.0101389794119073,0.00315960489824257,-0.0163318050124627,-0.00394615381135183,0.00133605859689062
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.0300993959995207,0.00938955796805697,0.011695862382129,0.0485029296169123,0.00135152836308298
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP8,Neutrophil collagenase,42224,0.0249087802692281,0.00777613683992749,0.0096675520629702,0.040150008475486,0.00136206417303145
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.0130135838711044,0.00407075595518539,-0.0209922655432678,-0.00503490219894103,0.00139332067156841
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL12,Stromal cell-derived factor 1,41913,0.013675244788081,0.00429248908730849,0.00526196617695638,0.0220885233992056,0.00144660237606395
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SULT1A1,Sulfotransferase 1A1,42249,-0.044464512070706,0.0139619016190823,-0.0718298392441074,-0.0170991848973048,0.00145228194952082
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRA2,GDNF family receptor alpha-2,42070,0.00719070513489822,0.00226762630100753,0.00274615758492347,0.011635252684873,0.0015224126944632
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.011447485362926,0.00361440891906289,-0.0185317268442893,-0.00436324388156275,0.00154345928816037
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PREB,Prolactin regulatory element-binding protein,41913,0.00975820033516319,0.00308247204240189,0.00371655513205549,0.0157998455382709,0.00155055730064275
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL36G,Interleukin-36 gamma,39624,0.0230527157161126,0.00729928837357624,0.00874611050390319,0.0373593209283221,0.0015916725838926
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,42119,0.0125850480920023,0.0039880969320056,0.0047683781052713,0.0204017180787333,0.00160490797753041
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMOD4,Tropomodulin-4,39560,-0.0137229022343078,0.00435214864797952,-0.0222531135843477,-0.00519269088426797,0.00161964190513579
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,39657,0.0358311721552973,0.0113709929595281,0.0135440259546221,0.0581183183559724,0.00163089004202969
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALPP,"Alkaline phosphatase, placental type",42070,0.0356407171615376,0.0113197401205713,0.0134540265252177,0.0578274077978574,0.00164443416754749
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INHBB,Inhibin beta B chain,39736,0.0178649437230417,0.00567499637746007,0.00674195082321996,0.0289879366228634,0.00164820154019653
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPS10,40S ribosomal protein S10,39575,-0.0142310831265093,0.00453602075748669,-0.0231216838111832,-0.0053404824418354,0.0017093364693336
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.0122053625954301,0.00389408111262023,-0.0198377615761657,-0.00457296361469442,0.00172608773808438
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,39958,-0.0136049957462506,0.00436017664857013,-0.0221509419774481,-0.0050590495150532,0.00181128492425142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,41839,0.0129608512127837,0.00416342000165072,0.00480054800954828,0.0211211544160191,0.00185571782114262
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.0169477586492386,0.00549004257321811,0.00618727520573107,0.0277082420927461,0.00202688530389048
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HLA_DRA,,42060,-0.0121981110085174,0.00395465395571525,-0.0199492327617192,-0.00444698925531545,0.0020431103929225
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.00648755996284425,0.00210433935561593,-0.0106120650998515,-0.00236305482583702,0.00205454226559843
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,41879,0.0178865668463713,0.00581785395644234,0.00648357309174429,0.0292895606009983,0.00211335366233362
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,0.0243815755931437,0.00794198016508276,0.00881529446958151,0.0399478567167059,0.0021451058164364
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.0164261079202263,0.00535152581369151,0.00593711732539095,0.0269150985150617,0.00214978056530682
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA4,Ephrin type-A receptor 4,39736,0.00971813182140253,0.00317448716246503,0.00349613698297107,0.015940126659834,0.00220885937421178
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17C,Interleukin-17C,41913,-0.0235727645754695,0.00770594085964614,-0.038676408660376,-0.0084691204905631,0.00222490363700717
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF3,Granulocyte colony-stimulating factor,41913,0.0159345066485403,0.0052176187994621,0.00570797380159456,0.026161039495486,0.00226272723336461
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASPN,Asporin,39958,0.00923363260748492,0.00302439282867355,0.00330582266328476,0.0151614425516851,0.00227049582001828
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00687880537740209,0.00226187208394599,-0.0113120746619362,-0.00244553609286795,0.0023619329030715
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITM2A,Integral membrane protein 2A,42119,-0.0205127025161133,0.00674713417516445,-0.0337370854994356,-0.007288319532791,0.00236865802898367
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRLB,Fc receptor-like B,41843,0.02034719312401,0.00670419107811876,0.00720697861089724,0.0334874076371228,0.00241005716330379
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCP2,Non-specific lipid-transfer protein,41843,0.0244822016920451,0.00807233284323918,0.00866042931929625,0.0403039740647939,0.00242722253256542
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD27,CD27 antigen,42181,-0.0140500112987879,0.00463929768916602,-0.0231430347695533,-0.0049569878280225,0.00246250427021284
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,0.00935107378566268,0.00308996494853965,0.00329474248652496,0.0154074050848004,0.00248143695472537
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.0153011576034604,0.00505891759240244,-0.0252166360845692,-0.00538567912235163,0.00249545242490674
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QL2,Complement C1q-like protein 2,39657,0.014137907956992,0.00467959049693958,0.0049659105829904,0.0233099053309936,0.00252363249131104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,39090,0.018510520960131,0.00614721730836942,0.00646197503572694,0.030559066884535,0.00260834143816441
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.025148840987398,0.00837683404150667,-0.041567435708751,-0.00873024626604487,0.0026862848176771
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.0117942441476843,0.00394732883983931,0.00405747962159926,0.0195310086737693,0.00281513465035887
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX5,Syntaxin-5,39657,0.0129037131672855,0.0043224835797457,0.00443164535098394,0.0213757809835871,0.00283962663380671
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.0115432295644322,0.00387520390908338,0.00394782990262881,0.0191386292262357,0.00289957502437633
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.00974530867332504,0.00327473353522906,0.00332683094427608,0.016163786402374,0.00292754128286144
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100G,Protein S100-G,39934,-0.0157672429745829,0.00531324421995281,-0.0261812016456904,-0.0053532843034754,0.00300824380398637
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTF3,Neurotrophin-3,42119,0.0111042918938228,0.00374234430470252,0.00376929705660582,0.0184392867310397,0.00301049448056105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP164,Centrosomal protein of 164 kDa,41913,0.0199934385269651,0.00676598217007232,0.00673211347362337,0.0332547635803069,0.00313222421620122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G1B,Phospholipase A2,42299,-0.0142722011945722,0.00484060640703859,-0.0237597897523679,-0.00478461263677659,0.00319929062209709
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NLGN2,Neuroligin-2,39586,-0.014963627322376,0.00508200774399863,-0.0249243625006133,-0.0050028921441387,0.00324225596323126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,39951,-0.00473237209349158,0.00161620013565803,-0.00790012435938132,-0.00156461982760183,0.00341733911949589
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSTN1,Calsyntenin-1,41839,0.0161021095390441,0.00551293088675421,0.0052967650010059,0.0269074540770824,0.00349735209221944
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MERTK,Tyrosine-protein kinase Mer,42296,0.00781734661421532,0.00268084864336484,0.00256288327322024,0.0130718099552104,0.00355128952784315
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOP1,DNA topoisomerase 1,39930,0.038184919547069,0.0131085773515797,0.0124921079379729,0.0638777311561652,0.00358705954097071
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLL4,Delta-like protein 4,39638,0.0279088403370862,0.00958622300233099,0.00911984325251749,0.046697837421655,0.00360591963066063
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,42095,0.0121395227621061,0.00417087937126962,0.00396459919441762,0.0203144463297945,0.00361391465335886
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.0176493811421028,0.00607290287789503,0.00574649150142859,0.0295522707827771,0.00366518435122018
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,0.0125217806107564,0.0043095894901938,0.00407498520997652,0.0209685760115362,0.00367188291901731
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK15,Kallikrein-15,39900,0.0165705658201055,0.00571479391304672,0.00536956975053391,0.0277715618896771,0.00374369369923173
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,39958,-0.0121314356865014,0.00418881064072046,-0.0203415045423135,-0.00392136683068934,0.00378489183186444
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.0195089017620483,0.00673721621698084,-0.0327138455473307,-0.00630395797676584,0.00379069618092797
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17A,Interleukin-17A,41877,-0.0134725827165229,0.00466490424272983,-0.0226157950322734,-0.00432937040077248,0.00388236477917355
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRR4,Proline-rich protein 4,39652,-0.0222388216724522,0.007720300465903,-0.037370610585622,-0.00710703275928229,0.00397727295933322
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCUN1D2,DCN1-like protein 2,39560,-0.0249172950121486,0.00867434536029675,-0.0419190119183302,-0.00791557810596696,0.00407984311055127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.0314992087982415,0.0109948892164464,-0.0530491916624764,-0.00994922593400657,0.00417938763137965
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.0251625891252666,0.00880096643697089,0.00791269490880366,0.0424124833417295,0.00425678792659212
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGA,Glycoprotein hormones alpha chain,42137,-0.0191897965178603,0.00672264285096957,-0.0323661765057606,-0.0060134165299599,0.0043169847607439
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,39929,0.021402912037168,0.00750617485915586,0.00669080931322253,0.0361150147611135,0.00436094253899115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.0120566617473516,0.00424735129501173,0.00373185320912865,0.0203814702855746,0.00453764983793809
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.0215852155366183,0.007613719637128,0.0066623250478474,0.0365081060253892,0.00458866836588788
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPC1,Glypican-1,42262,0.0090915800398137,0.00321060725389498,0.00279878982217954,0.0153843702574479,0.00463642834485938
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RYR1,Ryanodine receptor 1,39575,-0.0103873255812497,0.00366804515466,-0.0175766940843833,-0.00319795707811611,0.00463649051383172
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYO6,Unconventional myosin-VI,39934,0.0114306328582187,0.00406460782346291,0.00346400152423141,0.019397264192206,0.00492830925307735
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP290,Centrosomal protein of 290 kDa,39757,0.0162001861016665,0.00576265939389544,0.0049053736896314,0.0274949985137015,0.00494378888294558
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HRAS,GTPase Hras,39750,0.0302045367210314,0.0107682444262412,0.00909877764559852,0.0513102957964642,0.00504093249711213
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,39649,0.0196756599873197,0.00704004883517259,0.00587716427038138,0.0334741557042579,0.00520183630223788
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EXTL1,Exostosin-like 1,39575,0.0144184055919895,0.00517119041172333,0.00428287238501182,0.0245539387989673,0.00530900965738458
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0130826717246282,0.00470013662394098,-0.0222949395075525,-0.0038704039417039,0.00538561624752914
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.0186556879170486,0.00673948355991624,-0.0318650756944845,-0.00544630013961281,0.00564741991446828
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAV,Integrin alpha-V,42262,-0.00499820270291119,0.00180569981740219,-0.00853737434501948,-0.00145903106080291,0.00564749506534475
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEZ6L2,Seizure 6-like protein 2,42070,-0.00726684819283387,0.00262811386882924,-0.0124179513757392,-0.00211574500992856,0.00569927075179623
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNL1,Thioredoxin-like protein 1,39570,0.0305449117200539,0.0110577900589754,0.00887164320446211,0.0522181802356457,0.00574916122737295
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0347739078254953,0.0125910139361534,0.0100955205106346,0.059452295140356,0.00575618413719245
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK11,Kallikrein-11,42062,0.00964823764111141,0.00350470628037017,0.00277901333158588,0.0165174619506369,0.00591423027063205
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY6D,Lymphocyte antigen 6D,42041,0.0118832473495042,0.00431938986466408,0.00341724321476261,0.0203492514842458,0.00594677293318768
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.016097246728732,0.0058548223691177,0.00462179488526131,0.0275726985722027,0.00597850653153876
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTX1,Neuronal pentraxin-1,42137,0.0124417252469801,0.00453797001915381,0.00354730400943864,0.0213361464845216,0.00612035146467534
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSTN2,Calsyntenin-2,42296,-0.0119258942339464,0.00434987123380557,-0.0204516418522054,-0.00340014661568751,0.006120779231306
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMP4,Bone morphogenetic protein 4,41992,-0.0140653251234063,0.0051445471016234,-0.0241486374425882,-0.00398201280422446,0.00626473336926651
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFNA1,Ephrin-A1,42113,0.00872467424148408,0.00319926052207643,0.00245412361821429,0.0149952248647539,0.00639778900800437
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARTN,Artemin,41913,0.0133653261854192,0.00491428836298195,0.00373332099397456,0.0229973313768638,0.00654284948953981
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,42145,0.00932772285895699,0.00343906223779404,0.00258716087288067,0.0160682848450333,0.00669051264524823
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,42223,0.0120490804931688,0.00446026088791493,0.00330696915285552,0.0207911918334821,0.00691275367619893
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.0205153229364356,0.00762215429662585,0.00557590051504898,0.0354547453578223,0.0071209943178118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA6C,Semaphorin-6C,39657,0.00754372001099825,0.00280457338865308,0.00204675616923821,0.0130406838527583,0.00716038224134199
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.0112084504296953,0.00417299838523464,0.00302937359463538,0.0193875272647552,0.00724300890505592
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.0156855353316545,0.00584498752769266,-0.0271417108859322,-0.00422935977737694,0.00729465268974552
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0130471522073328,0.00487751718672679,-0.0226070858933173,-0.00348721852134832,0.00748277776862724
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM171B,Protein FAM171B,39919,0.00769399540427626,0.00288565451100747,0.00203811256270161,0.0133498782458509,0.00768022010241528
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST6,Cystatin-M,41864,0.0144104761947423,0.00540671153585823,0.00381332158446017,0.0250076308050244,0.00770141768286937
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,39586,0.0128832893304874,0.00483683687108233,0.00340308906316606,0.0223634895978088,0.00774274125719512
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSG4,Desmoglein-4,42018,0.0138087666756543,0.00520413186887276,0.00360866821266367,0.0240088651386449,0.00797736632616332
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEG1,Protein LEG1 homolog,39398,-0.0203514965193545,0.00767952510624911,-0.0354033657276028,-0.0052996273111063,0.00805856370295709
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.0078675707715095,0.00297174746195095,-0.0136921957969334,-0.00204294574608563,0.00812138970318462
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC13A1,Solute carrier family 13 member 1,39919,0.0172656257111589,0.00652657670776393,0.00447353536394159,0.0300577160583762,0.00816990107533526
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTR,Methionine synthase,39575,0.0187615140425902,0.00709790195023917,0.00484962622012146,0.032673401865059,0.00822315733837909
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JCHAIN,Immunoglobulin J chain,41913,-0.0175976555275154,0.00666306161092029,-0.0306572562849191,-0.00453805477011163,0.00827395640191318
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,0.0122931498792105,0.00466248387370179,0.00315468148675497,0.021431618271666,0.00838355918122614
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MB,Myoglobin,42310,-0.0160556270533026,0.00609464225648751,-0.0280011258760182,-0.00411012823058712,0.00843848618275153
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR101,Probable G-protein coupled receptor 101,39586,-0.0166356738759088,0.00631700848325758,-0.0290170105030936,-0.00425433724872395,0.00846348390177422
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,41900,-0.00972805797305594,0.00370319780220206,-0.016986325665372,-0.0024697902807399,0.00862567256288711
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB5,Serpin B5,41900,0.0138946056683564,0.00529087881955922,0.00352448318202034,0.0242647281546925,0.00864573924755715
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB39B,Ras-related protein Rab-39B,39575,0.0263228655363112,0.0100317349356597,0.00666066506241815,0.0459850660102042,0.00870344389534893
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0119266338003369,0.00454535212645631,-0.0208355239681913,-0.00301774363248256,0.00870431382206843
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.015939295871249,0.00610758509292752,-0.027910162653387,-0.00396842908911111,0.00907294866557362
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSAP,Gamma-secretase-activating protein,41843,0.0239083915812152,0.00916321842847135,0.00594848346141134,0.041868299701019,0.00908642606293195
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOX9,Transcription factor SOX-9,39649,0.0078379180274205,0.0030043874874199,0.00194931855207749,0.0137265175027635,0.00909763354912381
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.0193946856142076,0.00746839067277539,0.00475663989556782,0.0340327313328474,0.00941725247755412
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD200,OX-2 membrane glycoprotein,42119,-0.00767427035331001,0.00295665030163384,-0.0134693049445123,-0.00187923576210768,0.00945290302200623
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH6,Cadherin-6,42145,-0.0109699382522364,0.00422648674347047,-0.0192538522694385,-0.00268602423503426,0.00945493128262181
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKCQ,Protein kinase C theta type,41913,0.0120178531479767,0.00464987824348962,0.00290409179073702,0.0211316145052163,0.00976109559828387
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD109,CD109 antigen,42137,-0.00956560200009939,0.00370800188431589,-0.0168332856933585,-0.00229791830684024,0.00989852484379803
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.0111963163358216,0.00434029307840346,-0.0197032907694924,-0.00268934190215078,0.00990365690535024
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,0.0101811127876807,0.00396316690576945,0.00241330565237263,0.0179489199229889,0.0102138838595348
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAL,Galanin peptides,42185,-0.0185628258867904,0.00723495898277891,-0.032743345493037,-0.0043823062805437,0.0103070373859794
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,42310,0.00865296450588075,0.00337737296954978,0.00203331348556319,0.0152726155261983,0.0104165247791978
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL14,C-X-C motif chemokine 14,41913,0.0159139647501791,0.00621488464842201,0.00373279083927195,0.0280951386610862,0.0104594534743
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.00920406696392352,0.00359678878540947,0.00215436094452097,0.0162537729833261,0.0105093111127895
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,39757,-0.0115942202898422,0.00456151252288756,-0.0205347848347018,-0.00265365574498257,0.0110433432562485
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFF3,Trefoil factor 3,42143,-0.00994447907360157,0.00391791923459975,-0.0176236007734171,-0.00226535737378605,0.0111534001341055
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0148847127826049,0.005888534437841,0.00334318528443656,0.0264262402807733,0.0114913045490175
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0184935916633878,0.00731979404634071,0.00414679533256004,0.0328403879942156,0.0115334449086217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.0104708189780753,0.00414864946106452,0.00233946603438882,0.0186021719217617,0.011617549394563
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGA4,Pepsin A-4,39990,0.0204632362202416,0.00814294800299998,0.00450305813436164,0.0364234143061216,0.0119845951449346
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKLR,Pyruvate kinase PKLR,42143,0.0170049254104192,0.00676929716593645,0.00373710296518375,0.0302727478556546,0.0120141753779103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPLX2,Complexin-2,39560,-0.00835722145264681,0.00333224371155691,-0.0148884191272984,-0.00182602377799528,0.0121564726865506
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYT1,Synaptotagmin-1,39929,0.0108979971690828,0.00435208352004985,0.0023679134697851,0.0194280808683805,0.0122907168403144
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFAP,Glial fibrillary acidic protein,41820,0.0124055910491504,0.00495567794571938,0.0026924622755404,0.0221187198227604,0.0123157842714887
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTXR,Neuronal pentraxin receptor,42145,0.00919499710931408,0.00370719251676814,0.00192889977644852,0.0164610944421796,0.0131387732136543
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",39575,0.0148744849766893,0.00599838468631847,0.00311765099150513,0.0266313189618736,0.0131624030430245
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR158,Probable G-protein coupled receptor 158,39934,0.00930251799480256,0.00376655331163737,0.00192007350399332,0.0166849624856118,0.0135346383038641
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RALB,Ras-related protein Ral-B,39657,0.00795131358347037,0.00322291730406644,0.00163439566750015,0.0142682314994406,0.013635630651007
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,39930,0.0145700694697536,0.00591798047815714,0.00297082773256564,0.0261693112069416,0.0138312372674929
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.0149897695510696,0.00609289765865751,0.00304769014010089,0.0269318489620383,0.0138984259168831
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXDC2,Plexin domain-containing protein 2,39929,0.00731236095234218,0.00297763129351454,0.00147620361705368,0.0131485182876307,0.0140734360576634
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0396830681646407,0.0161821752197202,0.0079660047339891,0.0714001315952924,0.0142086132659665
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELENOP,Selenoprotein P,39979,0.00601649116404511,0.00245759978737821,0.00119959558078383,0.0108333867473064,0.014375507151819
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG1B,Lithostathine-1-beta,42310,-0.0151361333987255,0.00619841951393062,-0.0272850356460295,-0.00298723115142147,0.014621352074622
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.0226362278486429,0.00931374912131554,0.00438127957086447,0.0408911761264214,0.0150975664728123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OPTC,Opticin,42070,-0.0119748973985412,0.00493035463797236,-0.0216383924889671,-0.00231140230811541,0.0151614406541684
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,42070,0.0211963784378104,0.00872796138804591,0.00408957411724041,0.0383031827583804,0.0151719137354687
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GM2A,Ganglioside GM2 activator,39733,0.0101348892043478,0.00418675536684715,0.00192884868532737,0.0183409297233682,0.0155064399662084
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,39736,0.00786946055031456,0.00325137282874069,0.00149676980598282,0.0142421512946463,0.0155214649845665
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.0180768468393835,0.00751466948086064,0.00334809465689661,0.0328055990218703,0.0161648607714446
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACAN,Aggrecan core protein,41994,0.00713353557799641,0.00296930397214297,0.00131369979259618,0.0129533713633966,0.0163002148702595
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,-0.00708631181243912,0.00295720125837475,-0.0128824262788536,-0.00129019734602461,0.0165780420603461
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOA4,Apolipoprotein A-IV,39979,0.00894754090228277,0.00373912829486818,0.00161884944434114,0.0162762323602244,0.0167297044652098
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACE,Angiotensin-converting enzyme,39990,-0.00700688245802567,0.00293506882054542,-0.0127596173462947,-0.00125414756975665,0.016988960623203
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.013714908786032,0.00574514073803062,-0.024975384632572,-0.00245443293949198,0.0169929566588925
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL3A1,Collagen alpha-1(III) chain,39966,0.00610771217114709,0.00256273381806088,0.00108475388774776,0.0111306704545464,0.0171754654163783
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMIGO1,Amphoterin-induced protein 1,39649,0.0130819602063667,0.00551505922529468,0.00227244412478912,0.0238914762879443,0.0177070404897348
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,39560,-0.0100528891875382,0.00424574740662841,-0.0183745541045299,-0.00173122427054651,0.0179136480683189
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.0115182464986479,0.00490399607872764,0.00190641418434172,0.021130078812954,0.0188540482559882
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPSAB1,Tryptase alpha/beta-1,42281,0.013295033707832,0.00566176385926323,0.00219797654367604,0.0243920908719879,0.0188778339411994
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOS1,"Nitric oxide synthase, brain",41839,-0.0150007977109897,0.00639331280292014,-0.0275316908047131,-0.00246990461726619,0.0189741682108081
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD86,T-lymphocyte activation antigen CD86,39930,0.00774513051969271,0.00330173857154111,0.00127372291947213,0.0142165381199133,0.0190047948358943
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD5L,CD5 antigen-like,39925,0.0122306292345488,0.00521688972782683,0.00200552536800821,0.0224557331010894,0.0190734048337725
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RSPO3,R-spondin-3,42262,0.00715116088219742,0.00305302196096017,0.00116723783871549,0.0131350839256794,0.0191784457026354
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN2B,Sodium channel subunit beta-2,39649,-0.00716398495374808,0.00306699407513664,-0.0131752933410159,-0.00115267656648026,0.0195177574426263
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,42123,0.0758769454037248,0.0325393812597566,0.0120997581346019,0.139654132672848,0.0197232071546412
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.016661709942003,0.0071513346242941,-0.0306783258056195,-0.0026450940783866,0.0198273996858478
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0102999170907438,0.00442875263127711,-0.0189802722480469,-0.00161956193344065,0.0200497589444396
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPN1,Epsin-1,39757,0.0109291191509951,0.00470112003706482,0.00171492387834801,0.0201433144236421,0.0201010170137354
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.0218263511641375,0.00939132083952259,0.00341936231867318,0.0402333400096017,0.020138457199247
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFD,Complement factor D,39979,0.005105127587099,0.0022003899207431,0.000792363342442522,0.00941789183175548,0.0203529950409088
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.0099110914689321,0.00427396883826345,0.00153411254593573,0.0182880703919285,0.0204129965835545
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLIN3,Perilipin-3,42145,0.0107677707726514,0.00465148256333306,0.00165086494851861,0.0198846765967842,0.0206326457372738
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP7,Dipeptidyl peptidase 2,42054,0.0157911242195744,0.00682642633598778,0.00241132860103831,0.0291709198381104,0.0207247582067131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.0132014881926854,0.00570843053977507,0.00201296433472625,0.0243900120506445,0.020758243308217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,42017,0.0147216709072918,0.00636640808117297,0.0022435110681928,0.0271998307463909,0.0207708055083811
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,0.00868072288026863,0.00376146911257709,0.00130824341961755,0.0160532023409197,0.0210250791389268
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,42119,0.0122195567922253,0.00529666796665155,0.00183808757758824,0.0226010260068623,0.0210683442677347
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,41913,0.00787888485183805,0.00341686501092864,0.00118182943041791,0.0145759402732582,0.0211325606683579
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.00990279988740024,0.00431364150237661,0.00144806254274209,0.0183575372320584,0.0217115906883214
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALM3,Paralemmin-3,39575,0.0188116884674489,0.00824071494408327,0.00265988717704574,0.0349634897578522,0.0224627305906034
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNGR1,Interferon gamma receptor 1,42185,0.00535439883453199,0.0023503626245944,0.000747688090326964,0.00996110957873702,0.0227351222008279
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP2,Guanylate-binding protein 2,41913,0.0149659042297085,0.00659384100770657,0.00204197585460358,0.0278898326048133,0.0232429710944629
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIF20B,Kinesin-like protein KIF20B,39586,0.0184421027946511,0.00812768925530293,0.00251183185425741,0.0343723737350449,0.0232848205953376
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMBN,Ameloblastin,41913,-0.00674674399491013,0.00297435909512166,-0.0125764878213486,-0.000917000168471663,0.023326765029325
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP1,"Fatty acid-binding protein, liver",42123,0.0234249130767652,0.0103322102180472,0.00317378104939275,0.0436760451041376,0.0233953461876258
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00961490023706198,0.0042451256815292,0.00129445390126475,0.0179353465728592,0.0235364602990616
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TTN,Titin,39575,-0.0170298909455356,0.00752487912145908,-0.0317786540235954,-0.00228112786747582,0.0236462160282896
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,-0.0147408001434209,0.00651846041828292,-0.0275169825632554,-0.00196461772358642,0.0237509530432565
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,42016,0.00586364517304937,0.00260195565156319,0.000763812095985514,0.0109634782501132,0.0242403739474876
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,42181,0.0103061191713544,0.0045776579387862,0.00133390961133343,0.0192783287313753,0.024376406705098
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOC,Myocilin,42137,-0.0109230625100571,0.00486054340286449,-0.0204497275796715,-0.00139639744044275,0.0246373816368
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,39649,0.0189128696822873,0.00841918022366819,0.00241127644389761,0.0354144629206769,0.0246978910901642
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEX101,Testis-expressed protein 101,39649,0.0149124876745922,0.00669682851555645,0.00178670378410154,0.0280382715650828,0.0259808198707415
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0299166928386066,0.0134633771368201,0.00352847365043924,0.0563049120267739,0.02629477193784
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NME1,Nucleoside diphosphate kinase A,39657,-0.00529831485932763,0.00238459325222725,-0.00997211763369305,-0.000624512084962221,0.0263105924496214
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0123655634169706,0.0055739109316282,-0.0232904288429619,-0.00144069799097933,0.026539365320284
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NINJ1,Ninjurin-1,41843,0.0130576910936167,0.00590952046827289,0.00147503097580188,0.0246403512114316,0.0271498083010478
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.0100289607017903,0.00455516298798904,-0.0189570801582488,-0.00110084124533178,0.0277087800737151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,0.0080741919749037,0.00367786603596632,0.000865574544409701,0.0152828094053977,0.0281594269847203
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSBP1,Heat shock factor-binding protein 1,39638,0.0229489674092284,0.0104655999108128,0.00243639158403527,0.0434615432344216,0.0283425874841297
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.0136499071797084,0.0062467172723073,-0.0258934730334307,-0.00140634132598606,0.0289001568961558
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.0103572464978765,0.00474702999470129,0.00105306770826199,0.019661425287491,0.0291386293490715
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCND2,G1/S-specific cyclin-D2,39757,0.00878499656982616,0.0040350084038151,0.000876380098348565,0.0166936130413038,0.0294869739312302
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,42189,-0.0070748907858248,0.00325301919284196,-0.013450808403795,-0.000698973167854566,0.0296571171464484
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,39930,-0.0102950282547653,0.00474357524291939,-0.0195924357308873,-0.000997620778643338,0.0300040816843641
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.0198268497617784,0.00916709430477354,-0.0377943545991345,-0.00185934492442224,0.0305724299881604
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.0166131607901755,0.00769136078069797,-0.0316882279203435,-0.00153809366000746,0.030796026936979
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLR1,Folate receptor alpha,42110,0.00691186273728148,0.00320521414033123,0.000629643022232266,0.0131940824523307,0.0310666525359775
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAPS,Calcyphosin,39929,0.0222402997041385,0.01032107818649,0.00201098645861806,0.042469612949659,0.0311951557420313
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.0199308794886266,0.00925657256653785,0.00178799725821239,0.0380737617190407,0.0313237577070736
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.0144602432799207,0.00672460702069557,0.00128001351935738,0.027640473040484,0.0315494756238489
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00734272912771488,0.00342763140768034,-0.0140608866867684,-0.000624571568661412,0.0321979674563552
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.013546468964413,0.00633868233450776,0.00112265158877784,0.0259702863400482,0.0326071357253742
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD48,CD48 antigen,42166,0.00711957147003181,0.00333991323761078,0.000573341524314673,0.0136658014157489,0.0330524290292751
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMG4,Proteasome assembly chaperone 4,39657,0.0129341973207933,0.00608117867741986,0.00101508711305041,0.0248533075285363,0.0334485783366073
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,39934,0.00918122334319813,0.00432083431516637,0.000712388085472049,0.0176500586009242,0.0336188037057238
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00698062389344553,0.00329516696129976,-0.0134391511375931,-0.000522096649297999,0.0341599401804857
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUCL3,Mucin-like protein 3,39560,-0.00976979504448888,0.0046324715246794,-0.0188494392328605,-0.000690150856117261,0.0349688340328341
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C8B,Complement component C8 beta chain,39979,0.00692889243531586,0.00328598874849182,0.000488354488271891,0.0133694303823598,0.0349994334646968
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNL1,Interferon lambda-1,41839,0.0104190455857396,0.00494611087152232,0.000724668277555858,0.0201134228939234,0.035178606068209
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.00522912324681313,0.00248272326757573,0.0003629856423647,0.0100952608512616,0.0352047097188342
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.0159969783671666,0.00760358163711374,0.00109395835842366,0.0308999983759095,0.0354114051730103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MKI67,Proliferation marker protein Ki-67,39657,0.00927668098745518,0.0044237465930802,0.000606137665017988,0.0179472243098924,0.0360145417746138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.00670599856594556,0.00319811905979765,-0.012974311923149,-0.000437685208742165,0.0360290341453216
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGM2,Phosphoglucomutase-2,39649,0.0137772562791195,0.00659969379241125,0.00084185644599344,0.0267126561122455,0.0368604014915348
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUP50,Nuclear pore complex protein Nup50,39575,-0.00718108305560778,0.00344671707962465,-0.0139366485316721,-0.000425517579543474,0.0372327704627575
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,0.0101097207188571,0.00485769285522666,0.000588642722612793,0.0196307987151013,0.0374404183646775
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,39757,0.0153735217952083,0.00743741072380448,0.000796196776551541,0.0299508468138651,0.0387521756645784
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD82,CD82 antigen,39757,-0.00925557193532876,0.00450337706313537,-0.0180821909790741,-0.000428952891583442,0.0398779571850811
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEDD9,Enhancer of filamentation 1,39657,0.00751845754106925,0.00368024762802938,0.000305172190131668,0.0147317428920068,0.0410838562311453
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.0211176552967103,0.0103464018646512,0.000838707641993917,0.0413966029514267,0.0412684960291299
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,39930,0.0106383367341059,0.00523525823087909,0.00037723060158284,0.0208994428666289,0.0421712908126185
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.0167275005430361,0.00823198090241187,0.000592817974308862,0.0328621831117634,0.0421721620702373
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00692828231469046,0.00341151056254316,-0.0136148430172751,-0.000241721612105869,0.0422936293636298
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3GL3,Endophilin-A3,39690,0.0188036800354854,0.00926033216435273,0.000653428993354088,0.0369539310776168,0.0423232416550154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.013731485314215,0.00677115376953259,0.000460023925931164,0.0270029467024989,0.0425904258541295
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN1,Contactin-1,42310,-0.0058742644960125,0.00290186804927718,-0.0115619258725958,-0.000186603119429234,0.0429581832931111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.0112944716284302,0.00560319350774208,0.000312212353255762,0.0222767309036047,0.0438531459310146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UNG,Uracil-DNA glycosylase,39919,0.0077083228530041,0.00382834758045379,0.000204761595314674,0.0152118841106935,0.0440871883475809
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB2,Integrin beta-2,42079,-0.00624201072706515,0.00312442115828999,-0.0123658761973135,-0.000118145256816774,0.0457569437894822
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.00531498611038052,0.00266886922872308,8.40024220832769e-05,0.0105459697986778,0.04645326142401
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSC1,Hamartin,39657,0.0160034211813616,0.00804302261918387,0.000239096847761196,0.031767745514962,0.0466455806184609
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,-0.00577419975995389,0.00290679628333359,-0.0114715204752877,-7.68790446200474e-05,0.0470038277631581
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,41430,0.00904122215821257,0.00457017615663786,8.36768912023597e-05,0.0179987674252228,0.0479151765652421
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSPN,Claspin,41820,0.00764059272401544,0.00386737094612897,6.05456696026498e-05,0.0152206397784282,0.0482145694988425
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EVI2B,Protein EVI2B,39560,-0.00857722652236616,0.0043439199967718,-0.0170913097160389,-6.31433286934352e-05,0.0483458880662475
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAPN3,Calpain-3,39919,-0.00836332468444472,0.00424045491461441,-0.016674616317089,-5.20330518004753e-05,0.0486030246715708
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HIP1,Huntingtin-interacting protein 1,39575,0.00706036973211374,0.00358010487601348,4.33641751273091e-05,0.0140773752891002,0.0486218288978255
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,39638,0.0121599054505815,0.00616933256647496,6.80136202905624e-05,0.0242517972808724,0.048746020249723
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.006987089401281,0.00354659932125189,3.57547316273011e-05,0.0139384240709347,0.0488541427620162
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.010367426867155,0.00527355859396128,3.12520229908565e-05,0.0207036017113191,0.0493322840427493
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYH4,Myosin-4,39575,-0.0097772242068847,0.00497928808475452,-0.0195366288530036,-1.78195607658336e-05,0.0496041735993555
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00627240237536535,0.00319938831302537,1.60128183562033e-06,0.0125432034688951,0.0499623909851478
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DRAXIN,Draxin,42016,0.00905112749504273,0.00462190761715772,-7.81143458641019e-06,0.0181100664246719,0.0502143499503596
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DHODH,Dihydroorotate dehydrogenase,39575,0.00988434675933726,0.00504842898441203,-1.05740501103145e-05,0.0197792675687848,0.0502664052819847
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A3,Protein S100-A3,39919,0.00900193735376886,0.00463998256799969,-9.2428479510534e-05,0.0180963031870482,0.0523947742700109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB118,Beta-defensin 118,39586,0.0119631625617345,0.00619615972147893,-0.000181310492364153,0.0241076356158332,0.053541132071323
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL5,Interleukin-5,41913,0.0289633540586695,0.0150202739828775,-0.000476382947770325,0.0584030910651093,0.0538410503601543
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR1,Toll-like receptor 1,39657,0.00559435889361698,0.00290902051421027,-0.000107321314235146,0.0112960391014691,0.054492214327158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,39649,0.00766901968836281,0.00399061235642945,-0.000152580530238915,0.0154906199069645,0.0546610078675978
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FRMD7,FERM domain-containing protein 7,39649,0.0070952762119143,0.00369560027610145,-0.000148100329244549,0.0143386527530731,0.0548930624255886
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAN,Brevican core protein,42016,0.0071927163522594,0.00375143431400838,-0.000160094903197022,0.0145455276077158,0.0552179507568524
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00933858699042856,0.00488226314834911,-0.000230648780335695,0.0189078227611928,0.0558006160729735
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPHS2,Podocin,39657,-0.0211782683037344,0.0110752633677257,-0.0428857845044767,0.000529247897007954,0.055874626506571
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACRV1,Acrosomal protein SP-10,39657,0.0220792612427307,0.0115533640333602,-0.00056533226265525,0.0447238547481166,0.0560217068482024
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSN,Gelsolin,39943,-0.00393271704973739,0.00205804829872308,-0.00796649171523462,0.000101057615759838,0.0560430792359751
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENOPH1,Enolase-phosphatase E1,39919,0.0110729611109485,0.00579480728164698,-0.000284861161079621,0.0224307833829766,0.0560501244175401
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC4A1,Band 3 anion transport protein,39966,0.00987585114215465,0.00517574920623407,-0.000268617302064122,0.0200203195863734,0.0564033607135351
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,0.00623777155614508,0.00327971849352093,-0.000190476691155941,0.0126660198034461,0.0572026382474517
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEB,Nebulin,39575,-0.00822169876776847,0.00432526727468409,-0.0166992226261493,0.000255825090612354,0.0573473963945676
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.0173019281724655,0.00910449730422851,-0.0351467428887534,0.000542886543822389,0.057410549085871
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN5,Contactin-5,42170,0.00762530643206967,0.00402321271391274,-0.000260190487199297,0.0155108033513386,0.0580702337423196
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYH7B,Myosin-7B,39560,-0.00880355150952294,0.0046627280707122,-0.0179424985281189,0.00033539550907298,0.0590431009329091
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.00591170479714218,0.00313681811553642,-0.0120598683035936,0.000236458709309206,0.0595029887646767
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,39657,0.025679085841186,0.0136267532267706,-0.00102935048328431,0.0523875221656563,0.0595288450664039
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLAU,Urokinase-type plasminogen activator,42137,-0.00583442659578758,0.00310389070033839,-0.0119180523684508,0.000249199176875661,0.0601685352689969
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,42118,-0.00990696014183346,0.00527398365566125,-0.0202439681069295,0.000430047823262589,0.060339954361957
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPM1B,Protein phosphatase 1B,39657,0.0125757724362382,0.00670519639073594,-0.0005664124896042,0.0257179573620807,0.0607466791630621
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MATN3,Matrilin-3,41992,-0.00672440511609908,0.00358705486514425,-0.0137550326517818,0.000306222419583643,0.0608652208320905
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM3D,Protein FAM3D,39930,0.0178217866794921,0.00951205928900072,-0.000821849526949303,0.0364654228859335,0.0610114088277151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.0121004525340745,0.00646851239691293,-0.000577831763874839,0.0247787368320238,0.0614174541862605
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBA,Lysosomal acid glucosylceramidase,39649,0.0112685980451036,0.00602926167197755,-0.000548754831972345,0.0230859509221796,0.0616513740123306
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.0081029397369624,0.00434378831586253,-0.000410885362128161,0.016616764836053,0.0621506473711824
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEBP1,Heme-binding protein 1,41900,-0.010519933242332,0.00565277837975048,-0.0215993788666429,0.000559512381978955,0.0627634105976345
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.0169006286897254,0.00910351910073001,-0.000942268747705408,0.0347435261271562,0.063409991156542
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,39657,0.00411668354561202,0.00221811958989314,-0.000230830850578532,0.00846419794180257,0.0634895543422154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PZP,Pregnancy zone protein,39979,0.00668236394843159,0.00360733470235612,-0.000388012068186409,0.0137527399650496,0.063988828333196
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA8,Carbonic anhydrase-related protein,39657,0.00535198793978734,0.00289563616800926,-0.000323458949510809,0.0110274348290855,0.064586458156247
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1A,Interleukin-1 alpha,41913,0.011591869205849,0.00629209883377415,-0.000740644508348307,0.0239243829200463,0.0654550020339807
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEZ6L,Seizure 6-like protein,42181,0.00550339590857879,0.00299036863720764,-0.000357726620348181,0.0113645184375058,0.0657351910675617
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FZD8,Frizzled-8,39586,0.0086062035670672,0.00468239856784728,-0.000571297625913476,0.0177837047600479,0.0660908061786296
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDNRB,Endothelin receptor type B,39657,0.00870680739318765,0.00476339713286033,-0.000629450987218609,0.0180430657735939,0.0675979930385155
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,39638,0.00767484196509201,0.00420903581465549,-0.000574868231632741,0.0159245521618168,0.0682667672915374
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC44A4,Choline transporter-like protein 4,39649,-0.0136355717754751,0.00748197421799611,-0.0283002412427475,0.00102909769179729,0.0684127797366831
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL5,Fc receptor-like protein 5,42137,-0.0117016002237169,0.00642707587472975,-0.0242986689381872,0.00089546849075345,0.068678723942272
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FH,"Fumarate hydratase, mitochondrial",39586,0.0162203463064377,0.00894738959548953,-0.00131653730072177,0.0337572299135972,0.0698810153229536
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELL,L-selectin,39979,0.00458919294408777,0.00253156917564616,-0.000372682640178711,0.00955106852835425,0.0698911869127643
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRC1,Macrophage mannose receptor 1,39990,0.0055872986460835,0.00308717558048555,-0.000463565491668175,0.0116381627838352,0.0703467082926114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.0115132987468165,0.00638784943286825,-0.00100688614160525,0.0240334836352383,0.0715138574225597
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.0160223685033635,0.00889891675542971,-0.0334642453440057,0.00141950833727875,0.0718110461537872
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB6B,Ras-related protein Rab-6B,41839,0.00926680658319653,0.00515328133622055,-0.00083362483579575,0.0193672380021888,0.0721626794173257
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AREG,Amphiregulin,42070,0.00764391643314315,0.00425444201746231,-0.000694789921082989,0.0159826227873693,0.0724071307191266
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.00767226531354084,0.00428041386709443,-0.0160618764930459,0.000717345865964242,0.0730945213659012
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR4,Toll-like receptor 4,39657,0.00552602584395824,0.00308567105365562,-0.000521889421206781,0.0115739411091233,0.0733420169218542
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSP90B1,Endoplasmin,41774,0.012354453230865,0.00691842145410272,-0.00120565281917629,0.0259145592809064,0.0741655004349525
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GKN1,Gastrokine-1,41538,0.00550664078607022,0.00308494121449127,-0.000539843994332679,0.0115531255664731,0.0742836479810645
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1R1,Interleukin-1 receptor type 1,42113,-0.00461376777956025,0.0025928434431688,-0.00969574092817109,0.000468205369050597,0.0751927490563365
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBH,Dopamine beta-hydroxylase,39978,0.0219848878659521,0.0123836852761599,-0.00228713527532136,0.0462569110072256,0.075873340211553
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.0242519619684059,0.0137369713907994,-0.00267250195756091,0.0511764258943726,0.077510891861911
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.00904286845082109,0.00512321712402881,-0.000998637112275387,0.0190843740139176,0.0775779264683912
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL28,C-C motif chemokine 28,42075,0.0113052199936762,0.0064068065632054,-0.00125212087020641,0.0238625608575588,0.0776597274307718
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELAVL4,ELAV-like protein 4,39586,0.0156530751447573,0.00891323494858788,-0.00181686535447495,0.0331230156439895,0.0790887916624761
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0132836069436565,0.00756839172616651,-0.00155044083962987,0.0281176547269429,0.079257736679548
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.00874415988768889,0.00498634958072903,-0.0185174050659178,0.00102908529054,0.079523431481956
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00487395818219816,0.00278511971889917,-0.0103327928312405,0.000584876466844212,0.0801461807601877
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0166584159712768,0.00956705562032654,-0.0354098449871168,0.00209301304456322,0.0816716492376283
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TYMP,Thymidine phosphorylase,42070,0.0125514671746556,0.00722533983514898,-0.00161019890223638,0.0267131332515476,0.082384335652251
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OTOA,Otoancorin,39586,-0.00991794518889929,0.00571336267239222,-0.021116136026788,0.00128024564898946,0.0826058735690934
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.00698386485410143,0.00402504297985071,-0.000905219386405966,0.0148729490946088,0.0827456738485756
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARB1,Scavenger receptor class B member 1,41839,0.0104530797596064,0.00604506492287769,-0.00139524748923392,0.0223014070084466,0.0837979936686391
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMCH,Pro-MCH,39575,-0.0154854138387661,0.00896762407020312,-0.0330619570163642,0.00209112933883197,0.0842293110915889
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EP300,Histone acetyltransferase p300,39657,0.00574991854316197,0.00334683552498219,-0.000809879085803126,0.0123097161721271,0.085821608874073
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B4,Protein ATP1B4,39560,-0.00782143105654962,0.00455315664541099,-0.0167456180815552,0.00110275596845592,0.0858606037829302
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0170858152213195,0.00999490033386273,-0.00250418943305146,0.0366758198756904,0.0873952583772034
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,39586,-0.0103652441620941,0.00606900499804304,-0.0222604939582584,0.0015300056340703,0.0876834406515313
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAG,S-arrestin,39586,-0.00967600557381992,0.0056852213121344,-0.0208190393456033,0.0014670281979635,0.0887916113245371
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,0.00641078227402727,0.00377447001649269,-0.000987178958298412,0.0138087435063529,0.0894441479650495
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANSC4,MANSC domain-containing protein 4,39575,0.0125384596807608,0.00738569934234496,-0.00193751103023529,0.027014430391757,0.0895989378639395
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FSHB,Follitropin subunit beta,39638,-0.00755766114642856,0.00446047940601868,-0.0163002007822252,0.00118487848936804,0.0902249667074451
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTKN2,Rhotekin-2,39575,-0.00936904116352863,0.00553387110292787,-0.0202154285252673,0.00147734619820999,0.0904770584653293
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAP1A,Ras-related protein Rap-1A,39657,-0.0127109687015861,0.00751728780050085,-0.0274448527905678,0.00202291538739556,0.0908844232584559
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.00893792396123526,0.00531471838264635,-0.0193547719912221,0.0014789240687516,0.0926496016611191
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00629292116447253,0.00375345515969466,-0.0136496932774741,0.001063850948529,0.093655526234068
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.00852616417996581,0.00509096219377894,-0.0185044500797725,0.00145212171984091,0.0940089211416282
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.0148491719478309,0.00887211174764682,-0.0322385109732187,0.00254016707755687,0.094219915250448
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.012507624192061,0.0074789074087362,-0.00215103432906193,0.027166282713184,0.0944713458457693
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,-0.00392130073392497,0.00235068861052199,-0.00852865041054807,0.000686048942698119,0.0953143573509564
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX1B,Syntaxin-1B,39649,0.00724965643183472,0.00436620459862442,-0.00130810458146913,0.0158074174451386,0.096861910420109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL4,Interleukin-4,41913,0.016982565269443,0.0102627726224343,-0.0031324690705282,0.0370975996094143,0.0979940019595183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFF2,Trefoil factor 2,42166,0.0104257320234936,0.00634806293021045,-0.00201647131971889,0.0228679353667061,0.100540965805529
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTO1,Protein LTO1 homolog,41913,0.00734844845981467,0.00449116766485224,-0.00145424016329572,0.0161511370829251,0.101821377980812
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAD2,Glutamate decarboxylase 2,39657,-0.00805489310404648,0.00492457110470337,-0.0177070524692651,0.00159726626117213,0.101940541206305
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,39575,0.017722702846705,0.0108445590795285,-0.00353263294917081,0.0389780386425808,0.102235393919402
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,0.00930049982595782,0.00569249523427016,-0.00185679083321169,0.0204577904851273,0.102324932615809
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00529843477906299,0.00324840867498359,-0.00106844622390484,0.0116653157820308,0.102896563346505
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,0.00488452431530294,0.00299685055943629,-0.00098930278119218,0.0107583514117981,0.103149305850244
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBM25,RNA-binding protein 25,39560,-0.00828617815408007,0.00509042203497131,-0.0182634053426238,0.0016910490344637,0.103596495868795
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0131333380278602,0.00808023321578286,-0.00270391907507424,0.0289705951307946,0.104112355008957
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFRC,Transferrin receptor protein 1,42200,0.00659499419887905,0.0040708786114355,-0.00138392787953453,0.0145739162772926,0.105246446796336
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF7,Fibroblast growth factor 7,39560,-0.0136756562119679,0.00844965947865314,-0.0302369887901281,0.00288567636619221,0.10558665955449
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,41900,0.00838844479463639,0.00519744623785294,-0.00179854983155538,0.0185754394208282,0.106560891430585
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNNI3,"Troponin I, cardiac muscle",41900,0.0146508065944347,0.00912521506429395,-0.00323461493158144,0.0325362281204508,0.108400956493218
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.0120263396750785,0.00751964866084924,-0.00271217170018603,0.026764851050343,0.109777384932907
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.00791253509206226,0.00496099825813443,-0.0176360916780057,0.00181102149388123,0.110746900049875
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.0050976899095787,0.00320047211707142,-0.00117523543988128,0.0113706152590387,0.111230377071086
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,42070,0.00818223553160813,0.00513824637704369,-0.0018887273673975,0.0182531984306138,0.11131430022257
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,39963,-0.00440416264861657,0.00278150912401236,-0.0098559205316808,0.00104759523444765,0.113364613755639
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS5,Transmembrane protease serine 5,41946,-0.00662751056042119,0.0041899659519543,-0.0148398438262516,0.00158482270540924,0.113728610211369
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00530831245888303,0.00336065718834406,-0.00127857563027133,0.0118952005480374,0.114234642500279
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFL4,Insulin growth factor-like family member 4,39657,0.0122451329950772,0.00777000455588173,-0.00298407593445102,0.0274743419246054,0.11506610403006
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RETN,Resistin,42105,0.00734915545569588,0.00467088714251533,-0.00180578334363416,0.0165040942550259,0.115650562394122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.00860418280411213,0.00548245969016661,-0.0193498037968387,0.00214143818861442,0.116582729422947
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA3G,Semaphorin-3G,39736,0.00774927548706298,0.00494821976694518,-0.00194923525614957,0.0174477862302755,0.117359842060689
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.00540883523109513,0.00345946944546378,-0.0121893953442041,0.00137172488201388,0.117962003903602
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.00656022610542641,0.0042130734699548,-0.001697397895685,0.0148178501065378,0.119472795263703
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,41839,0.00673286308473106,0.00433778694652403,-0.00176919933045605,0.0152349254999182,0.120652055563579
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.00610258000021228,0.00393501214745969,-0.00161004380880872,0.0138152038092333,0.120968350540513
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.00686278857549312,0.00443776137068271,-0.001835223711045,0.0155608008620312,0.122023203291622
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGMA,Repulsive guidance molecule A,42249,-0.00539004151771419,0.00349497317041294,-0.0122401889317236,0.00146010589629517,0.123041656504271
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.00810183669071536,0.00525456977939291,-0.00219712007689474,0.0184007934583255,0.123134382339755
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.011610563918231,0.00753702339130362,-0.0263831297651861,0.00316200192872407,0.123474453483092
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.00984593468304829,0.0063946030845134,-0.00268748736259798,0.0223793567286946,0.123656060051078
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.00604653977256731,0.0039363585484603,-0.0137618025275495,0.00166872298241488,0.124548756665754
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LIFR,Leukemia inhibitory factor receptor,42119,-0.00400634032428398,0.00261093308348312,-0.00912376916791089,0.00111108851934293,0.124942945775879
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YY1,Transcriptional repressor protein YY1,39657,0.00464722606205377,0.00303205383917243,-0.0012955994627242,0.0105900515868317,0.125378631246176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.00613321128867893,0.00401346315198045,-0.0139995990665606,0.00173317648920276,0.126496340217083
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,42070,0.0043090748819911,0.00281988807648152,-0.00121790574791269,0.00983605551189488,0.12651084758499
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.00727623852400611,0.00479064728312839,-0.0166659071989378,0.00211343015092553,0.128830083816218
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.00672298400478396,0.00443033281768028,-0.0019604683178694,0.0154064363274373,0.129166172464216
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNN,Tenascin-N,39966,0.0071100096980098,0.00469849972504972,-0.00209904976308765,0.0163190691591072,0.130243702608121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.00643210960755712,0.00425865755183581,-0.0147790784091553,0.00191485919404107,0.130975407414751
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00570792547125571,0.00377931926988138,-0.0016995402977118,0.0131153912402232,0.130993889740527
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRR5,Proline-rich protein 5,39657,0.0077397425586176,0.00512902560929583,-0.00231314763560222,0.0177926327528374,0.131325217230861
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC1,Sialoadhesin,42185,0.00681320763670439,0.00451831265014543,-0.00204268515758065,0.0156691004309894,0.131600884178581
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.0081742750313199,0.00543522724997822,-0.0188273204412772,0.00247877037863741,0.132624644955686
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP9,Matrix metalloproteinase-9,42125,0.00977559093992058,0.00650220682196482,-0.00296873443113046,0.0225199163109716,0.132752410282443
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCN,Decorin,41900,-0.0037582931354445,0.00250011042733846,-0.00865850957302788,0.00114192330213887,0.132798111311259
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VCAN,Versican core protein,42249,-0.00491344812403308,0.00326921407860954,-0.0113211077181078,0.00149421147004161,0.132876428353599
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TUBB3,Tubulin beta-3 chain,39586,-0.00466853576504305,0.00311239487219649,-0.0107688297145482,0.00143175818446207,0.133647844453531
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL6,Fc receptor-like protein 6,42119,0.0111823678087302,0.00746332561465317,-0.00344575039598999,0.0258104860134504,0.134076339657951
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH23,Cadherin-23,39929,-0.00434727170474806,0.00290788208920164,-0.0100467205995833,0.00135217719008714,0.1349433736814
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRND,Prion-like protein doppel,39929,0.00793041378350301,0.00531182951496041,-0.0024807720658194,0.0183415996328254,0.135472311963384
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",39575,0.0101767752594919,0.00684516660817917,-0.00323975129253923,0.0235933018115231,0.13712023881466
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00864697094862936,0.00588962264010735,-0.00289668942598105,0.0201906313232398,0.142086578929568
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.008629467480601,0.00588235615262455,-0.0201588855397451,0.00289995057854312,0.142402158116355
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCAM1,Neural cell adhesion molecule 1,42217,0.00520326839470873,0.0035545658882075,-0.00176368074617797,0.0121702175355954,0.143264392966342
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHPK,Sedoheptulokinase,39757,-0.00635723018686585,0.0043442280198005,-0.0148719171056748,0.00215745673194313,0.143393249102191
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.00978087946495342,0.00668861258933426,-0.0228905601400486,0.00332880121014173,0.143682685454735
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.00826869108062216,0.00568149823038037,-0.0194044276121677,0.00286704545092336,0.145594991694521
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.0064715467993044,0.00446328092576532,-0.00227648381519563,0.0152195774138044,0.147099783355594
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMP10,Bone morphogenetic protein 10,39736,0.0044541550783505,0.00307361754657051,-0.00157013531292769,0.0104784454696287,0.147321837947541
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,39560,0.00686887908414253,0.00474372869781235,-0.00242882916356968,0.0161665873318547,0.147648017511041
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHAD,Chondroadherin,39736,0.00737865087194812,0.00509842396784954,-0.00261426010503698,0.0173715618489332,0.147857439174484
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPA33,Cell surface A33 antigen,42070,0.0210136474963298,0.0145309109176193,-0.00746693790220404,0.0494942328948636,0.148162826571548
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGS8,Regulator of G-protein signaling 8,41913,-0.0100208342987786,0.00694826850185567,-0.0236394405624157,0.00359777196485852,0.149267801592292
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDHB15,Protocadherin beta-15,39919,-0.00623784004879104,0.00433113158398783,-0.0147268579534072,0.00225117785582511,0.149829055133042
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPSG1,Tryptase gamma,39657,0.00408712917009943,0.0028481400776845,-0.00149522538216219,0.00966948372236105,0.151310563489737
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEX33,Testis-expressed protein 33,39757,-0.00598097895309972,0.00419186931326104,-0.0141970428070914,0.00223508490089192,0.153664171210834
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK3,Prostate-specific antigen,39966,0.0177519622632365,0.0124452197075918,-0.00664066836364338,0.0421445928901164,0.153778041600602
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD5,Sushi domain-containing protein 5,39695,-0.00529892707145687,0.00374520228854321,-0.0126395235570016,0.00204166941408782,0.157138382427103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.00879835268819218,0.00623037547936388,-0.0210098886277454,0.00341318325136103,0.157928106275997
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF9,Fibroblast growth factor 9,39539,0.006322565462067,0.00448000671057085,-0.00245824769065186,0.0151033786147859,0.158189088917672
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,42119,0.0074275190446004,0.00527282258846634,-0.00290721322879362,0.0177622513179944,0.158964068487905
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00388092495360924,0.00275527593011114,-0.00928126577662707,0.0015194158694086,0.158997751036728
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP1,Retinol-binding protein 1,39649,0.0107452741661514,0.00763805291594438,-0.00422530954909958,0.0257158578814024,0.159512447378175
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00666517417911674,0.00475163960799354,-0.0159783878107841,0.00264803945255061,0.16073148034612
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00635679412249884,0.00453550408207295,-0.00253279387836413,0.0152463821233618,0.161069263374217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD58,Lymphocyte function-associated antigen 3,42100,-0.00263499507907452,0.00189310087425717,-0.00634547279261857,0.00107548263446953,0.16397753633951
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPT2,Angiopoietin-2,42262,-0.00561529170664972,0.00405717955106837,-0.0135673636267437,0.0023367802134443,0.166369349731007
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL4,Myosin light chain 4,39638,0.00774412859059796,0.00560611545954457,-0.0032438577101094,0.0187321148913053,0.167192699629863
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLL1,Delta-like protein 1,42181,-0.00460401926531326,0.00333514083027112,-0.0111408952926446,0.00193285676201813,0.167468629850669
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.0108576486879881,0.00786823778662552,-0.0262793947497741,0.00456409737379792,0.167635054597808
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,H2AP,Huntingtin-interacting protein M,39560,-0.00755527873642857,0.00547732238530413,-0.0182908306116247,0.00318027313876753,0.167807465948586
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.0113369081388828,0.00825868653549889,-0.00485011747069498,0.0275239337484607,0.169860899482445
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRXN3,Neurexin-3,39649,0.00536805856316584,0.00391061205138481,-0.0022967410575484,0.0130328581838801,0.169876559657625
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMA1,Proteasome subunit alpha type-1,41843,0.00687954336295639,0.00503660155298266,-0.00299219568088962,0.0167512824068024,0.171990475577751
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,0.00317259259773623,0.00233765558861946,-0.00140921235595791,0.00775439755143036,0.17475470229783
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,39929,0.00450193571062273,0.00331715825458389,-0.0019996944683617,0.0110035658896072,0.174755382679926
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,39586,0.00876765050422924,0.00647091928521846,-0.00391535129479894,0.0214506523032574,0.175467334568301
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRL,Prolactin,42249,0.0108304813365638,0.0079964587916261,-0.00484257789502339,0.0265035405681509,0.175628125845007
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.00739663413357654,0.00548359149848992,-0.0033512052034637,0.0181444734706168,0.177407419687116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOP56,Nucleolar protein 56,39575,0.0164075532214151,0.0121737226125152,-0.00745294309911465,0.0402680495419449,0.177755561550489
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EXOSC10,Exosome component 10,39575,-0.00853578030005507,0.00633516833865757,-0.0209527102438239,0.00388114964371377,0.177890714846723
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOM1,Myomesin-1,39586,0.00712464070806561,0.00532493787784564,-0.00331223753251185,0.0175615189486431,0.180931854465211
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,39657,-0.00616395547402564,0.0046238108279888,-0.0152266246968837,0.0028987137488324,0.182529771933801
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00706983277925687,0.00530739797575894,-0.00333266725323065,0.0174723328117444,0.182864404400331
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FBN2,Fibrillin-2,39649,0.00867535707279965,0.00653297331520235,-0.00412927062499696,0.0214799847705963,0.18422735872454
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLGN,Calmegin,39649,0.00657869873148082,0.00496731467939831,-0.00315723804013985,0.0163146355031015,0.1853984856862
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NXPE4,NXPE family member 4,39575,-0.00460118974150492,0.00347713363892961,-0.011416371673807,0.00221399219079711,0.185772873312587
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSB,Lupus La protein,41839,0.00847143061086676,0.00640621295307692,-0.00408474677716401,0.0210276079988975,0.186065386889493
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD160,CD160 antigen,42296,0.00694605843978254,0.00526459836011682,-0.00337255434604643,0.0172646712256115,0.187060818204601
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBX2,Chromobox protein homolog 2,39575,-0.0056590495669646,0.00428976612235076,-0.0140669911667721,0.0027488920328429,0.187130551319478
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00564268787863756,0.00429158508109168,-0.0140541946375772,0.00276881888030214,0.188595841782467
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOS,Proto-oncogene c-Fos,39539,-0.0051540502619406,0.00392503438894013,-0.0128471176642633,0.00253901714038205,0.189169277912779
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD177,CD177 antigen,42123,-0.0183522360303315,0.0139979753528835,-0.0457882677219832,0.00908379566132025,0.189858537376388
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMMD9,COMM domain-containing protein 9,39919,0.00565366538620461,0.00433319071227217,-0.00283938840984886,0.0141467191822581,0.192009640373121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUMF1,Formylglycine-generating enzyme,39657,0.00933395714798219,0.00718207168605474,-0.0047429033566851,0.0234108176526495,0.193758663088759
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNPO1,Transportin-1,39757,0.00500778798177174,0.00385642150793545,-0.00255079817378174,0.0125663741373252,0.194122411125352
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA4C,Semaphorin-4C,42070,-0.00389686991043583,0.00302570833711467,-0.00982725825118058,0.00203351843030892,0.197795980105225
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBM19,Probable RNA-binding protein 19,39575,-0.00673090965255835,0.00522614841184212,-0.0169741605397689,0.00351234123465221,0.197797730352983
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.00427772169898579,0.00332694365758168,-0.00224308786987429,0.0107985312678459,0.198545703685031
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.00376122218824108,0.00293344547872695,-0.00198833095006374,0.00951077532654591,0.199799414219166
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,0.00367648645848861,0.00286778580667075,-0.00194437372258606,0.00929734663956328,0.199870567770628
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEF,Thyrotroph embryonic factor,39575,0.00596517164201456,0.00465441318087325,-0.003157478192497,0.0150878214765261,0.200004366438093
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.00681165680444977,0.00539918973259762,-0.00377075507144155,0.0173940686803411,0.20711676717698
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00838367401155809,0.00667282884623443,-0.0214624185501776,0.0046950705270614,0.2090009882017
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,39560,0.00710351917105399,0.00566667268523564,-0.00400315929200786,0.0182101976341158,0.210028398698716
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL36A,Interleukin-36 alpha,39657,-0.00781471186438829,0.00624451910374869,-0.0200539693077357,0.00442454557895915,0.210796328029013
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADA2,Adenosine deaminase 2,42096,-0.00594442369047794,0.00476764413214299,-0.0152890061894782,0.00340015880852233,0.212482863937677
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00478414092994132,0.00384133106370334,-0.00274486795491723,0.0123131498147999,0.212992707795722
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RELB,Transcription factor RelB,39657,0.00632742762688629,0.00509904731637357,-0.00366670511320591,0.0163215603669785,0.214667584451313
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00792509782452932,0.00639122398317273,-0.00460170118248924,0.0204518968315479,0.215003093774179
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00622556198907832,0.0050376533389926,-0.00364823855534718,0.0160993625335038,0.216557151470492
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF8,SLAM family member 8,41843,0.00723991169385907,0.00585987068762025,-0.00424543485387662,0.0187252582415948,0.216663761649041
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GH2,Growth hormone variant,41843,0.0216786181383233,0.0176345786672697,-0.0128851560495254,0.0562423923261719,0.218972037401737
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANK2,Ankyrin-2,39575,-0.00931653202057594,0.0075963026855975,-0.024205285284347,0.00557222124319516,0.220053385224071
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.00683542684710031,0.00557940791822262,-0.0177710663668166,0.00410021267261604,0.220552459449539
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNW1,Interferon omega-1,39575,-0.0046945135950752,0.00383469007056577,-0.0122105061333841,0.00282147894323372,0.220894608532624
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OBP2B,Odorant-binding protein 2b,41979,-0.00762220418831632,0.00622636774650945,-0.0198258849714748,0.0045814765948422,0.220905323839183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REST,RE1-silencing transcription factor,39560,-0.0045543316139841,0.00372176266898446,-0.0118489864451936,0.00274032321722544,0.221090647805953
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00452130118839067,0.00369738477828204,-0.0117681753538235,0.00272557297704212,0.221417292291027
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NME3,Nucleoside diphosphate kinase 3,42144,0.00316322940615428,0.00259667419697965,-0.00192625201992583,0.0082527108322344,0.223174920455422
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUSP29,Dual specificity phosphatase 29,39649,-0.0088927801256658,0.00732348175920541,-0.0232468043737084,0.0054612441223768,0.224665589294135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,0.00502533661447094,0.00413936130138346,-0.00308781153624063,0.0131384847651825,0.224754881891883
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,39586,0.0142938151328031,0.0118145840533364,-0.00886276961173628,0.0374503998773425,0.226364417247998
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCB,Calcitonin gene-related peptide 2,39929,0.00532425036614152,0.00441427045475076,-0.00332771972516996,0.013976220457453,0.22778676285574
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,39958,-0.0037359396926453,0.00310221997060463,-0.00981629083503038,0.00234441144973977,0.228506690022577
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMA1,Laminin subunit alpha-1,39575,-0.00671229675153186,0.00561711809465458,-0.0177218482170548,0.00429725471399113,0.232123937361307
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,41913,0.00774589973653229,0.00648788559068958,-0.00497035602121929,0.0204621554942839,0.232537568658244
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFDN4,Prefoldin subunit 4,39560,-0.00683965736832734,0.00573834462513087,-0.0180868128335838,0.00440749809692916,0.233317763859807
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,0.00765923564000177,0.0064321713040731,-0.0049478201159815,0.020266291395985,0.23376970270753
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00614385927016522,0.00516608754892975,-0.0162693908660675,0.0039816723257371,0.234360034118614
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHP1,Calcineurin B homologous protein 1,39586,0.00950651475063413,0.00802576353433531,-0.00622398177666308,0.0252370112779313,0.236240927298175
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPB41L5,Band 4.1-like protein 5,39649,0.00799288957255966,0.00676255256178702,-0.00526171344854289,0.0212474925936622,0.237257398196353
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.00990944509034472,0.00838796111946459,-0.00653095870380587,0.0263498488844953,0.237473648797936
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,39743,-0.00686641432605459,0.00582485107116057,-0.0182831224255293,0.00455029377342013,0.238497532550636
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,39575,0.0050074053045259,0.00425609977114576,-0.00333455024691978,0.0133493608559716,0.239410898106269
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL6,Interleukin-6,42070,0.00948546824518949,0.00811447735127016,-0.00641890736330003,0.025389843853679,0.242441982929034
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.00834275807584508,0.0071697202125396,-0.0223954096924227,0.00570989354073253,0.244607397019929
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.00790166830382587,0.00680601654632964,-0.00543812412698022,0.021241460734632,0.245673948582351
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.0070827251911502,0.00610553153640621,-0.00488411662020598,0.0190495670025064,0.246053496621367
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRK1,Protein BRICK1,41839,0.00572180974477826,0.00494240777904391,-0.00396530950214779,0.0154089289917043,0.24700866946078
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRING1,SREBP regulating gene protein,39560,0.00777757036189553,0.00674928619893622,-0.00545103058801945,0.0210061713118105,0.249200561466395
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBQLN3,Ubiquilin-3,39575,0.00702196985123309,0.00611136829631861,-0.00495631200955138,0.0190002517120176,0.250580502481648
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.0130727836127366,0.0115147186082781,-0.0356416320849617,0.00949606485948843,0.256269939882543
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,0.00359224929560586,0.00316739478322732,-0.00261584447951968,0.0098003430707314,0.256758535269215
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TG,Thyroglobulin,39919,-0.0129044542918011,0.0113871915577967,-0.0352233497450827,0.00941444116148046,0.257136254344623
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00509080295899583,0.00452493567971195,-0.0037780709732396,0.0139596768912313,0.260589417188191
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STEAP4,Metalloreductase STEAP4,39586,0.00886257996197432,0.00791655945578951,-0.00665387657137312,0.0243790364953218,0.262951815543819
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,39575,-0.00472346566163469,0.00422415289199428,-0.0130028053299435,0.00355587400667409,0.263504250267541
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCNE1,G1/S-specific cyclin-E1,39657,0.0111144321818671,0.00995809255236777,-0.00840342922077375,0.0306322935845079,0.264394772328676
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00416235709247718,0.00373338006695762,-0.00315506783875976,0.0114797820237141,0.264916170421876
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.00398917842828545,0.00358785485877898,-0.0110213739514922,0.00304301709492134,0.26622401521111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",39929,0.0071503267975358,0.00644708587015976,-0.00548596150797733,0.0197866151030489,0.267419696166542
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKKL1,Dickkopf-like protein 1,42070,-0.0100531973803151,0.00910064163747146,-0.0278904549897592,0.00778406022912892,0.269322739778477
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,-0.00434340227313593,0.0039367685065513,-0.0120594685459765,0.00337266399970463,0.269924126720989
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BEX3,Protein BEX3,39560,-0.00561034139241872,0.00508566815436494,-0.015578250974974,0.00435756819013657,0.269978861074282
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL6B,Myosin light chain 6B,39649,0.0109396865643735,0.00992332968122634,-0.00851003961083013,0.0303894127395771,0.270302718345523
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.00906388159353633,0.00823507210517539,-0.0252046229196801,0.00707685973260743,0.271075801526837
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.00703281373125541,0.0063954038364331,-0.0195678052506643,0.00550217778815347,0.271501235433994
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.00820969601635236,0.00749573684228151,-0.0064819481945194,0.0229013402272241,0.273431338597738
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR2,Toll-like receptor 2,39757,-0.00275330689775844,0.00251580974975926,-0.00768429400728658,0.0021776802117697,0.27380238961984
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.00652574993399623,0.00597083559208209,-0.0182285876944771,0.00517708782648466,0.274445221119311
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTNL10,Butyrophilin-like protein 10,39560,-0.00473232608436786,0.00433606996646778,-0.0132310232186447,0.00376637104990897,0.275127058623511
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGR,Progesterone receptor,39657,0.0118570084142949,0.0108941971547262,-0.0094956180089685,0.0332096348375584,0.276451833154799
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.00793774557454516,0.00729369114063047,-0.0222333802101809,0.00635788906109057,0.276485287078791
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.00429854839935997,0.00396061231088223,-0.0120613485286892,0.0034642517299692,0.27780192878447
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00256285540984223,0.00236229992826424,-0.00206725244955568,0.00719296326924014,0.2779861140823
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA10,Ephrin type-A receptor 10,41839,0.00774754730869371,0.00715483694135346,-0.00627593309635907,0.0217710277137465,0.278898940748803
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00776617683506534,0.00718945737929776,-0.021857513298489,0.00632515962835828,0.280068739232367
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.00518604942507758,0.00482145713961525,-0.00426400656856832,0.0146361054187235,0.282117316385726
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRA3,GDNF family receptor alpha-3,41989,0.00324751314796132,0.00302283189810299,-0.00267723737232055,0.00917226366824319,0.282695030571264
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.00871749418702693,0.00812606083492154,-0.00720958504941929,0.0246445734234731,0.283392370590421
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECTIN4,Nectin-4,42181,-0.0039072442969259,0.0036528778974227,-0.0110668849758744,0.00325239638202259,0.284802860624268
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOS2,"Nitric oxide synthase, inducible",39575,-0.00467596851785152,0.00438120957468083,-0.0132631392842259,0.00391120224852291,0.285869803034513
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL24,Interleukin-24,41913,-0.00552994949681718,0.005243590978641,-0.0158073878149535,0.00474748882131918,0.291622342221122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA2,Ephrin type-A receptor 2,41614,0.00369561950430054,0.0035139384364586,-0.00319169983115831,0.0105829388397594,0.292955373575978
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.00540973403738225,0.00514934617913664,-0.0155024525484901,0.00468298447372556,0.293480426052836
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.0086807100758441,0.00828886321499131,-0.0249268819772271,0.00756546182553886,0.294995958582355
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.00365262535399166,0.00350075882203496,-0.0105141126451802,0.00320886193719688,0.296790475747706
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00528210671530712,0.00507406348394509,-0.00466305771322525,0.0152272711438395,0.297893380851644
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,0.00378125766511453,0.00366754832552869,-0.00340713705292171,0.0109696523831508,0.30256144797215
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MBL2,Mannose-binding protein C,39826,-0.0123518388157328,0.0119847141897376,-0.0358418786276185,0.011138200996153,0.302735280830614
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00462272438486488,0.00449689316906315,-0.0134366349962287,0.00419118622649889,0.303980870556252
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,39575,-0.0039946528507144,0.00388628658984894,-0.0116117745668183,0.00362246886538953,0.304026922954047
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.00416454420381766,0.00407277882226566,-0.0121471906954584,0.00381810228782303,0.306547758957878
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,0.00328243739743054,0.00322965482780573,-0.00304768606506869,0.00961256085992977,0.309484295413567
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRD2,Bromodomain-containing protein 2,39586,0.00386606306782656,0.00380940157351964,-0.00360036401627193,0.011332490151925,0.31018818638706
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,0.00677045808959136,0.00668619251033069,-0.00633447923065678,0.0198753954098395,0.311268123908176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMP,Cartilage oligomeric matrix protein,42042,0.00366279299718182,0.0036203376880115,-0.00343306887132072,0.0107586548656844,0.311686864388694
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TJP3,Tight junction protein ZO-3,39586,-0.00457125989717905,0.00452309459279174,-0.0134365252990509,0.00429400550469277,0.312206832370245
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,0.0128774004812314,0.0128102780820318,-0.012230744559551,0.0379855455220139,0.314802888719103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FBLN2,Fibulin-2,39966,-0.00350003762758563,0.00349231744633236,-0.010344979822397,0.00334490456722579,0.316263215989604
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLI2,Zinc finger protein GLI2,39657,-0.00361322653606322,0.00360813059330272,-0.0106851624989366,0.00345870942681012,0.316649410218701
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACTA2,"Actin, aortic smooth muscle",41900,0.00473607069150868,0.00474034857316899,-0.00455501251190254,0.0140271538949199,0.317765609717607
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NENF,Neudesin,39919,0.0121936428839613,0.0122185764909632,-0.0117547670383267,0.0361420528062492,0.318320394690783
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,0.016263555155389,0.016313966319736,-0.0157118188312936,0.0482389291420716,0.318826070148592
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALMS1,Alstrom syndrome protein 1,39757,-0.00479413486182148,0.00482657540028279,-0.0142542226463757,0.00466595292273278,0.320595663159663
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,0.00319138427879974,0.00322424854348008,-0.00312814286642122,0.0095109114240207,0.322289524184574
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.0044670569739345,0.00454493166469482,-0.0133751230367363,0.00444100908886734,0.325695112759678
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,-0.00631849374949372,0.00648143885386675,-0.0190221139030726,0.00638512640408512,0.329651184539026
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUOX2,Dual oxidase 2,41900,0.00743441172431974,0.00763905930364655,-0.00753814451082749,0.022406967959467,0.330466457659145
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASQ2,Calsequestrin-2,39575,0.00498330899521173,0.00517148827545852,-0.00515280802468696,0.0151194260151104,0.335261638120745
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00384395178608394,0.00400620406207487,-0.0116961117477507,0.00400820817558281,0.337327413630748
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.00291900768879154,0.00304247196578084,-0.00304423736413891,0.00888225274172199,0.337368308573229
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTNNA1,Catenin alpha-1,39586,-0.00351292370824557,0.00367745083246847,-0.0107207273398838,0.00369487992339264,0.339466970500382
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,-0.0050957298250352,0.00533939562865824,-0.0155609452572053,0.00536948560713495,0.339919910028663
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,39929,0.00289610468826686,0.00305064818003441,-0.00308316574460059,0.00887537512113431,0.342467575410176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP6,Guanylate-binding protein 6,39575,-0.0046003848491597,0.00485955096354162,-0.0141251047377013,0.00492433503938187,0.343828460833099
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTX2,Neuronal pentraxin-2,39966,-0.00351271610963518,0.00372057136928262,-0.0108050359934291,0.00377960377415876,0.345121495178254
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,42262,-0.00607024321073161,0.00647271458978626,-0.0187567638067127,0.00661627738524947,0.348353339470585
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMY2B,Alpha-amylase 2B,41300,-0.00510870132426572,0.00544906332597822,-0.015788865443183,0.00557146279465159,0.348499960923588
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BSND,Barttin,39560,0.00341748003089001,0.00364829607354842,-0.00373318027326489,0.0105681403350449,0.348916457438696
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,0.0101997633452597,0.0109000949333198,-0.0111644227240471,0.0315639494145664,0.349421906703547
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DENND2B,DENN domain-containing protein 2B,39575,-0.0049829497360967,0.00532520074310924,-0.0154203431925908,0.00545444372039742,0.349432843141671
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,42040,0.00287715511446718,0.00309551748105349,-0.00319005914839766,0.00894436937733203,0.352668202275689
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPEP,Glutamyl aminopeptidase,39575,0.00423416414937657,0.00461199098759076,-0.00480533818630131,0.0132736664850545,0.358598582653988
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.00281319450277333,0.00307586633973425,-0.0032155035231058,0.00884189252865246,0.360416718906759
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENG,Endoglin,42310,0.00171668836467573,0.0018777706618063,-0.00196374213246462,0.00539711886181608,0.360619329252075
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.0050264777327123,0.00554173555373096,-0.00583532395260037,0.015888279418025,0.364411512640304
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.00490833585315112,0.00544450863176114,-0.00576290106510071,0.015579572771403,0.367331430784897
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCN1,Transcobalamin-1,39806,-0.00348496720480515,0.00387483386299077,-0.0110796415762671,0.00410970716665677,0.368466985819694
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,42248,0.0040749456849116,0.00456064661350164,-0.00486392167755161,0.0130138130473748,0.371604295543409
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.00884066094597491,0.00995164657321545,-0.0106645663375274,0.0283458882294772,0.374365754954036
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.00266668841982476,0.00300199910803033,-0.00321722983191468,0.00855060667156421,0.374392872483788
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.0257286584758342,0.0289880264787437,-0.0825451903741718,0.0310878734225034,0.374795968616693
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY96,Lymphocyte antigen 96,42016,-0.00352063828318823,0.00397261045647798,-0.0113069547778851,0.0042656782115086,0.375510608767317
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRC1,Protein regulator of cytokinesis 1,39919,0.00424708661224764,0.00479446698446992,-0.00515006867731341,0.0136442419018087,0.375727518646778
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,39560,0.00298565614212668,0.00339223481494468,-0.0036631240951649,0.00963443637941825,0.378800440377735
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.00546513229732458,0.00621415376030308,-0.0176448736675186,0.00671460907286945,0.379168302212378
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL22,Interleukin-22,39919,0.0067214457722929,0.00765367681893033,-0.00827976079281055,0.0217226523373964,0.379854769136633
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCNIP4,Kv channel-interacting protein 4,41839,0.00486414233297856,0.00554189822800229,-0.00599797819390593,0.0157262628598631,0.380120683537818
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.00608179699577316,0.00693702263026215,-0.019678361351087,0.00751476735954065,0.380656667537984
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.00585657859911927,0.00669090877151232,-0.0189707597912834,0.00725760259304488,0.381427704024208
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAPPA,Pappalysin-1,41913,0.00448572569828517,0.00515838946099852,-0.00562471764527194,0.0145961690418423,0.384535751650399
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.00287590285332405,0.00331101549577825,-0.00936549322504942,0.00361368751840132,0.385092443997421
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACTN4,Alpha-actinin-4,41913,0.00297130099390333,0.00343042476609604,-0.00375233154764491,0.00969493353545158,0.38641735086193
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK1,Kallikrein-1,42016,-0.0119443602381018,0.0138889260631374,-0.0391666553218511,0.0152779348456474,0.389809020490644
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00314185399468624,0.00366732331766128,-0.0103298076973023,0.00404609970792986,0.391617273759298
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD33,Myeloid cell surface antigen CD33,42181,0.00739411986693171,0.00863369929955345,-0.00952793076019304,0.0243161704940565,0.391777599076283
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,41913,0.0032253063962991,0.00377375307745263,-0.00417124963550805,0.0106218624281062,0.392750291203813
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COPE,Coatomer subunit epsilon,41839,0.00428401942558003,0.00504813240390021,-0.00561032008606439,0.0141783589372244,0.396100035273679
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.0070811173758892,0.00839571383893158,-0.0093744817484167,0.0235367165001951,0.399011555122431
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDAC8,Histone deacetylase 8,39657,0.00551415215928646,0.00654511944326806,-0.00731428194951893,0.0183425862680918,0.399535848713415
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA2,Protein disulfide-isomerase A2,39560,0.00365653525450013,0.0043454042116774,-0.00486045700038757,0.0121735275093878,0.400102016327132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,0.00298190720504593,0.0035555846603238,-0.00398703872918873,0.00995085313928058,0.401678014631363
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN2,Contactin-2,42262,0.00399415174357004,0.0047829420610237,-0.00538041469603642,0.0133687181831765,0.403685799453645
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESPL1,Separin,39560,-0.00481863109359457,0.00580285165846543,-0.0161922203441868,0.00655495815699768,0.406336297598852
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH4,Cadherin-4,39586,0.00419718485513594,0.00505879834672007,-0.00571805990443539,0.0141124296147073,0.406737642948253
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC123,Cell division cycle protein 123 homolog,39560,0.00564373318231068,0.00682502184743022,-0.00773330963865254,0.0190207760032739,0.408301562052936
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHGB,Secretogranin-1,42210,0.00379096409654697,0.00459283746333666,-0.00521099733159289,0.0127929255246868,0.409154546901217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.0031805349252638,0.00385608438308611,-0.0107384603161126,0.00437739046558497,0.409494301434101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYTH3,Cytohesin-3,39560,0.00650595077358808,0.00794758366411687,-0.00907131320808099,0.0220832147552572,0.413028243432028
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00435677331288792,0.00533628675469977,-0.0148158953520995,0.00610234872632363,0.414261571761019
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00438734372917847,0.00541027231026893,-0.0149914774573056,0.00621678999894863,0.417424346765304
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAYN,Layilin,41997,-0.00314339358560756,0.00389062325091931,-0.0107690151574094,0.00448222798619428,0.419138959948054
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPT,Microtubule-associated protein tau,41839,0.00464034969639856,0.00574949297028139,-0.00662865652535297,0.0159093559181501,0.41962999233138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FZD10,Frizzled-10,39649,0.00523473847413878,0.00648683599518449,-0.00747946007642282,0.0179489370247004,0.419696125492114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMMR,Hyaluronan mediated motility receptor,39541,0.00418017959924801,0.0052565432198305,-0.00612264511161976,0.0144830043101158,0.426494901934951
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMY2A,Pancreatic alpha-amylase,41665,-0.00418318698433144,0.00531740408074212,-0.014605298982586,0.00623892501392313,0.431473403626637
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTTG1,Securin,39757,0.00352375274942439,0.00452349634823535,-0.0053423000931169,0.0123898055919657,0.436002865626843
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,39757,0.00338394877958914,0.00437202831551505,-0.00518522671882036,0.0119531242779986,0.438947345109759
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.00531435221208031,0.00688295654193866,-0.00817624261011946,0.0188049470342801,0.440069709120045
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,39586,0.00634502976663211,0.00825473869037382,-0.00983425806650057,0.0225243175997648,0.442115848468821
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GDF15,Growth/differentiation factor 15,42310,-0.00381622011008622,0.00497374444500346,-0.013564759222293,0.00593231900212056,0.442932396285689
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0140802660688108,0.0183769580253891,-0.0219385716609519,0.0500991037985736,0.443576022510985
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM2,Intercellular adhesion molecule 2,42310,-0.00265774709680085,0.00355772736047386,-0.00963089272332963,0.00431539852972792,0.455055204633362
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,0.00554994301137393,0.00744174493789771,-0.00903587706690559,0.0201357630896534,0.45581006683518
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00491142549076452,0.00658803505205894,-0.00800112321127099,0.0178239741928,0.455981299917609
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCNA,Proliferating cell nuclear antigen,39560,0.00519511689765936,0.00701027420403581,-0.00854502054225083,0.0189352543375696,0.458665751717243
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCG3,Secretogranin-3,42144,-0.0026749474322675,0.00361660441505818,-0.00976349208578153,0.00441359722124653,0.459537635987645
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFF1,Trefoil factor 1,42084,0.00646717285214854,0.0087453794509767,-0.0106737708717658,0.0236081165760629,0.459618759884453
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL19,Interleukin-19,41756,0.00587985576807376,0.00797624709454589,-0.00975358853723618,0.0215133000733837,0.461031686559539
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHH,Sonic hedgehog protein,39657,-0.00341057052188224,0.00463760144922298,-0.0125002693623593,0.00567912831859481,0.46210122571529
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0054020427437114,0.00737537858545204,-0.0198577847711974,0.00905369928377459,0.4639110812764
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00556299434171927,0.00759800126296025,-0.00932908813368281,0.0204550768171214,0.464083092894524
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGN,Cingulin,39649,0.00297831010428638,0.00407031416090961,-0.00499950565109647,0.0109561258596692,0.464358030939877
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00436800842490398,0.00598426223881213,-0.0160971624129757,0.00736114556316779,0.465457165359988
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL9,Interleukin-9,39757,-0.00445237308983733,0.00610342678814039,-0.0164150895945925,0.00751034341491783,0.465718871329491
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,39586,0.00919365890963045,0.0127783869644985,-0.0158519795407866,0.0342392973600475,0.471867029421889
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MELTF,Melanotransferrin,39958,0.00232615798163788,0.0032701563635852,-0.00408334849098911,0.00873566445426487,0.476894817465894
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYBB2,Beta-crystallin B2,39929,0.00540107716768288,0.00760008312405131,-0.00949508575545769,0.0202972400908234,0.477309410957704
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABO,Histo-blood group ABO system transferase,39990,0.0111891818192588,0.0157511060040757,-0.0196829859487296,0.0420613495872473,0.477486563897387
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.00536445807249471,0.00755213336189968,-0.0201666394618181,0.00943772331682866,0.477518620818003
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.0041441654080089,0.00583420488693521,-0.0155792069864019,0.0072908761703841,0.477519417110247
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00347273375503093,0.00490960659282752,-0.00615009516691101,0.0130955626769729,0.479373584803761
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RUVBL1,RuvB-like 1,41843,0.00760850773075097,0.0107671933386372,-0.0134951912129779,0.0287122066744798,0.479803913844233
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ISM2,Isthmin-2,39966,0.00332630125104211,0.00471805445484506,-0.0059210854804542,0.0125736879825384,0.480815072465957
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,42248,0.00236346310301317,0.00338877359337236,-0.00427853313999666,0.009005459346023,0.485539938389056
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTRC,Chymotrypsin-C,42122,0.00493184118282715,0.00710070086497224,-0.00898553251251844,0.0188492148781727,0.487344928135473
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNLZ,DNL-type zinc finger protein,39586,-0.00637581163273027,0.00918512796570481,-0.0243786624455117,0.0116270391800512,0.487605890967377
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.00275401574894719,0.00397630289688349,-0.0105475694268388,0.00503953792894446,0.48857068888237
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB1,Integrin beta-1,42167,0.00158509241975714,0.0022917706427737,-0.0029067780400793,0.00607696287959359,0.489171934291042
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00200487886480718,0.00289979870700399,-0.00367872660092065,0.007688484330535,0.489337939303337
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF20,Fibroblast growth factor 20,39657,-0.00321534604708007,0.00469178877208669,-0.01241125204037,0.00598055994620984,0.493160499860944
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL13,Interleukin-13,41913,-0.00362055976851446,0.00528457153915757,-0.0139783199852633,0.00673720044823438,0.493280831409998
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,-0.00649652694575714,0.00949852965154907,-0.0251136450627933,0.012120591171279,0.494020567994289
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSLNL,Mesothelin-like protein,39649,-0.00280972237316866,0.00412377093153946,-0.010892313398986,0.00527286865264869,0.495665705476792
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00479989115637577,0.00706846049894538,-0.00905429142155718,0.0186540737343087,0.497115731264039
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC39A14,Zinc transporter ZIP14,41839,-0.0024864628734957,0.00367080075979555,-0.00968123236269498,0.00470830661570357,0.498187804976731
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNF174,Zinc finger protein 174,39657,0.00269975902970238,0.00399767699517504,-0.0051356878808407,0.0105352059402455,0.499479006864177
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC1A4,Neutral amino acid transporter A,39649,0.00371196133054449,0.00552499096373213,-0.00711702095837049,0.0145409436194595,0.501693684632254
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HLA_A,,39934,0.00239404939795213,0.00356603097276637,-0.00459537130866996,0.00938347010457422,0.50201225273272
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEFL,Neurofilament light polypeptide,41797,0.0034483382657338,0.00514897943555373,-0.00664366142795151,0.0135403379594191,0.503052504546553
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PODXL2,Podocalyxin-like protein 2,42181,0.00207378337459649,0.00310443866228221,-0.00401091640347665,0.00815848315266962,0.504141171530183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLNS1A,Methylosome subunit pICln,39649,0.00243762022937022,0.00365281350232754,-0.00472189423519176,0.0095971346939322,0.504577368138935
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMEM132A,Transmembrane protein 132A,39638,0.00454661351865733,0.00682481968501504,-0.00883003306397215,0.0179232601012868,0.505304813812252
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.00159069357739449,0.00239099669437912,-0.00309565994358857,0.00627704709837756,0.50588189816724
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMCN2,Hemicentin-2,39721,-0.00419029877468287,0.00630636288622884,-0.0165507700316914,0.00817017248232565,0.506412468928465
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,42119,-0.00321814019545397,0.00484903275177157,-0.0127222443889262,0.0062859639980183,0.506915154732584
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.0064297187590033,0.00969538273778599,-0.0254326689250638,0.0125732314070572,0.507233088087208
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSTN,Osteocrin,39649,0.00291532504238321,0.00440010177888006,-0.00570887444422171,0.0115395245289881,0.507627146160235
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFDN6,Prefoldin subunit 6,39649,0.00465466162279888,0.00705228518895488,-0.00916781734755269,0.0184771405931505,0.509253628859807
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA10,Annexin A10,41839,0.00585151169790107,0.00889638546757876,-0.0115854038185533,0.0232884272143554,0.51071642494066
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VASN,Vasorin,41975,-0.00195518675719811,0.0029787928274316,-0.00779362069896404,0.00388324718456782,0.511598133765808
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.00325376212051819,0.00496873218875915,-0.00648495296944974,0.0129924772104861,0.512577000187256
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,0.00439752366591949,0.00683165653677143,-0.0089925231461525,0.0177875704779915,0.519784735837593
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00256672274093306,0.00399194565744513,-0.0103909362295255,0.0052574907476594,0.520253423666982
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXDC1,Plexin domain-containing protein 1,41843,-0.00224160422921975,0.00350428267062021,-0.00910999826363536,0.00462678980519587,0.522394566664509
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00235467448477215,0.00369160903590788,-0.00488087922560729,0.00959022819515158,0.523587447862982
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.00432367088007464,0.00677936397321214,-0.00896388250742115,0.0176112242675704,0.523634982311901
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NGF,Beta-nerve growth factor,42016,0.000843743948946082,0.00132388490044166,-0.00175107045591957,0.00343855835381174,0.523924535061189
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00372933628681914,0.0058630841634788,-0.0152209812472376,0.00776230867359931,0.524743597207584
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,39560,0.00230901476236591,0.00363425381666529,-0.00481412271829806,0.00943215224302988,0.525214941716985
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN15,Tetraspanin-15,39575,-0.00346553672798421,0.00546573013617967,-0.0141783677948964,0.00724729433892795,0.526062536401728
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD2,T-cell surface antigen CD2,39575,-0.00267965772384086,0.00422943769055524,-0.0109693555973291,0.0056100401496474,0.52637269827618
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,42081,0.00182282402216193,0.00290253905201916,-0.00386615251979563,0.00751180056411948,0.530007920640078
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,39919,0.00241754947258786,0.00386746809855653,-0.00516268800058294,0.00999778694575867,0.531918849777166
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,0.00805426272595873,0.0129123240157238,-0.0172538923448599,0.0333624177967774,0.532792085808515
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS4,Galectin-4,42123,0.00380649387918389,0.00613062578182566,-0.0082095326531944,0.0158225204115622,0.534677138104863
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPSD1,Tryptase delta,39934,0.00244751388563135,0.00397310466104581,-0.00533977125001844,0.0102347990212811,0.53789336641942
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSLN,Mesothelin,42048,0.00388928940425235,0.00631505046445209,-0.00848820950607374,0.0162667883145784,0.537986641204519
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.011447486961282,0.0187093979054018,-0.0252229329333056,0.0481179068558695,0.540644265717002
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN7,Septin-7,39757,-0.00352827631825155,0.00578347032072944,-0.0148638781468812,0.00780732551037815,0.54183306555837
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD4,Sushi domain-containing protein 4,39919,0.00254276919057946,0.00418895626512213,-0.00566758508905992,0.0107531234702188,0.543851564241408
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.00200115317256766,0.00330163336995714,-0.00847235457768366,0.00447004823254834,0.544453819148344
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.00474864036927956,0.00785721592906192,-0.0201487835902409,0.0106515028516818,0.545612099497909
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRR1B,Cornifin-B,39757,0.00563778032424108,0.0093914120469493,-0.0127693872877796,0.0240449479362617,0.54831030461082
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC51B,Organic solute transporter subunit beta,39575,-0.00472881742445312,0.00788540050283541,-0.0201842024100105,0.0107265675611043,0.548723408472004
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.00276414282615086,0.00463106343022423,-0.0118410271493904,0.00631274149708863,0.550606490607559
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00319120079163367,0.00537847279594263,-0.00735060588841389,0.0137330074716812,0.552973606091872
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,39560,-0.00163408988450645,0.00276287683343517,-0.00704932847803938,0.00378114870902648,0.554234447099448
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OMP,Olfactory marker protein,39586,-0.00304648587903433,0.00521419187567777,-0.0132663019553628,0.0071733301972941,0.559051960576868
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN7,Tetraspanin-7,39586,-0.00616706938319923,0.0106090096566972,-0.0269607283103258,0.0146265895439273,0.56104689915088
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MN1,Transcriptional activator MN1,39649,-0.00371846333543782,0.00640549996424738,-0.0162732432653627,0.00883631659448704,0.561581894582557
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00248184536344168,0.00428325348034411,-0.0108770221849161,0.00591333145803278,0.562310796932342
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FSTL1,Follistatin-related protein 1,39638,0.00146490158727437,0.00252824614273845,-0.003490460852493,0.00642026402704174,0.562321583929927
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLR3,Folate receptor gamma,42132,-0.0120640797525614,0.0208617255940928,-0.0529530619169833,0.0288249024118606,0.563079506429963
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00285492886288098,0.00494059797645584,-0.0125385008967344,0.00682864317097247,0.563376579787955
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDAC9,Histone deacetylase 9,39586,0.00411070837640876,0.00725531808054786,-0.0101097150614651,0.0183311318142826,0.571012052992721
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPBGL,Trophoblast glycoprotein-like,39649,-0.00249616744893778,0.00441990988364535,-0.0111591908208827,0.00616685592300711,0.57225169271304
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL33,Interleukin-33,41913,0.00240273304106344,0.00428950731496818,-0.00600470129627419,0.0108101673784011,0.57539203582324
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRN1,Neuritin,39934,0.0021110432587601,0.00377860853429985,-0.00529502946846762,0.00951711598598781,0.576389317915985
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDSN,Corneodesmosin,42246,0.00265433262878737,0.00475971654686004,-0.0066747118030583,0.011983377060633,0.577081548942866
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL31,Interleukin-31,39657,-0.00336874850277589,0.00604386089560103,-0.0152147158581539,0.00847721885260213,0.577276700928171
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,39560,-0.00228030731995039,0.00410640758599195,-0.0103288661884946,0.00576825154859384,0.578697616845028
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAEP,Glycodelin,42016,-0.00630029421901197,0.0113826728927704,-0.0286103330888419,0.016009744650818,0.57993122008136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAND5,DAN domain family member 5,39657,-0.00321151716174032,0.00594514042418748,-0.0148639923931478,0.00844095806966714,0.589075524465033
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCL2,Phosducin-like protein 2,39560,-0.00304717991013599,0.00567764757863936,-0.0141753691642691,0.00808100934399714,0.5914873979618
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.00189217067334246,0.00352589880950605,-0.00880293233997432,0.0050185909932894,0.591520839113086
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00211292967836538,0.00393848104846635,-0.00560649317662867,0.00983235253335943,0.591635310916004
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCARE,Photoreceptor cilium actin regulator,39586,-0.00481463782700463,0.009052473167512,-0.0225574852353281,0.0129282095813189,0.59483452489939
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARG2,"Arginase-2, mitochondrial",39919,-0.00243082443387221,0.00458448973361079,-0.0114164243117494,0.00655477544400493,0.595964319657813
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLHL41,Kelch-like protein 41,39934,-0.0030161720148638,0.00569920777480865,-0.0141866192534888,0.00815427522376116,0.596658672041451
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKAP12,A-kinase anchor protein 12,39736,-0.0012205453617738,0.00231063127728362,-0.00574938266524969,0.00330829194170209,0.59735005468566
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA11,Carbonic anhydrase-related protein 11,41843,-0.00175036242396554,0.00332028539351228,-0.00825812179524961,0.00475739694731854,0.598082786630543
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,0.00172230387669051,0.00327247647369854,-0.00469175001175863,0.00813635776513966,0.598690163852854
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.00159329532143158,0.00303694644977355,-0.00754571036298773,0.00435911972012457,0.599843886907301
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF6,Fibroblast growth factor 6,39657,0.00222292522324121,0.00424761230893702,-0.00610239490227536,0.0105482453487578,0.600751466591661
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,42185,0.0016177858154429,0.00311953231262338,-0.00449649751729892,0.00773206914818473,0.604048970102681
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCUN1D1,DCN1-like protein 1,39586,-0.00425088824873727,0.00819878809029399,-0.0203205129057135,0.011818736408239,0.604135503422658
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WNT9A,Protein Wnt-9a,41913,-0.00163818095763343,0.00316920082218552,-0.00784981456911706,0.0045734526538502,0.605229917043011
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,42223,0.00357694022107233,0.00692292742181738,-0.00999199752568974,0.0171458779678344,0.605387737066496
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRTAC1,Cartilage acidic protein 1,42310,-0.00173553814795074,0.00336482725272821,-0.00833059956329803,0.00485952326739655,0.606010671437094
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA5,Annexin A5,41780,0.00169924165315859,0.00330730962950119,-0.00478308522066375,0.00818156852698092,0.607411864851885
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTLA,B- and T-lymphocyte attenuator,39560,0.00478119029489127,0.00931661972981698,-0.01347938437555,0.0230417649653326,0.607829198421034
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSMB,Beta-microseminoprotein,42103,-0.00387868296045323,0.00758758190168762,-0.018750343487761,0.0109929775668545,0.609227580849228
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHC1,SHC-transforming protein 1,39560,-0.00647855013997688,0.0127203902404809,-0.0314105150113194,0.0184534147313656,0.610549159754165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.00141192607714402,0.00283053931931302,-0.00695978314299755,0.0041359309887095,0.617916732606943
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POF1B,Protein POF1B,39657,0.00246334557653505,0.00494055071607947,-0.00722013382698071,0.0121468249800508,0.618072978781428
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00296737184495554,0.00598516580026343,-0.00876355312356078,0.0146982968134719,0.620054090892073
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,0.00259183851482807,0.00525724880006976,-0.00771236913330866,0.0128960461629648,0.622020454098323
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,-0.00184077329004186,0.00375281172795943,-0.00919628427684234,0.00551473769675863,0.623786319394329
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.00263951317712993,0.00539965873340549,-0.00794381794034483,0.0132228442946047,0.624972087149816
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RASA1,Ras GTPase-activating protein 1,41839,0.00173093555519865,0.00354715942830839,-0.0052214969242858,0.0086833680346831,0.625573546931925
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.00192837370307614,0.00395721102810338,-0.00968450731815876,0.00582775991200648,0.626049336302507
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESR1,Estrogen receptor,39657,0.00302418621956315,0.00621330432892028,-0.00915389026512059,0.0152022627042469,0.626461086208606
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN3B,Sodium channel subunit beta-3,39586,-0.00246414278417058,0.00506614323877522,-0.01239378353217,0.00746549796382885,0.626697390761965
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17F,Interleukin-17F,41913,-0.00384880485602674,0.0079806969673073,-0.0194909709119491,0.0117933611998956,0.629626166874573
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00321911687973465,0.00667875736890372,-0.00987124756331664,0.0163094813227859,0.629819963898294
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.00299002005953685,0.00620737020712685,-0.0151564656655055,0.00917642554643178,0.63003664074726
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAT1,Diamine acetyltransferase 1,39575,-0.00250585107459156,0.00525712528626528,-0.0128098166356715,0.00779811448648839,0.633615131021203
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,39657,0.00209100175416944,0.00443430474868153,-0.00660023555324636,0.0107822390615852,0.637256465647505
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.00324807375553958,0.00690441899780519,-0.0102845874801586,0.0167807349912378,0.638054306865721
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JUN,Transcription factor AP-1,41913,0.00245634004701927,0.00525004776016553,-0.00783375356290517,0.0127464336569437,0.639885189611319
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBR1,T-box brain protein 1,39649,0.0023993933199673,0.00521718825571212,-0.00782629566122846,0.0126250823011631,0.645595888106832
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGLON5,IgLON family member 5,39560,-0.00460805038939238,0.0100741441438617,-0.0243533729113613,0.0151372721325765,0.647382868314664
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD70,CD70 antigen,42119,-0.00213020292325055,0.00480714467120461,-0.0115522064788116,0.00729180063231048,0.657676855994319
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAMDC2,MAM domain-containing protein 2,39958,-0.00171323084925093,0.00386742434905812,-0.00929338257340484,0.00586692087490298,0.657781304113832
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RLN1,Prorelaxin H1,39934,0.00211213823685479,0.00481530917356435,-0.00732586774333134,0.0115501442170409,0.660938140506517
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.0012631152479952,0.0028908559671844,-0.00440296244768623,0.00692919294367663,0.662167337992237
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,39919,0.00255014769835997,0.00583949616657698,-0.00889526478813092,0.0139955601848509,0.662332325479815
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYB5A,Cytochrome b5,39560,0.0033527035515385,0.00774034947813966,-0.0118183814256152,0.0185237885286922,0.664917029503667
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSCA,Prostate stem cell antigen,39930,0.012175898738489,0.0282456513095071,-0.043185577828145,0.0675373753051229,0.666424494486821
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,42137,0.00197602376088299,0.00458923365868643,-0.0070188742101424,0.0109709217319084,0.666781982978072
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHD,SH2 domain-containing adapter protein D,39554,0.00383735367090527,0.00896375448166505,-0.0137316051131582,0.0214063124549688,0.668589139166751
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.00248601418243433,0.00584518119949189,-0.00897054096856977,0.0139425693334384,0.670618886710375
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,39757,-0.00359587291595338,0.00858572776635377,-0.0204238993380068,0.0132321535061,0.675355884363516
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCLRE1C,Protein artemis,39560,-0.00138563952165144,0.00331016141779099,-0.00787355590052177,0.00510227685721889,0.6755153775433
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MLLT1,Protein ENL,39560,-0.00301689762845764,0.00721414084575301,-0.0171566136861335,0.0111228184292183,0.675814771526946
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,-0.00118545484334784,0.00285710068482569,-0.0067853721856062,0.00441446249891052,0.67821200496613
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CORO6,Coronin-6,39586,-0.00175840681900793,0.00424595518385212,-0.0100804789793581,0.00656366534134223,0.678781917722538
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00316743027166791,0.00771022959569842,-0.0182794802792368,0.011944619735901,0.681220742341817
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTF,Ciliary neurotrophic factor,39586,-0.00153695607422195,0.00375758560467449,-0.00890182385938395,0.00582791171094005,0.682527408785296
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,0.00342278121936885,0.00838952496048012,-0.0130206877031722,0.0198662501419099,0.683294330162303
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.0021262626047247,0.00521585489780052,-0.00809681299496432,0.0123493382044137,0.683535747358549
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00209620920187325,0.00514925995015234,-0.0121887587041719,0.00799634030042534,0.683950259141848
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSLP,Thymic stromal lymphopoietin,41900,0.00263400132958059,0.00654567592270793,-0.0101955234789269,0.0154635261380881,0.687393738277417
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,39649,0.00183209678781064,0.00456929355216028,-0.0071237185744235,0.0107879121500448,0.688458480122152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORN4,MORN repeat-containing protein 4,39560,0.00339091090854027,0.00851008859872885,-0.0132888627449683,0.0200706845620488,0.690300544635888
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,-0.00148682818481842,0.00373802858337723,-0.00881336420823779,0.00583970783860096,0.69081682593741
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KHDC3L,KH domain-containing protein 3,39560,-0.00288288391346249,0.00729627379312217,-0.0171835805479819,0.011417812721057,0.692764020176235
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.00122112144144517,0.00309775186273324,-0.00729271509240233,0.00485047220951198,0.69344370705089
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00252633149942865,0.00644670129396119,-0.0101092030367353,0.0151618660355926,0.695154465514723
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PADI2,Protein-arginine deiminase type-2,41913,0.0024191580827466,0.00620054390476521,-0.00973390797059321,0.0145722241360864,0.696429980263192
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERVV_1,,39575,-0.00184164974467704,0.00473641868327982,-0.0111250303639055,0.00744173087455141,0.697411313586467
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,39657,0.00137270449117765,0.0035332298025894,-0.00555242592189758,0.00829783490425289,0.697644171148257
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNF75D,Zinc finger protein 75D,39757,-0.00258097800146715,0.00664855604430995,-0.0156121478483146,0.0104501918453803,0.697874488773147
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH22,Cadherin-22,39757,0.001156754016089,0.00299632496388816,-0.0047160429131318,0.0070295509453098,0.699461373781765
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,39649,0.00441879294895902,0.0114775689112343,-0.0180772421170602,0.0269148280149782,0.700249414402215
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALLD,Palladin,39657,-0.00159540619212688,0.00414498738279922,-0.00971958146241334,0.00652876907815958,0.700318810953201
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.00285401224481877,0.00742067293468468,-0.0173985311968008,0.0116905067071632,0.700539115995793
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL21R,Interleukin-21 receptor,39657,-0.00224995991322898,0.0058858145393666,-0.0137861564103875,0.00928623658392956,0.702269763336778
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,-0.00176013682388541,0.00464100998275692,-0.010856516390089,0.00733624274231814,0.704504102358618
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP4,Caspase-4,39757,-0.00683908340930565,0.0180408394645293,-0.042199128759783,0.0285209619411717,0.704629004259916
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.00144102886655663,0.00381467257442248,-0.00891778711242468,0.00603572937931142,0.705615153811424
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-0.00149173653812576,0.00398987516860836,-0.00931189186859815,0.00632841879234663,0.708500395872934
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNXB,Tenascin-X,42137,-0.00104947400594432,0.00284161785533119,-0.00661904500239347,0.00452009699050482,0.71189297699473
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBLN1,Cerebellin-1,39586,-0.00371938875698324,0.0100756257427092,-0.0234676152126932,0.0160288376987267,0.712025143465056
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.00221512596514905,0.00602113455651835,-0.014016549695925,0.00958629776562692,0.712961017410227
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMOD2,Leiomodin-2,39586,0.00244914787513225,0.00668680818277986,-0.0106569961631163,0.0155552919133808,0.714173941839923
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.00139430992339343,0.00384508869005042,-0.00893068375589225,0.00614206390910539,0.716895000098739
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LHB,Lutropin subunit beta,41843,-0.00344854314779702,0.00962591268478411,-0.0223153320099739,0.0154182457143798,0.720157283926537
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GJA8,Gap junction alpha-8 protein,39560,-0.0024072603812026,0.00678526390489804,-0.0157063776348028,0.0108918568723976,0.722762955499637
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IKZF2,Zinc finger protein Helios,41843,0.00341337954180088,0.0096709075658397,-0.0155415992872449,0.0223683583708467,0.724129006639639
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.00250443697215301,0.00717429931699484,-0.0165660636334629,0.0115571896891569,0.727031279926453
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00151848074370463,0.00438043719799394,-0.00706717616436349,0.0101041376517728,0.728860541465351
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.00518146956658016,0.0150677172405778,-0.0347141953581126,0.0243512562249523,0.730943744888642
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.00163126029879785,0.00475906087958704,-0.0109590196227884,0.00769649902519274,0.731778329653697
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.00181168206050697,0.00529166759313839,-0.00855998642204426,0.0121833505430582,0.732081482997205
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.00130789148103915,0.0039206990434683,-0.00899246160623701,0.00637667864415871,0.738696925660421
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL5A1,Collagen alpha-1(V) chain,39736,-0.00148443711285614,0.0044606984741293,-0.0102274061221496,0.00725853189643729,0.739305626377614
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAG,Myelin-associated glycoprotein,39649,0.00175949820064745,0.00529047941524876,-0.00860984145324013,0.012128837854535,0.73945899940025
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPO,Lactoperoxidase,41647,0.00222295987244852,0.00669102115931495,-0.0108914415998088,0.0153373613447058,0.73972071361544
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,0.00280377491086687,0.00852173501739836,-0.0138988257232339,0.0195063755449676,0.742149884451774
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00234839019046845,0.00714207460009975,-0.016346856406664,0.0116500760257271,0.742304984245743
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2,Interleukin-2,41913,-0.00112476079595324,0.00347763267521682,-0.0079409208393782,0.00569139924747172,0.746376857127876
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KDM3A,Lysine-specific demethylase 3A,39657,-0.00303048683934839,0.00963883751678616,-0.0219226083722493,0.0158616346935525,0.753220326274337
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,0.00219409736852603,0.00698007627761991,-0.011486852135609,0.0158750468726611,0.753270959349165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PITHD1,PITH domain-containing protein 1,39539,-0.00262024796560756,0.0083972124317341,-0.0190787843318064,0.0138382884005913,0.755017718834189
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRP15,RRP15-like protein,39586,0.00307849586437922,0.00991700497725839,-0.0163588338910472,0.0225158256198057,0.75624293838857
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CADPS,Calcium-dependent secretion activator 1,39649,-0.0013756657195128,0.0044363994115254,-0.0100710085661026,0.00731967712707697,0.756501342851832
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,42296,-0.00199958263656149,0.00646525822630761,-0.0146714887601244,0.0106723234870014,0.757112357268495
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL10,Interleukin-10,41913,0.00258330477726614,0.00836314929597057,-0.0138084678428362,0.0189750773973685,0.757408983129232
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,0.00490673955207953,0.0159535303142857,-0.0263621798639205,0.0361756589680796,0.758419581539211
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.00100858983864177,0.00328924186022572,-0.00543832420740063,0.00745550388468418,0.759127613626655
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB116,Beta-defensin 116,39586,0.00248990391076484,0.00816473642866171,-0.0135129794894121,0.0184927873109418,0.760403710672782
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNR,Tenascin-R,42016,-0.00138142429905374,0.00455132913801126,-0.0103020294095558,0.00753918081144833,0.761497497890217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53BP1,TP53-binding protein 1,39657,-0.00281522095198018,0.00934826721060552,-0.021137824684767,0.0155073827808066,0.763306570596552
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCLN,Nicalin,41913,0.00164607730121355,0.00556886036356113,-0.00926888901136626,0.0125610436137934,0.767550856943715
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAP1,Antigen peptide transporter 1,39757,0.00187031957016221,0.00634161263142752,-0.0105592411874357,0.0142998803277601,0.76805431643204
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,-0.00241534142531915,0.00821820464875608,-0.0185230225368811,0.0136923396862428,0.768838676743213
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAGEA3,Melanoma-associated antigen 3,39757,0.00275260466109492,0.00936634673338544,-0.0156054349363405,0.0211106442585304,0.768853217374344
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTN,Neuroplastin,41843,0.00249001996432703,0.0085197846668352,-0.01420875798267,0.019188797911324,0.770089932603653
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC25A,M-phase inducer phosphatase 1,39560,-0.00126911469955044,0.00435533515256888,-0.00980557159858544,0.00726734219948455,0.770756190082614
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOX2,Transcription factor SOX-2,39915,0.000755216473144327,0.00266770743216156,-0.00447349009389233,0.00598392304018098,0.777108665117599
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PXDNL,Peroxidasin-like protein,39919,-0.00174928968521833,0.00622041869588865,-0.0139413103291601,0.0104427309587234,0.778548835451097
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNF830,Zinc finger protein 830,39919,0.00235014427949186,0.00843757743444771,-0.0141875074920257,0.0188877960510094,0.780608276871419
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,39930,-0.00151458722251776,0.00546528643562079,-0.0122265486363345,0.009197374191299,0.781686411453194
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,39649,0.0015431307163296,0.0055687942756993,-0.00937170606404102,0.0124579674967002,0.78170604823917
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UPK3A,Uroplakin-3a,39586,-0.00145802154561675,0.00526794288645935,-0.0117831896030771,0.00886714651184357,0.781960031095176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB5,Integrin beta-5,42181,0.00114115824932587,0.0041754234771116,-0.00704267176581287,0.00932498826446461,0.784624007449896
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF3,Fibroblast growth factor 3,39657,0.000879432283402453,0.00322009289916555,-0.00543194979896203,0.00719081436576694,0.78477550031201
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.00139934989683317,0.0052416611784485,-0.00887430601292589,0.0116730058065922,0.789499689570797
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00110712247150175,0.00415323810395708,-0.00924746915525763,0.00703322421225413,0.789806415870713
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PI16,Peptidase inhibitor 16,39990,0.000678299267821997,0.00262318600500611,-0.00446314530198998,0.00581974383763397,0.795965215026993
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,39575,-0.0020953254197719,0.00812145177385003,-0.018013370896518,0.0138227200569742,0.796412613078285
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCP11,T-complex protein 11 homolog,39757,-0.00162137557142164,0.0062868964093945,-0.0139436925338349,0.0107009413909916,0.796490684430044
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,42070,0.000881440933807067,0.00344504493472689,-0.00587084713825764,0.00763372900587177,0.798064701134535
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL3,Interleukin-3,39560,0.00169842915601006,0.00665897933135169,-0.0113531703334393,0.0147500286454594,0.79868271657974
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLGAP5,Disks large-associated protein 5,39934,0.00136639673975836,0.00536933070189649,-0.00915749143595876,0.0118902849154755,0.799128008711858
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAGE2A,G antigen 2A,39560,-0.00179761742969235,0.00710630803251213,-0.0157259811734161,0.0121307463140314,0.800303242387727
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00146391337781118,0.00585363654953644,-0.0129370410149026,0.0100092142592802,0.80252540925971
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.00103692474221619,0.00416214037249826,-0.0071208703878804,0.00919471987231278,0.8032627639952
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDAN1,Codanin-1,39929,0.000554852758478776,0.00237567417949732,-0.00410146863333597,0.00521117415029352,0.815333975182499
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.000755306558133185,0.00324744840820766,-0.00560969232195384,0.00712030543822021,0.816088275086564
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HBZ,Hemoglobin subunit zeta,39958,0.00267011489750955,0.0116749957576488,-0.0202128767874821,0.0255531065825012,0.819103324955286
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXK,Tyrosine-protein kinase TXK,39757,-0.00181945834036247,0.00795948375854474,-0.0174200465071102,0.0137811298263852,0.819191792184812
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HK2,Hexokinase-2,41900,0.00067153479136724,0.00296689800029411,-0.00514358528920922,0.00648665487194369,0.82093860768958
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRTN3,Myeloblastin,41800,-0.00117950440396407,0.00523366821827799,-0.0114374941117889,0.00907848530386079,0.821696036930827
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.00165057231955181,0.00741846634614327,-0.0161907663579926,0.012889621718889,0.823932569668839
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HYAL1,Hyaluronidase-1,42077,0.000542527651574406,0.00250677669778689,-0.0043707546760879,0.00545580997923671,0.828660221392954
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMI,N-myc-interactor,39875,-0.00171089209076156,0.00792360168527841,-0.0172411513939073,0.0138193672123841,0.829051256971563
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.000946178702814754,0.00439952184290362,-0.00767688410927635,0.00956924151490585,0.829721401405534
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPEP2,Dipeptidase 2,42070,-0.000699488515118954,0.00326879183587534,-0.00710632051343462,0.00570734348319671,0.830558153956524
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEPACAM2,HEPACAM family member 2,39929,0.000989028087628067,0.00474790054468003,-0.0083168569799448,0.0102949131552009,0.834991832137264
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL11,Interleukin-11,41913,-0.0013773455745209,0.00662487040800138,-0.0143620915742036,0.0116074004251618,0.835306102225561
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBR1,TGF-beta receptor type-1,39657,0.000495062106432038,0.00238986410243269,-0.00418907153433604,0.00517919574720012,0.835895954798343
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,0.000672350943504154,0.00326106334679446,-0.00571933321621298,0.00706403510322129,0.83665762929048
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP2BP,LRP2-binding protein,39649,-0.00169808484453926,0.00845016911702324,-0.0182604163139048,0.0148642466248263,0.840739207910831
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.00100538276076928,0.00506652498746042,-0.00892500621465313,0.0109357717361917,0.842707349745399
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEZ6,Seizure protein 6 homolog,39649,0.000671493160996173,0.0034053729941654,-0.006003037907568,0.00734602422956035,0.843685318415767
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PYDC1,Pyrin domain-containing protein 1,39638,0.000881551636477402,0.00448538405140256,-0.00790980110427161,0.00967290437722641,0.844192148361398
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRX,Cone-rod homeobox protein,41900,0.00222689237257659,0.0116882928044951,-0.0206821615242338,0.025135946269387,0.848901977508859
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,0.000679110584106592,0.0035649450821719,-0.00630818177695033,0.00766640294516352,0.848923384041232
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL20,Interleukin-20,41913,-0.000960783680383491,0.00507350598185101,-0.0109048554048115,0.00898328804404448,0.849803582656926
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,0.000496197737706607,0.00262436596610211,-0.00464755955585353,0.00563995503126674,0.850038692028708
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HBQ1,Hemoglobin subunit theta-1,42262,-0.00124348107390733,0.00668107054717774,-0.0143383793463757,0.011851417198561,0.852353395216728
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,0.000746255600673835,0.00403864153535123,-0.00716948180861457,0.00866199300996224,0.853405843869144
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.00333307265402966,0.0180531546803796,-0.0387172558275737,0.0320511105195143,0.853526090467901
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.00136172652019764,0.00741589656021414,-0.0158968837782174,0.0131734307378221,0.854312891449265
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.000803444204203889,0.00458489647576159,-0.00818295288828882,0.0097898412966966,0.860896472237991
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCIN,Adseverin,39586,0.00136335194749325,0.00802428015034038,-0.0143642371471739,0.0170909410421604,0.865089287829708
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,-0.000934272302386942,0.00551934222985341,-0.0117521830728996,0.00988363846812574,0.865585504401721
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP350,Centrosome-associated protein 350,39560,0.000670880364270167,0.00397464778979965,-0.00711942930373716,0.00846119003227749,0.865965025389685
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPGN,Epigen,39919,-0.000772181034673861,0.00503440970583917,-0.0106396240581186,0.00909526198877091,0.878100837317528
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP15,Matrix metalloproteinase-15,39958,0.000796765152197955,0.0052881285126153,-0.00956796673252804,0.011161497036924,0.880238293097707
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,-0.000789747697226022,0.00526047850162634,-0.0111002855604137,0.00952079016596161,0.880666005042258
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB7,Integrin beta-7,42262,0.000729681655702533,0.00501329866259364,-0.00909638372298101,0.0105557470343861,0.884279413277615
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00124601144917176,0.00870283630689277,-0.0183035706106816,0.0158115477123381,0.88615611433284
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.000531537020565214,0.00372002510345857,-0.00782278622334402,0.00675971218221359,0.886382880540154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.000728801712986206,0.00531271460699287,-0.00968411891671982,0.0111417223426922,0.890890508809882
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,-0.000614107804838118,0.00449710475060625,-0.00942843311602637,0.00820021750635014,0.89138405431272
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM171A2,Protein FAM171A2,39934,-0.00224206686283258,0.0169703989705978,-0.0355040488452043,0.0310199151195391,0.894894623325937
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFNB2,Ephrin-B2,39649,-0.000792098644261219,0.00629131433824017,-0.0131230747472119,0.0115388774586895,0.89981058407122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.000871870951048891,0.00700596006265853,-0.0146035526738596,0.0128598107717618,0.900963598759528
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSL4,Early placenta insulin-like peptide,39919,0.000641613038812714,0.0052328700392473,-0.009614812238112,0.0108980383157374,0.902416471175113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.000639129019439122,0.00561473596307625,-0.0116440115070686,0.0103657534681903,0.909374173297421
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NLGN1,Neuroligin-1,39649,-0.000767283645926547,0.00730521463116799,-0.0150855043230158,0.0135509370311627,0.916352068875803
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCN15,Lipocalin-15,39934,-0.000675876121218031,0.00658977519159734,-0.0135918354967488,0.0122400832543128,0.918310539127114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRNN,Cornulin,41749,-0.00074979400823112,0.00732234048379865,-0.0151015813564765,0.0136019933400142,0.91844222552205
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,39657,-0.000455390584380529,0.00455732828015502,-0.00938775401348436,0.0084769728447233,0.92040575748399
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,42119,-0.000459988263105856,0.00466801038916189,-0.00960928862586317,0.00868931209965145,0.921504543500522
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EVPL,Envoplakin,39757,-0.000356561860987506,0.00362964377072319,-0.00747066365160496,0.00675753992962995,0.921746623147474
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,-0.000456572865811864,0.00499455898571544,-0.0102459084778141,0.0093327627461904,0.927165213544778
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA3,Carbonic anhydrase 3,42287,-0.000574019220702533,0.00638888214642447,-0.0130962282276945,0.0119481897862894,0.928410445778664
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,-0.000248598975146618,0.00279015234678279,-0.00571729757484089,0.00522009962454765,0.929005036741463
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TET2,Methylcytosine dioxygenase TET2,39750,-0.000946263754085034,0.0109200455755051,-0.022349553082075,0.020457025573905,0.930948233985188
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.000608080575843467,0.00709989116418395,-0.014523867257644,0.0133077061059571,0.931748997686105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.000397233530767914,0.00492751519000611,-0.0100551633031799,0.00926069624164407,0.935749299549721
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,0.000492231430350067,0.00629278826817581,-0.0118416335752745,0.0128260964359747,0.937653000690349
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNL2,Interferon lambda-2,39586,0.000441445401940212,0.00636550017620751,-0.0120349349434265,0.0129178257473069,0.944712543935129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,41843,-0.000349232457859967,0.0052389436162247,-0.0106175619456604,0.00991909702994044,0.94685270487127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.000384352984635379,0.00588969093270354,-0.0119281472127343,0.0111594412434636,0.947969284236206
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL25,Interleukin-25,39510,-0.000241743365878075,0.00373616669114055,-0.00756463008051356,0.00708114334875741,0.948411196653311
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENO1,Alpha-enolase,42119,0.000532101446646163,0.00854794851835018,-0.0162218776493202,0.0172860805426125,0.95036544343593
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZPR1,Zinc finger protein ZPR1,39586,-0.000576689804363136,0.0104794362819397,-0.021116384916965,0.0199630053082387,0.956115075628874
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAGLN3,Transgelin-3,39560,0.000358659669731878,0.00652541975355829,-0.0124311630472424,0.0131484823867061,0.956168573588049
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",39575,-0.000240893042650095,0.00438810574583098,-0.00884158030447882,0.00835979421917862,0.956221666138735
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHIT1,Chitotriosidase-1,42207,0.000931865953248914,0.0170318622905219,-0.0324505841361741,0.0343143160426719,0.956367837430674
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,0.000338291015837648,0.00639738135442422,-0.0122005764388338,0.0128771584705091,0.957828793874767
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,42262,-0.000286167734568262,0.00577059495280572,-0.0115965338420675,0.011024198372931,0.960449297758819
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,0.00025982607759293,0.00549044680946543,-0.0105014496689593,0.0110211018241452,0.962256416887633
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SKIV2L,Helicase SKI2W,39575,0.000198701927619348,0.00430115491127634,-0.00823156169848228,0.00862896555372098,0.963153800924483
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAD1,Glutamate decarboxylase 1,39560,0.000127035946373839,0.0028634973303908,-0.00548541882119213,0.0057394907139398,0.964615134789195
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK12,Kallikrein-12,41843,0.000567247340052842,0.0145140589584863,-0.0278803082185803,0.029014802898686,0.968825112824355
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLINT1,Clathrin interactor 1,39560,0.000198813024267443,0.00543381543061513,-0.0104514652197382,0.0108490912682731,0.970814092191138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF12,Fibroblast growth factor 12,39657,-0.000174029239027438,0.00492854936430659,-0.00983398599306835,0.00948592751501347,0.971832837233767
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPT1,Translationally-controlled tumor protein,41913,0.00024104239942853,0.00696700630159656,-0.0134142899517007,0.0138963747505578,0.972401053596026
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.000217965470562426,0.00657078870687723,-0.0126607803949169,0.0130967113360418,0.973538015549849
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,0.000103209683489081,0.00328901275077251,-0.00634325530802504,0.0065496746750032,0.974966929610247
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,42217,-8.52533150507943e-05,0.00295942057629754,-0.00588571764459397,0.00571521101449239,0.977018593457847
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,41839,-0.000115354778994779,0.00588441801993665,-0.0116488140980706,0.0114181045400811,0.984360022728147
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,8.09311820571145e-05,0.0047837627180677,-0.00929524374535558,0.00945710610946981,0.986502426829309
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH17,Cadherin-17,42145,-0.000122377914109113,0.00740941161073651,-0.0146448246711527,0.0144000688429344,0.986822542508824
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAX,Integrin alpha-X,39757,-6.92156539510894e-05,0.00561365886364917,-0.0110719870267035,0.0109335557188013,0.990162661078368
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UNC5D,Netrin receptor UNC5D,39657,3.1733765877738e-05,0.00283871542885752,-0.005532148474683,0.00559561600643847,0.991080901690777
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,2.58294773676412e-05,0.00364815690178551,-0.00712455805013195,0.00717621700486723,0.994351038215155
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP73,Tumor protein p73,39649,-2.44450855729846e-05,0.00372680067655968,-0.00732897441162996,0.00728008424048399,0.994766617031317
